<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Cognitive behavioural therapy (group) for schizophrenia - Guaiana, G - 2022 | Cochrane Library</title> <meta content="Cognitive behavioural therapy (group) for schizophrenia - Guaiana, G - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009608.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Cognitive behavioural therapy (group) for schizophrenia - Guaiana, G - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009608.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009608.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Cognitive behavioural therapy (group) for schizophrenia" name="citation_title"/> <meta content="Giuseppe Guaiana" name="citation_author"/> <meta content="Western University" name="citation_author_institution"/> <meta content="giuseppe.guaiana@gmail.com" name="citation_author_email"/> <meta content="Massimiliano Abbatecola" name="citation_author"/> <meta content="CEPICC Napoli" name="citation_author_institution"/> <meta content="Ghazaleh Aali" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="Federica Tarantino" name="citation_author"/> <meta content="CEPICC Napoli" name="citation_author_institution"/> <meta content="Ikenna D Ebuenyi" name="citation_author"/> <meta content="Valeria Lucarini" name="citation_author"/> <meta content="Université de Paris" name="citation_author_institution"/> <meta content="Wei Li" name="citation_author"/> <meta content="Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine" name="citation_author_institution"/> <meta content="Caidi Zhang" name="citation_author"/> <meta content="Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine" name="citation_author_institution"/> <meta content="Antonio Pinto" name="citation_author"/> <meta content="SITCC/EABCT" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD009608.pub2" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/07/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009608.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009608.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009608.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Cognitive Behavioral Therapy [methods]; Hallucinations [etiology, therapy]; *Psychotic Disorders [therapy]; Quality of Life; *Schizophrenia [drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009608.pub2&amp;doi=10.1002/14651858.CD009608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="tkZQC4GK";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009608\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009608\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","pt","ms","ja","hr","fa","pl","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009608.pub2",title:"Cognitive behavioural therapy (group) for schizophrenia",firstPublishedDate:"Jul 12, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Schizophrenia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=tkZQC4GK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009608.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009608.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009608.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009608.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009608.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009608.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009608.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009608.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009608.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009608.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>9979 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009608.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-sec-0205"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-sec-0090"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-sec-0186"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/supinfo/CD009608StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/supinfo/CD009608StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Cognitive behavioural therapy (group) for schizophrenia</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information#CD009608-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Giuseppe Guaiana</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information#CD009608-cr-0005">Massimiliano Abbatecola</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information#CD009608-cr-0006">Ghazaleh Aali</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information#CD009608-cr-0007">Federica Tarantino</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information#CD009608-cr-0008">Ikenna D Ebuenyi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information#CD009608-cr-0009">Valeria Lucarini</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information#CD009608-cr-0010">Wei Li</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information#CD009608-cr-0011">Caidi Zhang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information#CD009608-cr-0012">Antonio Pinto</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information/en#CD009608-sec-0219">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 July 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009608.pub2">https://doi.org/10.1002/14651858.CD009608.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009608-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009608-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009608-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009608-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009608-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009608-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD009608-abs-0006">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009608-abs-0001" lang="en"> <section id="CD009608-sec-0001"> <h3 class="title" id="CD009608-sec-0001">Background</h3> <p>Schizophrenia is a disabling psychotic disorder characterised by positive symptoms of delusions, hallucinations, disorganised speech and behaviour; and negative symptoms such as affective flattening and lack of motivation. Cognitive behavioural therapy (CBT) is a psychological intervention that aims to change the way in which a person interprets and evaluates their experiences, helping them to identify and link feelings and patterns of thinking that underpin distress. CBT models targeting symptoms of psychosis (CBTp) have been developed for many mental health conditions including schizophrenia. CBTp has been suggested as a useful add‐on therapy to medication for people with schizophrenia. While CBT for people with schizophrenia was mainly developed as an individual treatment, it is expensive and a group approach may be more cost‐effective. Group CBTp can be defined as a group intervention targeting psychotic symptoms, based on the cognitive behavioural model. In group CBTp, people work collaboratively on coping with distressing hallucinations, analysing evidence for their delusions, and developing problem‐solving and social skills. However, the evidence for effectiveness is far from conclusive. </p> </section> <section id="CD009608-sec-0002"> <h3 class="title" id="CD009608-sec-0002">Objectives</h3> <p>To investigate efficacy and acceptability of group CBT applied to psychosis compared with standard care or other psychosocial interventions, for people with schizophrenia or schizoaffective disorder. </p> </section> <section id="CD009608-sec-0003"> <h3 class="title" id="CD009608-sec-0003">Search methods</h3> <p>On 10 February 2021, we searched the Cochrane Schizophrenia Group's Study‐Based Register of Trials, which is based on CENTRAL, MEDLINE, Embase, four other databases and two trials registries. We handsearched the reference lists of relevant papers and previous systematic reviews and contacted experts in the field for supplemental data. </p> </section> <section id="CD009608-sec-0004"> <h3 class="title" id="CD009608-sec-0004">Selection criteria</h3> <p>We selected randomised controlled trials allocating adults with schizophrenia to receive either group CBT for schizophrenia, compared with standard care, or any other psychosocial intervention (group or individual). </p> </section> <section id="CD009608-sec-0005"> <h3 class="title" id="CD009608-sec-0005">Data collection and analysis</h3> <p>We complied with Cochrane recommended standard of conduct for data screening and collection. Where possible, we calculated risk ratio (RR) and 95% confidence interval (CI) for binary data and mean difference (MD) and 95% CI for continuous data. We used a random‐effects model for analyses. We assessed risk of bias for included studies and created a summary of findings table using GRADE. </p> </section> <section id="CD009608-sec-0006"> <h3 class="title" id="CD009608-sec-0006">Main results</h3> <p>The review includes 24 studies (1900 participants). All studies compared group CBTp with treatments that a person with schizophrenia would normally receive in a standard mental health service (standard care) or any other psychosocial intervention (group or individual). None of the studies compared group CBTp with individual CBTp. Overall risk of bias within the trials was moderate to low. </p> <p>We found no studies reporting data for our primary outcome of clinically important change. With regard to numbers of participants leaving the study early, group CBTp has little or no effect compared to standard care or other psychosocial interventions (RR 1.22, 95% CI 0.94 to 1.59; studies = 13, participants = 1267; I<sup>2</sup> = 9%; low‐certainty evidence). Group CBTp may have some advantage over standard care or other psychosocial interventions for overall mental state at the end of treatment for endpoint scores on the Positive and Negative Syndrome Scale (PANSS) total (MD –3.73, 95% CI –4.63 to –2.83; studies = 12, participants = 1036; I<sup>2</sup> = 5%; low‐certainty evidence). Group CBTp seems to have little or no effect on PANSS positive symptoms (MD –0.45, 95% CI –1.30 to 0.40; studies =8, participants = 539; I<sup>2</sup> = 0%) and on PANSS negative symptoms scores at the end of treatment (MD –0.73, 95% CI –1.68 to 0.21; studies = 9, participants = 768; I<sup>2</sup> = 65%). Group CBTp seems to have an advantage over standard care or other psychosocial interventions on global functioning measured by Global Assessment of Functioning (GAF; MD –3.61, 95% CI –6.37 to –0.84; studies = 5, participants = 254; I<sup>2</sup> = 0%; moderate‐certainty evidence), Personal and Social Performance Scale (PSP; MD 3.30, 95% CI 2.00 to 4.60; studies = 1, participants = 100), and Social Disability Screening Schedule (SDSS; MD –1.27, 95% CI –2.46 to –0.08; studies = 1, participants = 116). Service use data were equivocal with no real differences between treatment groups for number of participants hospitalised (RR 0.78, 95% CI 0.38 to 1.60; studies = 3, participants = 235; I<sup>2</sup> = 34%). There was no clear difference between group CBTp and standard care or other psychosocial interventions endpoint scores on depression and quality of life outcomes, except for quality of life measured by World Health Organization Quality of Life Assessment Instrument (WHOQOL‐BREF) Psychological domain subscale (MD –4.64, 95% CI –9.04 to –0.24; studies = 2, participants = 132; I<sup>2</sup> = 77%). The studies did not report relapse or adverse effects. </p> </section> <section id="CD009608-sec-0007"> <h3 class="title" id="CD009608-sec-0007">Authors' conclusions</h3> <p>Group CBTp appears to be no better or worse than standard care or other psychosocial interventions for people with schizophrenia in terms of leaving the study early, service use and general quality of life. Group CBTp seems to be more effective than standard care or other psychosocial interventions on overall mental state and global functioning scores. These results may not be widely applicable as each study had a low sample size. Therefore, no firm conclusions concerning the efficacy of group CBTp for people with schizophrenia can currently be made. More high‐quality research, reporting useable and relevant data is needed. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009608-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009608-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009608-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009608-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009608-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009608-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD009608-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD009608-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009608-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD009608-abs-0013">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD009608-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD009608-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009608-abs-0002" lang="en"> <h3>Group cognitive behavioural therapy for schizophrenia</h3> <p><b>Review question</b> </p> <p>Is group cognitive behavioural therapy (talking therapy) that targets psychoses (CBTp) more effective than standard care (the care a person would normally receive) or other forms of talking therapies (for example, counselling, supportive therapy; either group or individual) for people with schizophrenia? </p> <p><b>What is schizophrenia?</b> </p> <p>Schizophrenia is a disabling serious mental illness. It is characterised by delusions (bizarre beliefs), hallucinations (seeing or hearing things that are not there), negative symptoms (social withdrawal, apathy) and disorganised behaviour. Medications known as antipsychotics are the main treatment but are not always very effective at helping with the negative symptoms of schizophrenia. CBTp has been suggested as a useful add‐on treatment to medication for people with mental illness, but evidence for its effectiveness for people with schizophrenia is uncertain. CBTp is usually an individual therapy but can also be delivered to a group of people, which may be more cost‐effective. It is important to find out if group CBTp for people with schizophrenia is effective and acceptable. </p> <p><b>What did we do?</b> </p> <p>The Information Specialist of Cochrane Schizophrenia ran an electronic search of their specialised register up to 10 February 2021 for clinical trials that randomised group CBTp versus standard care or other psychosocial therapies (either group or individual) in people with schizophrenia. </p> <p><b>What did we find?</b> </p> <p>We found 24 studies involving 1900 participants that met the review requirements and provided usable data. All studies compared group CBTp with standard care. Our evidence suggests there is no substantial difference between group CBTp and standard care or other psychosocial interventions in terms of numbers of participants leaving the study early. Group CBTp may be better than standard care or other psychosocial interventions for overall mental state for total symptoms of schizophrenia. Group CBTp seems to show no difference on positive and negative symptoms of schizophrenia compared to standard care or other psychosocial interventions. Group CBTp seems to be better than standard care or other psychosocial interventions on global functioning. There were no real differences between treatment groups for number of participants hospitalised for group CBTp compared to standard care or other psychosocial interventions.  </p> <p><b>Conclusions</b> </p> <p>Group CBTp seems to be better than standard care or other psychosocial interventions on total symptoms of schizophrenia and global functioning. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>Studies with larger sample sizes and low risk of bias should be conducted. Longer‐term outcomes need to be addressed to establish whether any effect is transient or long‐lasting. Trials should improve their quality of data reporting. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009608-sec-0205" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009608-sec-0205">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009608-sec-0432">Deutsch</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009608-sec-0205"></div> <h3 class="title" id="CD009608-sec-0206">Implications for practice</h3> <section id="CD009608-sec-0206"> <section id="CD009608-sec-0207"> <h5 class="title">1. For people with schizophrenia</h5> <p>There was no clear difference between cognitive behavioural therapy targeting symptoms of psychosis (CBTp) and standard care and other psychosocial interventions for numbers of participants leaving the study early (dropouts). </p> <p>Based on the limited data available, group CBTp seem not to differ from standard care and other psychosocial interventions in effectiveness regarding outcomes on delusions, hallucinations, other positive symptoms or negative symptoms, and social functioning. </p> <p>There is some very limited evidence that group CBT may have some efficacy in positive symptoms, but this is based on a limited number of studies. </p> </section> <section id="CD009608-sec-0208"> <h5 class="title">2. For clinicians</h5> <p>The data from this meta‐analysis do not allow us to draw firm conclusions on whether group CBTp can be useful in the treatment for schizophrenia. However, we will try to discuss some tentative implications for practice stemming from this review. </p> <p>Another aspect we would like to discuss is the relationship between group and individual CBTp. Does group CBTp need to be supplemented with individual CBTp? We consider that in order for group CBTp to work, patients need to create an identity within the group and learn from interaction with other group members. However, this may be difficult due to the nature of schizophrenia, an illness where social cognition may be impaired (<a href="./references#CD009608-bbs2-0156" title="KurtzMM , GagenE , RochaNB , MachadoS , PennDL . Comprehensive treatments for social cognitive deficits in schizophrenia: a critical review and effect-size analysis of controlled studies. Clinical Psychology Review2016;43:80-9.">Kurtz 2016</a>). Some form of preparation to group work with individual CBTp may be necessary. Otherwise, it may be difficult to differentiate group CBTp from the aspecific factors associated with control groups. The main author of one of the included studies mentions that individual CBTp has advantages that may not be reachable in a group (<a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a>). One of these advantages is flexibility to respond to a wide range of symptoms (<a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a>). Moreover, another relevant aspect of individual therapy is that it allows a patient to more easily overcome suspiciousness that is linked to theory of mind deficits; it can also be better suited to create a solid therapeutic alliance, which should necessarily come before the technical CBTp intervention. Therapeutic alliance cannot be based on simply explaining a model to a group of people (<a href="./references#CD009608-bbs2-0181" title="PintoA , TurkingtonG , KingdonD . Cognitive behaviour therapy for psychosis: enhancing the therapeutic relationship to improve the quality of life. In: Cognitive Behaviour Therapy: a Guide for the Practising Clinician, Volume 2. London (UK): Routledge, 2008.">Pinto 2008</a>). Individual therapy can prepare patients for the group. To our understanding, no study has included individual therapy sessions before the group intervention. This may be a possible reason why there were minimal differences in our review between group CBTp and control groups (<a href="./references#CD009608-bbs2-0181" title="PintoA , TurkingtonG , KingdonD . Cognitive behaviour therapy for psychosis: enhancing the therapeutic relationship to improve the quality of life. In: Cognitive Behaviour Therapy: a Guide for the Practising Clinician, Volume 2. London (UK): Routledge, 2008.">Pinto 2008</a>). </p> <p>Group homogeneity can also be a very important factor. In one of the studies we included, Wykes and co‐authors say: "Group CBT treatments may … only be effective if there is some homogeneity of experience to share within the group" (<a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a>). Schizophrenia can present in several ways. For example, there are people with schizophrenia who are distressed by unpleasant auditory hallucinations, while others may be struggling with delusional thinking. It may not be useful to combine different subpopulations in a therapeutic group, as they may not relate to each other's experience thus decreasing the efficacy of the group CBTp. In this case, it may be helpful to screen patients before group CBTp and try to create groups that are as homogeneous as possible in terms of symptomatology or social functioning (or both). Maybe one of the reasons for small effect size is that the patients have been included in a group without individual screening of symptoms and functions. </p> <p>Finally, the length of treatment should also be carefully considered. Only some studies included in this review had a length of treatment of 24 weeks or more. Other studies included in our review treated patients for less than eight weeks. For example, treatments for other severe and chronic mental disorders such as dialectical behaviour therapy for borderline personality disorder can last for 13 to 14 months (<a href="./references#CD009608-bbs2-0126" title="DimeffLA , KoernerK . Dialectical Behavior Therapy in Clinical Practice: Applications Across Disorders and Settings. New York (NY): Guilford Press, 2007.">Dimeff 2007</a>). Other psychosocial interventions for schizophrenia, such as family interventions, last for more than 24 weeks (<a href="./references#CD009608-bbs2-0120" title="BurlingameGM , SvienH , HoppeL , HuntI , RosendahlJ . Group therapy for schizophrenia: a meta-analysis. Psychotherapy (Chicago, Ill.)2020;57:219-36.">Burlingame 2020</a>). Given the chronic nature of schizophrenia (<a href="./references#CD009608-bbs2-0198" title="vanOsJ , KapurS . Schizophrenia. Lancet2009;374:635-45.">van Os 2009</a>), we consider that it is reasonable to consider the possibility of a group CBTp length of treatment of one year or more. </p> </section> <section id="CD009608-sec-0209"> <h5 class="title">3. For managers and policy makers</h5> <p>In terms of planning for resources, group CBTp may not be used yet as a standard care for people with schizophrenia. Since the studies were characterised by a high risk of bias and a low‐ to moderate‐certainty evidence, it may be possible that the studies were underpowered to detect a difference. </p> </section> </section> <h3 class="title" id="CD009608-sec-0210">Implications for research</h3> <section id="CD009608-sec-0210"> <section id="CD009608-sec-0211"> <h5 class="title">1. General</h5> <p>We consider that consistently following the <a href="http://www.consort-statement.org/" target="_blank">CONSORT</a> guidance for reporting of clinical trials would help increase the quality of data available in this review (<a href="./references#CD009608-bbs2-0171" title="MoherD , SchulzKF , AltmanDG . The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Medical Research Methodology2001;1:2.">Moher 2001</a>). </p> </section> <section id="CD009608-sec-0212"> <h5 class="title">2. Specific</h5> <section id="CD009608-sec-0213"> <h6 class="title">2.1 Reviews</h6> <p>It will be advisable that quality of studies is improved by increasing the sample size and better reporting of results.  </p> </section> <section id="CD009608-sec-0214"> <h6 class="title">2.2 Trials</h6> <p>Future studies should aim to employ a blind rater for outcome assessment. Since blinding of participants and personnel is not possible in group CBTp studies, at least the raters should be masked. </p> <p>Studies should consider clinically important change, shown as improved (as defined by individual studies) as a primary outcome. </p> <p>Studies should also explicitly try to include a more homogeneous population within people with schizophrenia (e.g. including people with mainly auditory hallucinations or mainly paranoid delusions). This may allow better understanding on the effect of CBTp on the various symptoms. Social functioning should consistently be included as an outcome measure so that it will be possible to fully assess the effect of CBTp. </p> <p>Given the current limitations in the literature, we propose a design for a new randomised trial (see <a href="#CD009608-tbl-0006">Table 5</a>). What is also very important in the proposed future trials is that all outcomes are fully reported. </p> </section> </section> </section> <div class="table" id="CD009608-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Design of a future study</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Methods</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allocation: randomised (clearly described)</p> <p>Blinding: single‐blind (outcome assessors blinded to treatment)</p> <p>Duration: up to 52 weeks</p> <p>Design: parallel</p> <p>Setting: anywhere</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Participants</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis: schizophrenia or schizoaffective disorder</p> <p>n = 100</p> <p>Age: any</p> <p>Gender: males and females</p> <p>Inclusion criteria: standardised diagnostic criteria for schizophrenia or schizoaffective disorder </p> <p>Exclusion criteria: specific contraindication to evaluated treatments</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Interventions</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Group CBTp</p> <p>2. Standard care</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcomes</p> <p>1. Global state</p> <p>1.1 Clinically important change (as defined by individual studies)</p> <p>Secondary outcomes</p> <p>1. Leaving the study early</p> <p>1.1 For any reason</p> <p>1.2 For specific reason</p> <p>2. Mental state</p> <p>2.1 Clinically important change overall mental state – as defined by individual studies</p> <p>2.2 Relapse</p> <p>2.3 Average endpoint or change score, or both, on mental state scales</p> <p>2.4 Average endpoint or change scores, or both, on positive or negative symptom scales, or both </p> <p>2.5 Specific clinically important change in positive or negative symptoms, or both, – as defined by individual studies </p> <p>3. Adverse effects/events</p> <p>3.1 Incidence of clinically important depression/anxiety and psychotic symptoms</p> <p>3.2 Average endpoint and change scores on adverse effect scales</p> <p>3.3 Death: suicide or natural causes</p> <p>4. Service utilisation outcomes</p> <p>4.1 Hospital admission</p> <p>4.2 Days in hospital</p> <p>5. Quality of life</p> <p>5.1 Clinically important change – as defined by each of the studies</p> <p>5.2 General Impression of carer/rater or family member</p> <p>6. Social functioning</p> <p>6.1 Average endpoint or change score, or both, on social skills/functioning scales</p> <p>6.2 Occupational status</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CBTp: cognitive behavioural therapy model targeting symptoms of psychosis.</p> </div> </div> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009608-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009608-sec-0008"></div> <div class="table" id="CD009608-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Group cognitive behavioural therapy for psychosis compared to standard care for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Group cognitive behavioural therapy compared to standard care and other psychosocial interventions for schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with schizophrenia <br/><b>Setting:</b> inpatient and outpatient <br/><b>Intervention:</b> group cognitive behavioural therapy<br/><b>Comparison:</b> standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with standard care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with group cognitive behavioural therapy for psychosis</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinically important change</b>, shown as improved – as defined by individual studies </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> —</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>— </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> —</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Relapse</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Leaving the study early: for any reason</b> – end of treatment </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.22</b><br/>(0.94 to 1.59) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1267<br/>(13 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>155 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>195 per 1000<br/>(144 to 259) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: overall:</b> average endpoint score – end of treatment (PANSS total) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean mental state: overall: average endpoint score – end of treatment (PANSS total) was 0 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 3.73 lower</b><br/>(4.63 lower to 2.83 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1036<br/>(12 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Days in hospital</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life: clinically important change –</b> as defined by individual studies. </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Functioning: overall: global assessment of functioning</b> – average endpoint score – end of treatment (GAF) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functioning: overall: global assessment of functioning – average endpoint score – end of treatment (GAF) was 0 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 3.61 lower</b><br/>(6.37 lower to 0.84 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>GAF:</b> Global Assessment of Functioning; <b>MD:</b> mean difference; <b>PANSS:</b> Positive and Negative Syndrome Scale; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of performance bias for all studies and unclear selection bias for most studies.<br/><sup>b</sup>Downgraded one level due to imprecision: confidence interval ranged from no difference to appreciable benefit with standard care.<br/><sup>c</sup>Downgraded publication bias domain one level as the funnel plot on PANSS total outcome (<a href="./full#CD009608-fig-0001">Figure 1</a>) was asymmetrical, increasing the risk for publication bias. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="figure" id="CD009608-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Mental state: overall: average endpoint score – end of treatment (PANSS total, high = poor)." data-id="CD009608-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Mental state: overall: average endpoint score – end of treatment (PANSS total, high = poor). </p> </div> </div> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009608-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009608-sec-0009">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009608-sec-0236">Deutsch</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD009608-sec-0009"></div> <section id="CD009608-sec-0010"> <h3 class="title" id="CD009608-sec-0010">Description of the condition</h3> <p>Schizophrenia is a disabling psychotic disorder with a point prevalence of between 2.8 and 4.5 per 1000 population (<a href="./references#CD009608-bbs2-0122" title="CharlsonFJ , FerrariAJ , SantomauroDF , DiminicS , StockingsE , ScottJG , et al. Global epidemiology and burden of schizophrenia: findings from the Global Burden of Disease Study 2016. Schizophrenia Bulletin2018;44:1195-203.">Charlson 2018</a>; <a href="./references#CD009608-bbs2-0193" title='TandonR , KeshavanMS , NasrallahHA . Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophrenia Research2008;102:1-18.'>Tandon 2008</a>), and an annual incidence of 15 per 100,000 (<a href="./references#CD009608-bbs2-0146" title="JauharS , JohnstoneM , McKennaPJ . Schizophrenia. Lancet2022;399:473-86.">Jauhar 2022</a>; <a href="./references#CD009608-bbs2-0193" title='TandonR , KeshavanMS , NasrallahHA . Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophrenia Research2008;102:1-18.'>Tandon 2008</a>). It is characterised by delusions, hallucinations, negative symptoms and disorganised behaviour (<a href="./references#CD009608-bbs2-0111" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th edition. Washington (DC): American Psychiatric Press, 2013.">APA 2013</a>). Although prognosis can be debilitating for some people with a reduction in life expectancy (<a href="./references#CD009608-bbs2-0169" title="McCutcheonRA , Reis MarquesT , HowesOD . Schizophrenia – an overview. JAMA Psychiatry2020;77:201-10.">McCutcheon 2020</a>), it is possible to achieve recovery (<a href="./references#CD009608-bbs2-0198" title="vanOsJ , KapurS . Schizophrenia. Lancet2009;374:635-45.">van Os 2009</a>). Medication remains the mainstay of treatment (<a href="./references#CD009608-bbs2-0169" title="McCutcheonRA , Reis MarquesT , HowesOD . Schizophrenia – an overview. JAMA Psychiatry2020;77:201-10.">McCutcheon 2020</a>; <a href="./references#CD009608-bbs2-0198" title="vanOsJ , KapurS . Schizophrenia. Lancet2009;374:635-45.">van Os 2009</a>). However, not all patients respond well to medication and a significant number remain symptomatic (<a href="./references#CD009608-bbs2-0169" title="McCutcheonRA , Reis MarquesT , HowesOD . Schizophrenia – an overview. JAMA Psychiatry2020;77:201-10.">McCutcheon 2020</a>; <a href="./references#CD009608-bbs2-0176" title="MueserKT , McGurkSR . Schizophrenia. Lancet2004;362:2063-72.">Mueser 2004</a>). Cognitive behavioural therapy (CBT) has been suggested as a useful add‐on to medication, particularly for those who show active symptoms (<a href="./references#CD009608-bbs2-0116" title="BighelliI , SalantiG , HuhnM , Schneider-ThomaJ , KrauseM , ReitmeirC , et al. Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis. World Psychiatry2018;17:316-29.">Bighelli 2018</a>; <a href="./references#CD009608-bbs2-0158" title="LawsKR , DarlingtonN , KondelTK , McKennaPJ , JauharS . Cognitive behavioural therapy for schizophrenia – outcomes for functioning, distress and quality of life: a meta-analysis. BMC Psychology2018;6:32.">Laws 2018</a>; <a href="./references#CD009608-bbs2-0195" title="TurkingtonD , DudleyR , WarmanDM , BeckAT . Cognitive-behavioural therapy for schizophrenia: a review. Journal of Lifelong Learning in Psychiatry2006;2:223-33.">Turkington 2006</a>). However, the evidence is far from conclusive (<a href="./references#CD009608-bbs2-0147" title="JonesC , CormacI , Silveira da Mota NetoJI , CampbellC . Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews2004, Issue 4. Art. No: CD000524. [DOI: 10.1002/14651858.CD000524.pub2]">Jones 2004</a>; <a href="./references#CD009608-bbs2-0158" title="LawsKR , DarlingtonN , KondelTK , McKennaPJ , JauharS . Cognitive behavioural therapy for schizophrenia – outcomes for functioning, distress and quality of life: a meta-analysis. BMC Psychology2018;6:32.">Laws 2018</a>). The National Institute for Health and Care Excellence (NICE) in the UK has nevertheless recommended that CBT should be offered to all people with schizophrenia (<a href="./references#CD009608-bbs2-0178" title="National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults: Treatment and Management. London (UK): National Institute for Health and Care Excellence, 2014.">NICE 2014</a>). </p> </section> <section id="CD009608-sec-0011"> <h3 class="title" id="CD009608-sec-0011">Description of the intervention</h3> <p>CBT is a short‐term, problem‐focused, psychological intervention (<a href="./references#CD009608-bbs2-0205" title="WilliamsCJ , GarlandE . A cognitive-behavioural therapy assessment model for use in everyday clinical practice. Advances in Psychiatric Treatment2002;8:172-9.">Williams 2002</a>), based on the cognitive model. This model was created by Aaron Beck, and was originally developed for depression (<a href="./references#CD009608-bbs2-0113" title="BeckAT , RushA , ShawB , EmeryG . Cognitive Therapy of Depression. New York (NY): Guilford Press, 1979.">Beck 1979</a>). It is based on the principle that psychological symptoms are linked to maladaptive patterns of thinking which, in turn, influence behaviours and emotions (<a href="./references#CD009608-bbs2-0113" title="BeckAT , RushA , ShawB , EmeryG . Cognitive Therapy of Depression. New York (NY): Guilford Press, 1979.">Beck 1979</a>). CBT is a structured, problem‐oriented approach (<a href="./references#CD009608-bbs2-0153" title="KingdonD , TurkingtonD . Cognitive behaviour therapy of schizophrenia. In: WykesT , TarrierN , LewisS , editors(s). Outcome and Innovation in Psychological Treatment of Schizophrenia. Bridgewater (NJ): Wiley, 1998.">Kingdon 1998</a>; <a href="./references#CD009608-bbs2-0192" title="StuartGW . Cognitive behavioural therapy. In: StuartGW , SundeenSJ , editors(s). Principles and Practice of Psychiatric Nursing. 6th edition. London (UK): Mosby, 1998.">Stuart 1998</a>), and is based on collaborative empiricism, which is a goal‐driven process that is discussed and agreed by the clinician and the patient (<a href="./references#CD009608-bbs2-0113" title="BeckAT , RushA , ShawB , EmeryG . Cognitive Therapy of Depression. New York (NY): Guilford Press, 1979.">Beck 1979</a>). Several studies have shown that CBT is one of the most effective forms of treatment for mental health problems (<a href="./references#CD009608-bbs2-0132" title="FordhamB , SugavanamT , EdwardsK , HemmingK , HowickJ , CopseyB , et al. Cognitive-behavioural therapy for a variety of conditions: an overview of systematic reviews and panoramic meta-analysis. Health Technology Assessment2021;25:1-378.">Fordham 2021</a>; <a href="./references#CD009608-bbs2-0179" title="OttoMW , SmitsJA , ReeseHE . Cognitive-behavioural therapy for the treatment of anxiety disorders. Journal of Clinical Psychiatry2004;65:34-41.">Otto 2004</a>). CBT has been suggested as a highly effective method of treatment for a variety of mental health disorders (<a href="./references#CD009608-bbs2-0121" title="ButlerAC , ChapmanJE , FormanEM , BeckAT . The empirical status of cognitive-behavioural therapy: a review of meta-analyses. Clinical Psychology Review2006;26:17-31.">Butler 2006</a>; <a href="./references#CD009608-bbs2-0132" title="FordhamB , SugavanamT , EdwardsK , HemmingK , HowickJ , CopseyB , et al. Cognitive-behavioural therapy for a variety of conditions: an overview of systematic reviews and panoramic meta-analysis. Health Technology Assessment2021;25:1-378.">Fordham 2021</a>). </p> <p>The CBT model targeting symptoms of psychosis (CBTp) was developed in the late 1980s and early 1990s (<a href="./references#CD009608-bbs2-0153" title="KingdonD , TurkingtonD . Cognitive behaviour therapy of schizophrenia. In: WykesT , TarrierN , LewisS , editors(s). Outcome and Innovation in Psychological Treatment of Schizophrenia. Bridgewater (NJ): Wiley, 1998.">Kingdon 1998</a>). Individual studies have shown that cognitive‐based therapies can be used to manage schizophrenia (<a href="./references#CD009608-bbs2-0134" title="GledhillA , LobbanF , SellwoodW . Group CBT for people with schizophrenia: a preliminary evaluation. Behavioural and Cognitive Psychotherapy1998;26:63-76.">Gledhill 1998</a>; <a href="./references#CD009608-bbs2-0207" title="WykesT , ParrAM , LandauS . Group treatment of auditory hallucinations: exploratory study of effectiveness. British Journal of Psychiatry1999;175:180-5.">Wykes 1999</a>), although meta‐analyses show that the evidence is far from conclusive (<a href="./references#CD009608-bbs2-0147" title="JonesC , CormacI , Silveira da Mota NetoJI , CampbellC . Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews2004, Issue 4. Art. No: CD000524. [DOI: 10.1002/14651858.CD000524.pub2]">Jones 2004</a>; <a href="./references#CD009608-bbs2-0150" title="JonesC , HackerD , XiaJ , MeadenA , IrvingCB , ZhaoS , et al. Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia. Cochrane Database of Systematic Reviews2018, Issue 12. Art. No: CD007964. [DOI: 10.1002/14651858.CD007964.pub2]">Jones 2018</a>). <a href="./references#CD009608-bbs2-0150" title="JonesC , HackerD , XiaJ , MeadenA , IrvingCB , ZhaoS , et al. Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia. Cochrane Database of Systematic Reviews2018, Issue 12. Art. No: CD007964. [DOI: 10.1002/14651858.CD007964.pub2]">Jones 2018</a> suggests that CBT for schizophrenia did not reduce relapse and readmission to hospital compared with standard care. However, it did reduce risk of staying in hospital (<a href="./references#CD009608-bbs2-0150" title="JonesC , HackerD , XiaJ , MeadenA , IrvingCB , ZhaoS , et al. Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia. Cochrane Database of Systematic Reviews2018, Issue 12. Art. No: CD007964. [DOI: 10.1002/14651858.CD007964.pub2]">Jones 2018</a>). It may be less effective than other forms of interventions such as mindfulness‐based psychoeducation (<a href="./references#CD009608-bbs2-0170" title="Mc GlanaghyE , TurnerD , DavisGA , SharpeH , DougallN , MorrisP , et al. A network meta-analysis of psychological interventions for schizophrenia and psychosis: impact on symptoms. Schizophrenia Research2021;228:447-59.">Mc Glanaghy 2021</a>). Moreover, it appears that CBT for schizophrenia may be more useful in the short‐term, but less so in the medium‐ to long‐term (<a href="./references#CD009608-bbs2-0147" title="JonesC , CormacI , Silveira da Mota NetoJI , CampbellC . Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews2004, Issue 4. Art. No: CD000524. [DOI: 10.1002/14651858.CD000524.pub2]">Jones 2004</a>; <a href="./references#CD009608-bbs2-0158" title="LawsKR , DarlingtonN , KondelTK , McKennaPJ , JauharS . Cognitive behavioural therapy for schizophrenia – outcomes for functioning, distress and quality of life: a meta-analysis. BMC Psychology2018;6:32.">Laws 2018</a>). One recent meta‐analysis has shown that the effectiveness CBTp has improved for delusion over time (<a href="./references#CD009608-bbs2-0190" title="SitkoK , BewickBM , OwensD , MastersonC . Meta-analysis and meta-regression of cognitive behavioral therapy for psychosis (CBTp) across time: the effectiveness of CBTp has improved for delusions. Schizophrenia Bulletin Open2020;1:sgaa023.">Sitko 2020</a>). </p> <p>While CBT for schizophrenia was mainly developed as an individual treatment (<a href="./references#CD009608-bbs2-0157" title="LawrenceR , BradshawT . Group cognitive behavioral therapy for schizophrenia: a systematic review of the literature. Journal of Psychiatric and Mental Health Nursing2006;13:673-81.">Lawrence 2006</a>; <a href="./references#CD009608-bbs2-0159" title="LecomteT , LeclercC , WykesT . Group CBT for psychosis. Oxford (UK): Oxford University Press, 2016.">Lecomte 2016</a>), there has been some understanding of how a group approach may be more cost‐effective (<a href="./references#CD009608-bbs2-0157" title="LawrenceR , BradshawT . Group cognitive behavioral therapy for schizophrenia: a systematic review of the literature. Journal of Psychiatric and Mental Health Nursing2006;13:673-81.">Lawrence 2006</a>). Group delivery of CBTp is an adaptation to the current method of individual CBTp, to allow groups of people to receive this treatment as a cohort. This model of delivery has the advantage of allowing a greater number of individuals to be treated by a single therapist, which has the potential of reducing costs while maintaining efficacy and allowing greater access to treatment (<a href="./references#CD009608-bbs2-0157" title="LawrenceR , BradshawT . Group cognitive behavioral therapy for schizophrenia: a systematic review of the literature. Journal of Psychiatric and Mental Health Nursing2006;13:673-81.">Lawrence 2006</a>; <a href="./references#CD009608-bbs2-0159" title="LecomteT , LeclercC , WykesT . Group CBT for psychosis. Oxford (UK): Oxford University Press, 2016.">Lecomte 2016</a>). Other studies suggest that group CBTp has a positive impact on people with schizophrenia (<a href="./references#CD009608-bbs2-0207" title="WykesT , ParrAM , LandauS . Group treatment of auditory hallucinations: exploratory study of effectiveness. British Journal of Psychiatry1999;175:180-5.">Wykes 1999</a>). In contrast, <a href="./references#CD009608-bbs2-0112" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive-behavioural therapy for schizophrenia: randomised controlled trial. British Journal of Psychiatry2006;189:527-32.">Barraclough 2006</a> concluded that group CBTp is effective for reducing hallucinations and delusions, but not as effective for reducing the negative thoughts and feelings the person with schizophrenia may have. </p> </section> <section id="CD009608-sec-0012"> <h3 class="title" id="CD009608-sec-0012">How the intervention might work</h3> <p>CBT for psychosis could work by giving people with schizophrenia skills and tools to help them cope with their psychotic symptoms (<a href="./references#CD009608-bbs2-0175" title="MorrisonAP , BarrattS . What are the components of CBT for psychosis? A Delphi study. Schizophrenia Bulletin2010;1:136-42.">Morrison 2010</a>; <a href="./references#CD009608-bbs2-0191" title="SpencerHM , DudleyR , FreestonMH , TurkingtonD . What are the essential ingredients of a CBT case conceptualization for voices and delusions in schizophrenia spectrum disorders? A study of expert consensus. Schizophrenia Research2020;224:74-81.">Spencer 2020</a>). Moreover, it can help patients identify key cognitions, behaviours, emotions and images that are fundamental to their symptoms (<a href="./references#CD009608-bbs2-0175" title="MorrisonAP , BarrattS . What are the components of CBT for psychosis? A Delphi study. Schizophrenia Bulletin2010;1:136-42.">Morrison 2010</a>; <a href="./references#CD009608-bbs2-0191" title="SpencerHM , DudleyR , FreestonMH , TurkingtonD . What are the essential ingredients of a CBT case conceptualization for voices and delusions in schizophrenia spectrum disorders? A study of expert consensus. Schizophrenia Research2020;224:74-81.">Spencer 2020</a>). By identifying maladaptive thoughts, emotions and behaviours, the person with schizophrenia is, potentially, in a better position to change them. It is also possible that working on a CBTp model can help instil hope in recovery, reduce distress and improve quality of life (<a href="./references#CD009608-bbs2-0175" title="MorrisonAP , BarrattS . What are the components of CBT for psychosis? A Delphi study. Schizophrenia Bulletin2010;1:136-42.">Morrison 2010</a>). The converse could also be true. Greater understanding of maladaptive patterns of thinking could equally instil feelings of helplessness, loss, grief and distress with subsequent repercussions on quality of life (<a href="./references#CD009608-bbs2-0142" title="HesdonB . Seeking Consensus on Adverse Effects on Cognitive Behaviour Therapy for Schizophrenia. Leeds (UK): University of Leeds, 2004.">Hesdon 2004</a>). </p> <p>More specifically, CBT delivered by group for people with schizophrenia could have the additional effect of being applied in a group setting, thus indirectly improving social competence in a population who traditionally have been socially isolated and excluded (<a href="./references#CD009608-bbs2-0157" title="LawrenceR , BradshawT . Group cognitive behavioral therapy for schizophrenia: a systematic review of the literature. Journal of Psychiatric and Mental Health Nursing2006;13:673-81.">Lawrence 2006</a>; <a href="./references#CD009608-bbs2-0159" title="LecomteT , LeclercC , WykesT . Group CBT for psychosis. Oxford (UK): Oxford University Press, 2016.">Lecomte 2016</a>). Also, shared experience of tackling symptoms can be very powerful in a group setting. There can also be an opportunity of modelling positive behaviours and coping strategies, and also enhance motivation by observational learning (<a href="./references#CD009608-bbs2-0159" title="LecomteT , LeclercC , WykesT . Group CBT for psychosis. Oxford (UK): Oxford University Press, 2016.">Lecomte 2016</a>). </p> </section> <section id="CD009608-sec-0013"> <h3 class="title" id="CD009608-sec-0013">Why it is important to do this review</h3> <p>Group CBT for psychosis could be both effective and cost‐effective and a possible alternative to individual CBT. The UK National Health Service (NHS) has suggested that people with schizophrenia should receive individual therapy sessions (<a href="./references#CD009608-bbs2-0002" title="BechdolfA , KnostB , KuntermannC , SchillerS , HambrechtM , KlosterkotterJ , et al. Coping-oriented versus psychoeducational group therapy for post acute patients with schizophrenia: results of a 6 month follow-up. Schizophrenia Research2002;53(Suppl 1):263-4. [CSZG: Ref8053]BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110:21-8. [CSZG: Ref11268]BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144-50. [CSZG: Ref19694]BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112:173-9. [CSZG: Ref18491]BechdolfA . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia: commentary reply. Acta Psychiatrica Scandinavica2006;113:73-4. [CSZG: Ref18490]Munk-JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSZG: Ref18577]">Bechdolf 2004</a>). Due to the lack of resource this is unlikely to happen – and, perhaps less so as more evidence emerges as to the little or no benefits – and even drawbacks – of CBT for people with schizophrenia when compared with other psychological therapies (<a href="./references#CD009608-bbs2-0148" title="JonesC , HackerD , CormacI , MeadenA , IrvingCB . Cognitive behaviour therapy versus psychosocial treatments for schizophrenia. Cochrane Database of Systematic Reviews2010, Issue 9. Art. No: CD008712. [DOI: 10.1002/14651858.CD008712]">Jones 2010</a>). However, the group experience may have benefits that individual therapy simply cannot provide and therefore, a review of best evidence is indicated. Group CBTp can be an important part of a stepped care model for the treatment of schizophrenia spectrum disorder (<a href="./references#CD009608-bbs2-0155" title="KopelovichSL , StrachanE , SivecH , KreiderV . Stepped care as an implementation and service delivery model for cognitive behavioral therapy for psychosis. Community Mental Health Journal2019;55:755-67.">Kopelovich 2019</a>). </p> <p>This review is part of a series of Cochrane Reviews aiming to provide a comprehensive overview of the evidence for the effectiveness of CBT for people with schizophrenia. The protocol of this review was published in 2012 (<a href="./references#CD009608-bbs2-0210" title="GuaianaG , MorelliAC , ChiodoD . Cognitive behaviour therapy (group) for schizophrenia. Cochrane Database of Systematic Reviews2012, Issue 2. Art. No: CD009608. [DOI: 10.1002/14651858.CD009608]">Guaiana 2012</a>).  </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009608-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009608-sec-0014">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009608-sec-0241">Deutsch</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009608-sec-0014"></div> <p>To investigate efficacy and acceptability of group CBT applied to psychosis compared with standard care or other psychosocial interventions, for people with schizophrenia or schizoaffective disorder. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009608-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009608-sec-0015">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009608-sec-0242">Deutsch</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009608-sec-0015"></div> <section id="CD009608-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009608-sec-0017"> <h4 class="title">Types of studies</h4> <p>All relevant randomised controlled trials (RCT). If a trial was described as 'double blind' but implied randomisation, we included the trial in a sensitivity analysis (see <a href="#CD009608-sec-0082">Sensitivity analysis</a>). We excluded quasi‐randomised studies, such as those allocating by alternate days of the week. Where people were given additional treatments within group CBT, we included the data if the adjunct treatment was evenly distributed between groups and it was only the group CBT that was randomised. </p> </section> <section id="CD009608-sec-0018"> <h4 class="title">Types of participants</h4> <p>Adults aged 16 years and over, with schizophrenia or related disorders, including schizophreniform disorder, schizoaffective disorder and delusional disorder by any means of diagnosis. We did not exclude trials that included participants who had a concurrent secondary diagnosis of another psychiatric disorder but we excluded trials that included participants who had a concomitant medical illness. We only included studies where at least 80% of participants had a diagnosis of schizophrenia or schizoaffective disorder. </p> <p>We were interested in ensuring that information was relevant to the current care of people with schizophrenia so proposed to clearly highlight the current clinical state (acute, early postacute, partial remission, remission) and stage (prodromal, first episode, early illness, persistent), and whether the studies primarily focused on people with particular problems (e.g. negative symptoms, treatment‐resistant illnesses). </p> </section> <section id="CD009608-sec-0019"> <h4 class="title">Types of interventions</h4> <section id="CD009608-sec-0020"> <h5 class="title">1. Group cognitive behavioural therapy for schizophrenia (CBTp)</h5> <p>Defined as a structured psychotherapeutic intervention, carried out in any group setting, and based on the CBT model applied to psychosis (<a href="./references#CD009608-bbs2-0113" title="BeckAT , RushA , ShawB , EmeryG . Cognitive Therapy of Depression. New York (NY): Guilford Press, 1979.">Beck 1979</a>). The key components are: </p> <p> <ul id="CD009608-list-0001"> <li> <p>a structured approach to each session;</p> </li> <li> <p>homework assignments on monitoring thoughts and target symptoms;</p> </li> <li> <p>examination of evidence for and against a distressing thought;</p> </li> <li> <p>encouragement in developing alternatives in thinking about a belief;</p> </li> <li> <p>exploration of the relationship between thoughts, emotions and behaviours;</p> </li> <li> <p>teaching techniques to cope with target symptoms, such as delusions, hallucinations and negative symptoms (<a href="./references#CD009608-bbs2-0154" title="KingdonDG , TurkingtonD . Cognitive Therapy of Schizophrenia. New York (NY): Guilford Press, 2005.">Kingdon 2005</a>). </p> </li> </ul> </p> <p>Despite the above criteria, it is often difficult to define CBTp precisely. CBTp interventions that do not meet the key component criteria listed above were considered 'less defined CBTp', while CBTp interventions that met the same criteria were defined as CBTp. We aimed to perform a sensitivity analysis excluding studies where less‐defined criteria were applied to investigate whether the definition resulted in a difference in outcomes. </p> <p>CBT for schizophrenia could be applied as a stand‐alone intervention or in combination with medication. </p> </section> <section id="CD009608-sec-0021"> <h5 class="title">2. Standard care</h5> <p>We included interventions described as 'treatment as usual' and wait‐list control interventions as standard care. This is the care participants would normally receive in a standard mental health service and could consist of antipsychotic medication treatment alone or a combination of medication and additional psychosocial interventions of any type (other than group CBTp). </p> </section> <section id="CD009608-sec-0022"> <h5 class="title">3. Other interventions</h5> <p>As a comparator we also considered other psychosocial interventions of any type.</p> </section> </section> <section id="CD009608-sec-0023"> <h4 class="title">Types of outcome measures</h4> <p>We aimed to divide all outcomes into short‐term (less than six months), medium‐term (seven to 12 months) and long‐term (over one year). </p> <section id="CD009608-sec-0024"> <h5 class="title">Primary outcomes</h5> <section id="CD009608-sec-0025"> <h6 class="title">1. Global state</h6> <p>1.1 Clinically important change, shown as improved – as defined by individual studies.</p> </section> </section> <section id="CD009608-sec-0026"> <h5 class="title">Secondary outcomes</h5> <section id="CD009608-sec-0027"> <h6 class="title">1. Global state</h6> <p>1.1 Any change – as defined by individual studies.<br/>1.2 Relapse.<br/>1.3 Average endpoint or change score on global state scale. </p> </section> <section id="CD009608-sec-0028"> <h6 class="title">2. Leaving the study early</h6> <p>2.1 For any reason.<br/>2.2 For specific reason. </p> </section> <section id="CD009608-sec-0029"> <h6 class="title">3. Mental state</h6> <section id="CD009608-sec-0030"> <p><b>3.1 Overall</b></p> <p>3.1.1 Clinically important change overall mental state – as defined by individual studies.<br/>3.1.2 Any change in overall mental state – as defined by individual studies.<br/>3.1.3 Average endpoint or change score on mental state scale. </p> </section> <section id="CD009608-sec-0031"> <p><b>3.2 Specific</b></p> <p>3.2.1 Clinically important change in specific symptoms (e.g. positive or negative) – as defined by individual studies.<br/>3.2.2 Any change in specific symptoms (e.g. positive or negative).<br/>3.2.3 Depression.<br/>3.2.4 Average endpoint or change scores on positive or negative symptom scales. </p> </section> </section> <section id="CD009608-sec-0032"> <h6 class="title">4. Compliance</h6> <p>4.1 Taking drug treatment.<br/>4.2 Adherence to non‐drug treatments. </p> </section> <section id="CD009608-sec-0033"> <h6 class="title">5. Adverse effects/events</h6> <p>5.1 At least one adverse effect/event.<br/>5.2 Incidence of specific adverse effects.<br/>5.3 Average endpoint or change scores on adverse effect scales.<br/>5.4 Dependency.<br/>5.5 Death: suicide or natural causes. </p> </section> <section id="CD009608-sec-0034"> <h6 class="title">6. Service utilisation outcomes</h6> <p>6.1 Hospital admission.<br/>6.2 Days in hospital. </p> </section> <section id="CD009608-sec-0035"> <h6 class="title">7. Quality of life</h6> <p>7.1 Clinically important change – as defined by individual studies.<br/>7.2 Any change – as defined by individual studies.<br/>7.3 General impression of carer/rater or family member.<br/>7.4 Average endpoint/change score on quality of life scales. </p> </section> <section id="CD009608-sec-0036"> <h6 class="title">8. Functioning – social and living skills</h6> <p>8.1 Clinically important change in functioning – as defined by individual studies.<br/>8.2 Any change in functioning – as defined by individual studies.<br/>8.3 Average endpoint/change score, on social skills/functioning scales.<br/>8.4 Occupational status. </p> </section> </section> </section> </section> <section id="CD009608-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009608-sec-0038"> <h4 class="title">Electronic searches</h4> <section id="CD009608-sec-0039"> <h5 class="title">Cochrane Schizophrenia Group's Study‐Based Register of Trials</h5> <p>On 8 January 2018, 28 January 2019, 7 May 2020 and 10 February 2021, the information specialist searched the register using the following search strategy: </p> <p>*Cogniti* in Intervention Field of STUDY</p> <p>In such a study‐based register, searching the major concept retrieves all the synonyms and relevant studies because all the studies have already been organised based on their interventions and linked to the relevant topics (<a href="./references#CD009608-bbs2-0184" title="RobertsMT , ShokranehF , SunY , GroomM , AdamsCE . Classification of psychotherapy interventions for people with schizophrenia: development of the Nottingham Classification of Psychotherapies. Evidence-Based Mental Health2021;24:62-9. [DOI: 10.1136/ebmental-2020-300151]">Roberts 2021</a>; <a href="./references#CD009608-bbs2-0186" title="ShokranehF , AdamsCE . Study-based registers of randomized controlled trials: starting a systematic review with data extraction or meta-analysis. BioImpacts2017;7(4):209-17. [DOI: 10.15171/bi.2017.25]">Shokraneh 2017</a>; <a href="./references#CD009608-bbs2-0189" title="ShokranehF , AdamsCE . Classification of all pharmacological interventions tested in trials relevant to people with schizophrenia: a study-based analysis. Health Information and Libraries Journal 2021 Feb 18 [Epub ahead of print]. [DOI: 10.1111/hir.12366]">Shokraneh 2021</a>). This allows rapid and accurate searches that reduce waste in the next steps of systematic reviewing (<a href="./references#CD009608-bbs2-0187" title="ShokranehF , AdamsCE . Study-based registers reduce waste in systematic reviewing: discussion and case report. Systematic Reviews2019;8:129. [DOI: 10.1186/s13643-019-1035-3]">Shokraneh 2019</a>). </p> <p>Following the methods from Cochrane (<a href="./references#CD009608-bbs2-0160" title="LefebvreC , GlanvilleJ , BriscoeS , LittlewoodA , MarshallC , MetzendorfM , et al. Chapter 4: Searching for and selecting studies. In: HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editors(s). Cochrane Handbook for Systematic Reviews of Interventions. 2nd edition. Chichester (UK): John Wiley and Sons, 2019:67-107. [DOI: 10.1002/9781119536604.ch4]">Lefebvre 2019</a>), this register is compiled by systematic searches of major resources (CENTRAL, MEDLINE, Embase, CINAHL, ClinicalTrials.Gov, ISRCTN, PsycINFO, PubMed, World Health Organization (WHO) ICTRP) and their monthly updates, ProQuest Dissertations and Theses A&amp;I and its quarterly update, handsearches, grey literature and conference proceedings (<a href="./references#CD009608-bbs2-0188" title="ShokranehF , AdamsCE . Cochrane schizophrenia group’s study-based register of randomized controlled trials: development and content analysis. Schizophrenia Bulletin Open2020;1:sgaa061. [DOI: 10.1093/schizbullopen/sgaa061]">Shokraneh 2020</a>; see Schizophrenia Group's website at <a href="http://schizophrenia.cochrane.org/register-trials" target="_blank">schizophrenia.cochrane.org/register-trials</a>). There is no language, date, document type or publication status limitations for inclusion of records into the register. </p> </section> </section> <section id="CD009608-sec-0040"> <h4 class="title">Searching other resources</h4> <section id="CD009608-sec-0041"> <h5 class="title">1. Personal communication</h5> <p>We contacted experts in the field by email or mail to find potential suitable studies for the review, or to find out whether there are studies in progress. </p> <p>See <a href="#CD009608-tbl-0002">Table 1</a> for details of how authors of the studies awaiting classification were contacted. </p> <div class="table" id="CD009608-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Contact of authors of studies awaiting classification</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study name</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Contacted</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Replied</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Provided data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Notes</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0098" title="BrennerHD , HodelB , KubeG , RoderV . Cognitive therapy with schizophrenics: analysis of the problem and experimental results. Nervenarzt1987;58:72-83. ">Brenner 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Could not find author's contact details</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0099" title="ChungYC , KimJH , EunHB , HwangIK . Effect of cognitive-behavioral therapy on the delusion in schizophrenic patients. Journal of the Korean Neuropsychiatric Association2001;40:63-71. ">Chung 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> —</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0100" title="ClassenW , KrajewskiC , BoeskenS . Cognitive and social processes during art (AT) or cognitive (CT) therapy and a simultaneous CT + AT therapy in schizophrenics. Verhaltenstherapie1993;Suppl 1:A45. ClassenW , KrajewskiC , BoeskenS . Comparison of art and cognitive therapy (IPT) with simultaneous cognitive and art therapy for schizophrenic patients regarding the change of cognitive processes. Pharmacopsychiatry1993;26:171. ">Classen 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> —</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0101" title="KlingbergS , WiedemannG , BuchkremerG . Cognitive-behavioural therapy for schizophrenic patients – design and preliminary results of a randomised effectiveness trial. Zeitschrift Für Klinische Psychologie Und Psychotherapie2001;30:259-67. ">Klingberg 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> —</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0102" title="KraemerS , SulzKH , SchmidR , LassleR . Cognitive therapy of schizophrenic patients: a control study. Nervenarzt1987;58:84-90. ">Kraemer 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Could not find author's contact details</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0103" title="McLeodT , MorrisM , BirchwoodM , DoveyA . Cognitive behavioural therapy group work with voice hearers. Part 1. British Journal of Nursing2007;16:248-52. McLeodT , MorrisM , BirchwoodM , DoveyA . Cognitive behavioural therapy group work with voice hearers. Part 2. British Journal of Nursing2007;16:292-5. ">McLeod 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> —</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0104" title="Shafiei AmiriM , Ahmadi GatabT , BabakhaniN . The efficacy of cognitive-behavior group therapy and social skill trainings on reduction of negative symptoms of schizophrenic patients. European Psychiatry2011;26(Suppl 2):1327. ">Shafiei 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> —</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD009608-sec-0042"> <h5 class="title">2. Reference checking</h5> <p>Finally, we checked the reference lists of the included studies, previous systematic reviews written in English, Italian, French, German, Spanish, Chinese for published reports and citations of unpublished research. We checked the references of all included studies via Science Citation Index for articles which have cited the included study. </p> </section> </section> </section> <section id="CD009608-sec-0043"> <h3 class="title" id="CD009608-sec-0043">Data collection and analysis</h3> <section id="CD009608-sec-0044"> <h4 class="title">Selection of studies</h4> <p>Five review authors (MA, FT, IE, CZ, WL) independently inspected citations from the searches and identified relevant abstracts. Where disputes arose, we acquired the full report for more detailed scrutiny. We then obtained full reports of the abstracts meeting the review criteria and the same five review authors inspected them. Where it was not possible to resolve disagreement by discussion, we attempted to contact the study authors for clarification. </p> </section> <section id="CD009608-sec-0045"> <h4 class="title">Data extraction and management</h4> <section id="CD009608-sec-0046"> <h5 class="title">1. Extraction</h5> <p>Teams of two review authors (from MA, FT, GG, IE, CZ, WL) independently extracted data from all included studies. We discussed any disagreements, documented decisions and, if necessary, contacted study authors for clarification. With any remaining problems, another member of the review group (AP) helped clarify issues and we documented the final decisions. Whenever possible, we extracted data presented only in graphs and figures but we only included the data if two review authors independently had the same result. We attempted to contact authors through an open‐ended request to obtain missing information or for clarification whenever necessary. If studies were multicentre, where possible, we extracted data relevant to each component centre separately. </p> </section> <section id="CD009608-sec-0047"> <h5 class="title">2. Management</h5> <section id="CD009608-sec-0048"> <h6 class="title">2.1 Forms</h6> <p>We used <a href="./references#CD009608-bbs2-0123" title="Covidence. Version accessed 2 March 2022. Melbourne, Australia: Veritas Health Innovation. Available at covidence.org.">Covidence</a> to select and extract data from the studies. </p> </section> <section id="CD009608-sec-0049"> <h6 class="title">2.2 Scale‐derived data</h6> <p>We included continuous data from rating scales only if:</p> <p> <ul id="CD009608-list-0002"> <li> <p>the psychometric properties of the measuring instrument had been described in a peer‐reviewed journal (<a href="./references#CD009608-bbs2-0168" title="MarshallM , LockwoodA , BradleyC , AdamsCE , JoyC , FentonM . Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry2000;176:249-52.">Marshall 2000</a>); and </p> </li> <li> <p>the measuring instrument had not been written or modified by one of the trialists for that particular trial. </p> </li> </ul> </p> <p>Ideally, the measuring instrument should have either been a self‐report or completed by an independent rater or relative (not the therapist). We realise that this is not often reported clearly, but we noted if this was the case or not. </p> </section> <section id="CD009608-sec-0050"> <h6 class="title">2.3 Endpoint versus change data</h6> <p>There are advantages of both endpoint and change data. Change data can remove a component of between‐person variability from the analysis. However, calculation of change needs two assessments (baseline and endpoint), which can be difficult in unstable and difficult‐to‐measure conditions such as schizophrenia. We decided primarily to use endpoint data, and only use change data if the former were not available. We combined endpoint and change data in the analysis as we used mean differences (MD) rather than standardised mean differences (SMD) throughout (<a href="./references#CD009608-bbs2-0144" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). </p> </section> <section id="CD009608-sec-0051"> <h6 class="title">2.4 Skewed data</h6> <p>Continuous data on clinical and social outcomes are often not normally distributed. To avoid the problem of applying parametric tests to non‐parametric data, we aimed to apply the following standards to all data before inclusion: </p> <p> <ul id="CD009608-list-0003"> <li> <p>standard deviations (SDs) and means were reported in the paper or obtainable from the authors; </p> </li> <li> <p>when a scale started from the finite number zero, the SD, when multiplied by two, is less than the mean (as otherwise the mean is unlikely to be an appropriate measure of the centre of the distribution) (<a href="./references#CD009608-bbs2-0107" title="AltmanDG , BlandJM . Detecting skewness from summary information. BMJ1996;313:1200.">Altman 1996</a>); </p> </li> <li> <p>if a scale started from a positive value (such as the Positive and Negative Syndrome Scale (PANSS) which can have values from 30 to 210), we modified the calculation described above to take the scale starting point into account. In these cases, skew was present if 2 SD &gt; (S – S<sub>min</sub>), where S is the mean score and S<sub>min</sub> is the minimum score. Endpoint scores on scales often have a finite start and endpoint and these rules can be applied. When continuous data are presented on a scale that includes a possibility of negative values (such as change data), it is difficult to determine whether data are skewed or not. We entered skewed data from studies of fewer than 200 participants into additional tables rather than into an analysis. Skewed data pose less of a problem when using means if the sample size is large, and therefore, we entered such data into the analyses. </p> </li> </ul> </p> </section> <section id="CD009608-sec-0052"> <h6 class="title">2.5 Common measure</h6> <p>To facilitate comparison between trials, we intended to convert variables that could be reported in different metrics, such as days in hospital (mean days per year, per week or per month) to a common metric (e.g. mean days per month). </p> </section> <section id="CD009608-sec-0053"> <h6 class="title">2.6 Conversion of continuous to binary</h6> <p>Where possible, we attempted to convert outcome measures to dichotomous data. This could be done by identifying cut‐off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. It is generally assumed that if there is a 50% reduction in a scale‐derived score such as the Brief Psychiatric Rating Scale (BPRS; <a href="./references#CD009608-bbs2-0180" title="OverallJE , GorhamDR . The Brief Psychiatric Rating Scale. Psychological Reports1962;10:799-812.">Overall 1962</a>) or the PANSS (<a href="./references#CD009608-bbs2-0151" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda (NY): Multi-Health Systems, 1986.">Kay 1986</a>), this could be considered as a clinically significant response (<a href="./references#CD009608-bbs2-0161" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelR . Clinical implications of brief psychiatric rating scale scores. British Journal of Psychiatry2005;187:366-71.">Leucht 2005a</a>; <a href="./references#CD009608-bbs2-0162" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelR . What does the PANSS mean?Schizophrenia Research2005;79:231-8.">Leucht 2005b</a>). If data based on these thresholds were not available, we used the primary cut‐off presented by the original authors. </p> </section> <section id="CD009608-sec-0054"> <h6 class="title">2.7 Direction of graphs</h6> <p>Where possible, we entered data such that the area to the left of the line of no effect indicated a favourable outcome for group CBT. Where keeping to this made it impossible to avoid outcome titles with clumsy double‐negatives (e.g. 'not improved'), we reported data where the left of the line indicated an unfavourable outcome. We noted this in the relevant graphs. </p> </section> </section> </section> <section id="CD009608-sec-0055"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Teams of two review authors (from MA, FT, GG, IE, CZ, WL) independently assessed risk of bias using criteria described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to assess trial quality (<a href="./references#CD009608-bbs2-0144" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). This set of criteria is based on evidence of associations between overestimates of effect and high risk of bias of the article such as sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting. </p> <p>If the raters disagreed, we made the final rating by consensus, with the involvement of another member of the review group (AP). Where there were inadequate details of randomisation and other characteristics of trials provided, we contacted the study authors to request further information. We reported non‐concurrence in quality assessment, but if disputes arose as to which category a trial was to be allocated, we resolved this by discussion. </p> <p>We noted the level of risk of bias in both the text of the review and in the risk of bias summary and risk of bias graph (<a href="#CD009608-fig-0002">Figure 2</a>; <a href="#CD009608-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD009608-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009608-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD009608-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009608-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> </section> <section id="CD009608-sec-0056"> <h4 class="title">Measures of treatment effect</h4> <section id="CD009608-sec-0057"> <h5 class="title">1. Binary data</h5> <p>For binary outcomes, we calculated a standard estimation of the risk ratio (RR) and its 95% confidence interval (CI). It has been shown that RR is more intuitive than odds ratios (<a href="./references#CD009608-bbs2-0119" title="BoisselJP , CucheratM , LiW , ChatellierG , GueyffierF , BuyseM , et al. The problem of therapeutic efficacy indices. Comparison of the indices and their use. Therapie1999;54:405-11.">Boissel 1999</a>), and that odds ratios tend to be interpreted as RR by clinicians (<a href="./references#CD009608-bbs2-0124" title="DeeksJ . Issues in the selection for meta-analyses of binary data. In: Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town, South Africa. 2000.">Deeks 2000</a>). </p> </section> <section id="CD009608-sec-0058"> <h5 class="title">2. Continuous data</h5> <p>For continuous outcomes, we estimated MD between groups with 95% CIs. We preferred not to calculate effect size measures (SMD). However, if studies used scales of very considerable similarity, we presumed there was a small difference in measurement, and we calculated effect size and transformed the effect back to the units of one or more of the specific instruments. </p> </section> </section> <section id="CD009608-sec-0059"> <h4 class="title">Unit of analysis issues</h4> <section id="CD009608-sec-0060"> <h5 class="title">1. Cluster trials</h5> <p>Studies increasingly employ 'cluster randomisation' (such as randomisation by clinician or practice) but analysis and pooling of clustered data poses problems. First, authors often fail to account for intraclass correlation in clustered studies, leading to a 'unit of analysis' error (<a href="./references#CD009608-bbs2-0127" title="DivineGW , BrownJT , FrazierLM . The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine1992;7:623-9.">Divine 1992</a>), whereby P values are spuriously low, CIs unduly narrow and statistical significance overestimated. This causes type I errors (<a href="./references#CD009608-bbs2-0118" title="BlandJM . Statistics notes. Trials randomised in clusters. BMJ1997;315:600.">Bland 1997</a>; <a href="./references#CD009608-bbs2-0136" title="GullifordMC . Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149:876-83.">Gulliford 1999</a>). </p> <p>Where primary studies did not account for clustering, we presented data in a table, with a * symbol to indicate the presence of a probable unit of analysis error. We sought to contact first authors of studies to obtain intraclass correlation coefficients (ICCs) for their clustered data and to adjust for this by using accepted methods (<a href="./references#CD009608-bbs2-0136" title="GullifordMC . Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149:876-83.">Gulliford 1999</a>). Where clustering was incorporated into the analysis of primary studies, we presented these data as if from a non‐cluster randomised study, but adjust for the clustering effect. </p> <p>We sought statistical advice and have been advised that the binary data as presented in a report should be divided by a 'design effect'. This is calculated using the mean number of participants per cluster (m) and the ICC (design effect = 1 + (m – 1) × ICC) (<a href="./references#CD009608-bbs2-0128" title="DonnerA , KlarN . Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine2002;21:2971-80.">Donner 2002</a>). If the ICC was not reported, we assumed it to be 0.1 (<a href="./references#CD009608-bbs2-0196" title="UkoumunneOC , GullifordMC , ChinnS , SterneJA , BurneyPG . Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review. Health Technology Assessment1999;3(5):1-75.">Ukoumunne 1999</a>). </p> <p>If cluster studies had been appropriately analysed taking into account ICCs and relevant data documented in the report, synthesis with other studies would be possible using the generic inverse variance technique. </p> </section> <section id="CD009608-sec-0061"> <h5 class="title">2. Cross‐over trials</h5> <p>A major concern of cross‐over trials is the carry‐over effect. It occurs if an effect (e.g. pharmacological, physiological or psychological) of the treatment in the first phase is carried over to the second phase. As a consequence, on entry to the second phase the participants can differ systematically from their initial state despite a wash‐out phase. For the same reason, cross‐over trials are not appropriate if the condition of interest is unstable (<a href="./references#CD009608-bbs2-0131" title="ElbourneDR , AltmanDG , HigginsJP , CurtinF , WorthingtonHV , VailA . Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology2002;31:140-9.">Elbourne 2002</a>). As both effects are very likely in severe mental illness, we only used data from the first phase of cross‐over studies. </p> </section> <section id="CD009608-sec-0062"> <h5 class="title">3. Studies with multiple treatment groups</h5> <p>Where a study involved more than two treatment arms, if relevant, we presented the additional treatment arms in comparisons. If data were binary, we simply added and combined them in the two‐by‐two table. If data were continuous, we combined data following the formula in Section 7.7.3.8 (Combining groups) of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009608-bbs2-0144" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). Where the additional treatment arms were not relevant, we did not reproduce the data but listed them in the <a href="./references#CD009608-sec-0225" title="">Characteristics of included studies</a> table. </p> </section> </section> <section id="CD009608-sec-0063"> <h4 class="title">Dealing with missing data</h4> <section id="CD009608-sec-0064"> <h5 class="title">1. Overall loss of credibility</h5> <p>At some degree of loss of follow‐up, data must lose credibility (<a href="./references#CD009608-bbs2-0208" title="XiaJ , AdamsCE , BhagatN , BhagatV , BhoopathiP , El-SayehH . Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin2009;33(7):254-7.">Xia 2009</a>). We chose that, for any particular outcome, should more than 50% of data be unaccounted for, we did not reproduce these data or use them within analyses, except for the outcome leaving the study early. However, if more than 50% of those in one arm of a study were lost, but the total loss was less than 50%, we marked such data with (*) to indicate that such a result may well be prone to bias. </p> </section> <section id="CD009608-sec-0065"> <h5 class="title">2. Binary</h5> <p>In the case where attrition for a binary outcome was between 0% and 50% and where these data were not clearly described, we presented the data on a 'once‐randomised‐always‐analyse' basis (an intention‐to‐treat analysis). Those leaving the study early were all assumed to have the same rates of negative outcome as those who completed, with the exception of the outcome of death and adverse effects. For these outcomes, we used the rate of those who stayed in the study – in that particular arm of the trial – for those who did not. We aimed to undertake a sensitivity analysis to test how prone the primary outcomes were to change when comparing 'completer' data only with the intention‐to‐treat analysis using the above assumptions. </p> </section> <section id="CD009608-sec-0066"> <h5 class="title">3. Continuous</h5> <section id="CD009608-sec-0067"> <h6 class="title">3.1 Attrition</h6> <p>In the case where attrition for a continuous outcome was between 0% and 50% and completer‐only data are reported, we reproduced these. </p> </section> <section id="CD009608-sec-0068"> <h6 class="title">3.2 Standard deviations</h6> <p>If SDs were not reported, we first tried to obtain the missing values from the study authors. If not available, where there were missing measures of variance for continuous data, but an exact standard error (SE) and CIs were available for group means, and either a P value or a t value were available for differences in mean, we calculated them according to the rules described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009608-bbs2-0144" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>): when only the SE was reported, we calculated SDs using the formula SD = SE × square root (n). Sections 7.7.3 and 16.1.3 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> present detailed formulae for estimating SDs from P values, t or F values, CIs, ranges or other statistics (<a href="./references#CD009608-bbs2-0144" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). If these formulae did not apply, we calculated the SDs according to a validated imputation method which is based on the SDs of the other included studies (<a href="./references#CD009608-bbs2-0133" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology2006;59:7-10.">Furukawa 2006</a>). Although some of these imputation strategies could introduce error, the alternative would be to exclude a given study’s outcome and thus to lose information. Nevertheless, we examined the validity of the imputations in a sensitivity analysis excluding imputed values. </p> </section> <section id="CD009608-sec-0069"> <h6 class="title">3.3 Last observation carried forward</h6> <p>We anticipated that some studies would use the method of last observation carried forward (LOCF) within the study report. As with all methods of imputation to deal with missing data, LOCF introduces uncertainty about the reliability of the results (<a href="./references#CD009608-bbs2-0163" title="LeuchtS , EngelRR , BaumlJ , DavisJM . Is the superior efficacy of new generation antipsychotics an artifact of LOCF?Schizophrenia Bulletin2007;33:183-91.">Leucht 2007</a>). Therefore, where LOCF data had been used in the trial, if less than 50% of the data have been assumed, we reproduced these data and indicated that they were the product of LOCF assumptions. </p> </section> </section> </section> <section id="CD009608-sec-0070"> <h4 class="title">Assessment of heterogeneity</h4> <section id="CD009608-sec-0071"> <h5 class="title">1. Clinical heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge clinical heterogeneity. We simply inspected all studies for clearly outlying people or situations that we had not predicted. When such situations or participant groups arose, we discussed them fully in the text. </p> </section> <section id="CD009608-sec-0072"> <h5 class="title">2. Methodological heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge methodological heterogeneity. We simply inspected all studies for clearly outlying methods that we had not predicted. When such methodological outliers arose, we discussed them fully in the text. </p> </section> <section id="CD009608-sec-0073"> <h5 class="title">3. Statistical heterogeneity</h5> <section id="CD009608-sec-0074"> <h6 class="title">3.1 Visual inspection</h6> <p>We visually inspected graphs to investigate the possibility of statistical heterogeneity.</p> </section> <section id="CD009608-sec-0075"> <h6 class="title">3.2 Employing the I<sup>2</sup> statistic </h6> <p>We investigated heterogeneity between studies by considering the I<sup>2</sup> statistic alongside the Chi<sup>2</sup> P value. The I<sup>2</sup> statistic provides an estimate of the percentage of inconsistency thought to be due to chance (<a href="./references#CD009608-bbs2-0143" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327:557-60.">Higgins 2003</a>). The importance of the observed value of I<sup>2</sup> statistic depends on magnitude and direction of effects and strength of evidence for heterogeneity (e.g. P value from Chi<sup>2</sup> test, or a CI for I<sup>2</sup> statistic). We interpreted an I<sup>2</sup> statistic estimate of 50% or greater accompanied by a statistically significant Chi<sup>2</sup> statistic as evidence of substantial levels of heterogeneity (<a href="./references#CD009608-bbs2-0144" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). When there were substantial levels of heterogeneity in the primary outcome, we explored reasons for it (<a href="#CD009608-sec-0078">Subgroup analysis and investigation of heterogeneity</a>). </p> </section> </section> </section> <section id="CD009608-sec-0076"> <h4 class="title">Assessment of reporting biases</h4> <p>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results (<a href="./references#CD009608-bbs2-0129" title="EggerM , Davey-SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315:629-34.">Egger 1997</a>). These are described in Chapter 10 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009608-bbs2-0144" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). We are aware that funnel plots may be useful in investigating reporting biases but are of limited power to detect small‐study effects. We did not use funnel plots for outcomes where there were 10 or fewer studies, or where all studies were of similar sizes. In other cases, where funnel plots were possible, we aimed to seek statistical advice in their interpretation. </p> </section> <section id="CD009608-sec-0077"> <h4 class="title">Data synthesis</h4> <p>We understand that there is no closed argument for preference for use of fixed‐effect or random‐effects models. The random‐effects method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. This often seems to be true to us and the random‐effects model takes into account differences between studies even if there is no statistically significant heterogeneity. However, there is a disadvantage to the random‐effects model. It puts added weight onto small studies, which often are the most biased ones. Depending on the direction of effect these studies can either inflate or deflate the effect size. We used the random‐effects model for all analyses. However, readers are able to choose to inspect the data using the fixed‐effect model. </p> </section> <section id="CD009608-sec-0078"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <section id="CD009608-sec-0079"> <h5 class="title">1. Subgroup analyses – primary outcomes</h5> <p>We note that subgroup analyses are often exploratory in nature and should be interpreted with caution. First, because it often involves multiple analyses, this can lead to false positive results. Second, these analyses lack power and would more likely result in false‐positive results. Keeping in mind the above reservations, we aimed to perform the following subgroup analyses solely for the primary outcome. </p> <p> <ul id="CD009608-list-0004"> <li> <p>Number of sessions offered (six sessions or fewer, seven to 12 sessions, more than 12 sessions). </p> </li> <li> <p>People at their first episode of schizophrenia versus those with previous episodes of schizophrenia. </p> </li> <li> <p>Efficacy in the short‐term (six months or less) versus efficacy in the long‐term (over six months). </p> </li> </ul> </p> <section id="CD009608-sec-0080"> <h6 class="title">1.2 Clinical state, stage or problem</h6> <p>We proposed to undertake this review and provide an overview of the effects of group CBT for people with schizophrenia in general. In addition, we tried to report data on subgroups of people in the same clinical state, stage and with similar problems. </p> </section> </section> <section id="CD009608-sec-0081"> <h5 class="title">2. Investigation of heterogeneity</h5> <p>If inconsistency was high, we reported this. First, we investigated whether data had been entered correctly. Second, if data were correct, we visually inspected the graph and remove outlying studies to see if homogeneity was restored. Where unanticipated clinical or methodological heterogeneity were obvious, we simply stated hypotheses regarding these for future reviews or versions of this review. We did not anticipate undertaking analyses relating to these. </p> </section> </section> <section id="CD009608-sec-0082"> <h4 class="title">Sensitivity analysis</h4> <p>We planned the sensitivity analyses for the primary outcome only.</p> <section id="CD009608-sec-0083"> <h5 class="title">1. Implication of randomisation</h5> <p>We aim to include trials in a sensitivity analysis if they were described in some way as to imply randomisation. For the primary outcomes, we aimed to include these studies and if there was no substantive difference when the implied randomised studies are added to those with better descriptions of randomisation, then we used all data from these studies. </p> </section> <section id="CD009608-sec-0084"> <h5 class="title">2. Assumptions for lost binary data</h5> <p>Where assumptions had to be made regarding people lost to follow‐up (see <a href="#CD009608-sec-0063">Dealing with missing data</a>), we compared the findings of the primary outcomes when we used our assumption compared with completer data only. If there was a substantial difference, we reported results and discuss them but continued to employ our assumption. </p> <p>Where assumptions had to be made regarding missing SDs data (see <a href="#CD009608-sec-0063">Dealing with missing data</a>), we compared the findings on primary outcomes when we used our assumption compared with completer data only. We aimed to undertake a sensitivity analysis to test how prone results were to change when comparing 'completer' data only with the imputed data using the above assumption. If there was a substantial difference, we reported results and discussed them but continued to employ our assumption. </p> </section> <section id="CD009608-sec-0085"> <h5 class="title">3. Risk of bias</h5> <p>We analysed the effects of excluding trials that were at high risk of bias across one or more of the domains of randomisation (implied as randomised with no further details available) allocation concealment, blinding and outcome reporting for the meta‐analysis of the primary outcome. If the exclusion of trials at high risk of bias did not substantially alter the direction of effect or the precision of the effect estimates, then we included the data from these trials in the analysis. </p> </section> <section id="CD009608-sec-0086"> <h5 class="title">4. Imputed values</h5> <p>We undertook a sensitivity analysis to assess the effects of including data from trials where we used imputed values for ICC in calculating the design effect in cluster randomised trials. </p> <p>If there were substantial differences in the direction or precision of effect estimates in any of the sensitivity analyses listed above, we did not pool data from the excluded trials with the other trials contributing to the outcome, but presented them separately </p> </section> <section id="CD009608-sec-0087"> <h5 class="title">5. Fixed‐effect and random‐effects models</h5> <p>We synthesised all data using a random‐effects model; however, we planned to use a fixed‐effect model to evaluate whether the greater weights assigned to larger trials with greater event rates altered the significance of the results compared with the more evenly distributed weights in the random‐effects model (see <a href="#CD009608-sec-0223">Differences between protocol and review</a>). </p> </section> <section id="CD009608-sec-0088"> <h5 class="title">6. Dropout rates</h5> <p>We excluded studies with dropout rates of more than 50%.</p> </section> </section> <section id="CD009608-sec-0089"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We used the GRADE approach to interpret findings (<a href="./references#CD009608-bbs2-0185" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Available from handbook: training.cochrane.org/handbook/archive/v6.2.">Schünemann 2021</a>) and use the GRADE profiler (<a href="./references#CD009608-bbs2-0135" title="GRADE Profiler. Version 3.2. GRADE Working Group, 2004.">GRADE Profiler</a>) to import data from Review Manager 5 (<a href="./references#CD009608-bbs2-0183" title="Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>) to prepare the summary of findings table (<a href="./full#CD009608-tbl-0001">summary of findings Table 1</a>).  </p> <p>The summary of findings table provides outcome‐specific information concerning the overall certainty of the evidence from each included study in the comparison, the magnitude of effect of the interventions examined and the sum of available data on all outcomes we considered important to patient‐care and decision‐making. </p> <p>In the protocol, we planned to use the following outcome measures for the summary of findings table. </p> <p> <ul id="CD009608-list-0005"> <li> <p>Global state – clinically significant improvement in global state – as defined by each of the studies. </p> </li> <li> <p>Leaving the study early.</p> </li> <li> <p>Mental state.</p> <ul id="CD009608-list-0006"> <li> <p>Clinically significant response in mental state – as defined by each of the studies.</p> </li> <li> <p>Relapse.</p> </li> </ul> </li> <li> <p>Service utilisation outcomes.</p> <ul id="CD009608-list-0007"> <li> <p>Hospital admission.</p> </li> <li> <p>Days in hospital.</p> </li> </ul> </li> <li> <p>Quality of life.</p> </li> <li> <p>Significant change in quality of life – as defined by each of the studies.</p> </li> </ul> </p> <p>However, we selected the following main outcomes for inclusion in the summary of findings table (see <a href="#CD009608-sec-0223">Differences between protocol and review</a> for reasons): </p> <p> <ul id="CD009608-list-0008"> <li> <p>Clinically important change, shown as improved – as defined by individual studies.</p> </li> <li> <p>Relapse.</p> </li> <li> <p>Leaving the study early: for any reason.</p> </li> <li> <p>Mental state: overall: average endpoint score – end of treatment (PANSS total).</p> </li> <li> <p>Days in hospital.</p> </li> <li> <p>Quality of life: clinically important change – as defined by individual studies.</p> </li> <li> <p>Functioning: overall: global assessment of functioning – average endpoint score – end of treatment (Global Assessment of Functioning (GAF)). </p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009608-sec-0090" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009608-sec-0090">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009608-sec-0317">Deutsch</a> </li> </nav> </div> </div> <section class="results" lang="en"> <div class="section-header" id="CD009608-sec-0090"></div> <section id="CD009608-sec-0091"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD009608-sec-0225" title="">Characteristics of included studies</a>; <a href="./references#CD009608-sec-0226" title="">Characteristics of excluded studies</a>; <a href="./references#CD009608-sec-0227" title="">Characteristics of studies awaiting classification</a>; <a href="./references#CD009608-sec-0228" title="">Characteristics of ongoing studies</a> tables. </p> <section id="CD009608-sec-0092"> <h4 class="title">Results of the search</h4> <p>Initially, we identified 1324 references (764 studies) through database searching. After removing duplicates, we screened titles and abstracts of 741 records and excluded 579 records that were obviously irrelevant. We retrieved full‐text copies of the remaining 162 records (106 studies). We excluded 114 records (73 studies) overall. We excluded the studies for a variety of reasons (see <a href="#CD009608-fig-0004">Figure 4</a> for more information). In particular, we excluded 69 studies because the intervention was not group CBTp. We included 37 references referring to 24 studies in the qualitative and quantitative synthesis. We classified seven studies as awaiting classification since we could not obtain useful data for the analysis (see <a href="#CD009608-tbl-0002">Table 1</a> for more information). Two studies are ongoing. The literature search was last updated in February 2021. See <a href="#CD009608-fig-0004">Figure 4</a> for PRISMA flow diagram. </p> <div class="figure" id="CD009608-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009608-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD009608-sec-0093"> <h4 class="title">Included studies</h4> <p>We included 24 studies in this systematic review. All the studies were published trials except for <a href="./references#CD009608-bbs2-0011" title="JonesA . Targeting Reasoning Biases in Delusions; a Pilot Study of the 'Thinking Well Group' [Doctoral thesis]. London (UK): King's College, 2014. ">Jones 2014</a> (a PhD thesis dissertation). </p> <section id="CD009608-sec-0094"> <h5 class="title">1. Design and duration</h5> <p>Most RCTs had two arms except for <a href="./references#CD009608-bbs2-0009" title="GranholmE ,  HoldenJL , DwyerK , LinkP . Mobile-assisted cognitive-behavioral social skills training in older adults with schizophrenia. Journal of Behavioral and Cognitive Therapy2020;30:13-21. ">Granholm 2020</a> and <a href="./references#CD009608-bbs2-0014" title="Mortan SeviO , Tekinsav SutcuS , YesilyurtS , Turan ErogluS , GunesB . Comparison of the effectiveness of two cognitive-behavioral group therapy programs for schizophrenia: results of a short-term randomized control trial. Community Mental Health Journal2020;56:222-8. ">Mortan Sevi 2020</a>, which included three arms. However, we just included two arms for those studies, as the third arm was not relevant to the outcomes. </p> </section> <section id="CD009608-sec-0095"> <h5 class="title">2. Participants</h5> <p>All studies included participants with a diagnosis of schizophrenia or schizoaffective disorder, or both. </p> <p>All studies randomised participants aged at least 16 years or older, but the age ranges of participants varied: two studies recruited older participants (over 42 years) (<a href="./references#CD009608-bbs2-0006" title="GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520-9. [CSZG: Ref11453]GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. Journal of Clinical Psychiatry2007;68:730-7. [CSZG: Ref14560]">Granholm 2007</a>; <a href="./references#CD009608-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR , JesteDV . Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome. American Journal of Geriatric Psychiatry2013;21(3):251-62. [CSZG: Ref28246]NCT00237796. Functional rehabilitation of older patients with schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00237796 (first received 12 October 2005). ">Granholm 2013</a>); the remaining studies recruited people between the ages of 16 and 65 years.  </p> </section> <section id="CD009608-sec-0096"> <h5 class="title">3. Size</h5> <p>Overall, the studies included 1900 participants in active treatment arms. Of these, 949 were randomised to various forms of group CBTp. Of the remaining 951 participants, 495 were randomised to standard care, 228 to medication alone, 147 to supportive therapy, 48 to a psychoeducational group, 17 to mobile device control and 16 to wait‐list control. The mean sample size for both arms was about 40 participants (range six to 73). </p> </section> <section id="CD009608-sec-0097"> <h5 class="title">4. Setting</h5> <p>Five studies recruited participants from multiple centres (<a href="./references#CD009608-bbs2-0001" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive behavioural therapy for schizophrenia – randomised controlled trial. British Journal of Psychiatry2006;189:527-32. [CSZG: Ref14559]BarrowcloughC . An evaluation of the effectiveness of group cognitive therapy for people with recent onset schizophrenia. National Research Register2001;1. [CSZG: Ref12948]">Barrowclough 2006</a>; <a href="./references#CD009608-bbs2-0003" title="ChadwickP , StraussC , JonesAM , KingdonD , EllettL , DannahyL , et al. Group mindfulness-based intervention for distressing voices: a pragmatic randomised controlled trial. Schizophrenia Research2016;175:168-73. ">Chadwick 2016</a>; <a href="./references#CD009608-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR , JesteDV . Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome. American Journal of Geriatric Psychiatry2013;21(3):251-62. [CSZG: Ref28246]NCT00237796. Functional rehabilitation of older patients with schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00237796 (first received 12 October 2005). ">Granholm 2013</a>; <a href="./references#CD009608-bbs2-0015" title="PennD . A 24-week investigation of group cognitive behavioral therapy (CBT) for medication-resistant auditory hallucinations in 60 patients. Stanley Foundation Research Programs2004. PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52-9. [CSZG: Ref18213]">Penn 2009</a>; <a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a>). The remaining studies recruited participants from one centre only. All studies were conducted in a single nation: the USA (<a href="./references#CD009608-bbs2-0004" title="DanielsL . A group cognitive-behavioural and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness. Journal of Psychotherapy Practice and Research1998;7:167-76. ">Daniels 1998</a>; <a href="./references#CD009608-bbs2-0006" title="GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520-9. [CSZG: Ref11453]GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. Journal of Clinical Psychiatry2007;68:730-7. [CSZG: Ref14560]">Granholm 2007</a>; <a href="./references#CD009608-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR , JesteDV . Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome. American Journal of Geriatric Psychiatry2013;21(3):251-62. [CSZG: Ref28246]NCT00237796. Functional rehabilitation of older patients with schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00237796 (first received 12 October 2005). ">Granholm 2013</a>; <a href="./references#CD009608-bbs2-0008" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82:1173-85. GranholmE , HoldenJ , WorleyM . Improvement in negative symptoms and functioning in cognitive-behavioral social skills training for schizophrenia: mediation by defeatist performance attitudes and asocial beliefs. Schizophrenia Bulletin2018;44:653-61. ">Granholm 2014</a>; <a href="./references#CD009608-bbs2-0009" title="GranholmE ,  HoldenJL , DwyerK , LinkP . Mobile-assisted cognitive-behavioral social skills training in older adults with schizophrenia. Journal of Behavioral and Cognitive Therapy2020;30:13-21. ">Granholm 2020</a>; <a href="./references#CD009608-bbs2-0015" title="PennD . A 24-week investigation of group cognitive behavioral therapy (CBT) for medication-resistant auditory hallucinations in 60 patients. Stanley Foundation Research Programs2004. PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52-9. [CSZG: Ref18213]">Penn 2009</a>), China (<a href="./references#CD009608-bbs2-0005" title="DengM , DingN . Observation on the effect of implementing group CBT for patients with schizophrenia during rehabilitation [对精神分裂症康复期患者实施团体cbt的效果观察]. Contemporary Nurse2014;10:116-8. ">Deng 2014</a>; <a href="./references#CD009608-bbs2-0010" title="GuanT , YangD , HanP . The effect of olanzapine combined with group therapy on paranoid schizophrenia [奥氮平合并团体治疗对偏执型精神分裂症的影响]. Modern Chinese Doctor2016;54:58-61. ">Guan 2016</a>; <a href="./references#CD009608-bbs2-0012" title="LiX , GuoY , FuC , ChenL , ZhangZ . Group cognitive behavioral therapy efficacy for refractory auditory hallucinations in schizophrenia [小组认 知行 为治疗对 精神分裂症顽 固性幻 听的疗效 观察]. Chinese Journal of Rehabilitation2013;28:313-5. ">Li 2013a</a>; <a href="./references#CD009608-bbs2-0013" title="LiJ , DengX , XieY , LiangL . Effects on cognitive function in patients with chronic schizophrenia, cognitive behavioral therapy [认知行为治疗对慢性精神分裂症患者认知功能的影响]. Chinese and foreign medical research2013;24:130-2. ">Li 2013b</a>; <a href="./references#CD009608-bbs2-0016" title="QiH , LiuH . Studies on the efficacy of combining episode male schizophrenic cognitive behavioral therapy [结合认知行为治疗对首发男性精神分裂症的 疗效研究]. Hebei Medical Journal2012;34:3229-31. ">Qi 2012</a>; <a href="./references#CD009608-bbs2-0017" title="QuW . Exploring the impact of cognitive psychotherapy applied to patients with schizophrenia on their cognitive function [探析认知心理治疗应用于精神分裂症患者中对其认知功能的影响]. Psychologist2016;22:32-3. ">Qu 2016</a>; <a href="./references#CD009608-bbs2-0018" title="ShenF , YangYC , DengH . The effect of group cognitive-behavioural therapy for schizophrenia after acute episode. West China Medical Journal2007;22:236-7. ">Shen 2007</a>; <a href="./references#CD009608-bbs2-0019" title="ShiY , JiaoY , JiangL , SunY , BaiZ , WuQ , et al. The effect of cognitive behavioral therapy on executive function of patients with chronic schizophrenia [认知行为治疗对慢性精神分裂症患者执行功能的影响]. Neurological diseases and mental health2015;15:497-9. ">Shi 2015</a>; <a href="./references#CD009608-bbs2-0020" title="SongX , LuiY , ZhangY , ZhouL . Study on the effect of cognitive behavioral therapy on improving the negative symptoms of schizophrenia patients [认知行为治疗对改善精神分裂症病人阴性症状的效果研究]. Psychologist2012;7:30-1. ">Song 2012</a>; <a href="./references#CD009608-bbs2-0021" title="SongX , LiJ , ZhangY , WangX , WangE . Group CBT for patients with schizophrenia and auditory hallucinations: the impact of quality of life [团体cbt对精神分裂症幻听患者生存质量的影响]. International Medicine and Health Guidance News2014;20:2572-4. ">Song 2014</a>; <a href="./references#CD009608-bbs2-0022" title="TaoC , DingS , ZhuY , LiX . Evaluation of comprehensive family knowledge, belief and behavior intervention on the rehabilitation efficacy of schizophrenia patients in the rehabilitation period [家庭综合知信行干预对康复期精神分裂症患者康复疗效的评价]. China Journal of Health Psychology2015;23:970-2. ">Tao 2015</a>; <a href="./references#CD009608-bbs2-0024" title="ZhouJJ . The effect of cognitive behavior therapy on the social function and life quality of schizophrenia patients [认知行为疗法对精神分裂症患者社会功能和生活质量的影响]. Health Research2015;35:539-41. ">Zhou 2015</a>), the UK (<a href="./references#CD009608-bbs2-0001" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive behavioural therapy for schizophrenia – randomised controlled trial. British Journal of Psychiatry2006;189:527-32. [CSZG: Ref14559]BarrowcloughC . An evaluation of the effectiveness of group cognitive therapy for people with recent onset schizophrenia. National Research Register2001;1. [CSZG: Ref12948]">Barrowclough 2006</a>; <a href="./references#CD009608-bbs2-0003" title="ChadwickP , StraussC , JonesAM , KingdonD , EllettL , DannahyL , et al. Group mindfulness-based intervention for distressing voices: a pragmatic randomised controlled trial. Schizophrenia Research2016;175:168-73. ">Chadwick 2016</a>; <a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a>), Turkey (<a href="./references#CD009608-bbs2-0014" title="Mortan SeviO , Tekinsav SutcuS , YesilyurtS , Turan ErogluS , GunesB . Comparison of the effectiveness of two cognitive-behavioral group therapy programs for schizophrenia: results of a short-term randomized control trial. Community Mental Health Journal2020;56:222-8. ">Mortan Sevi 2020</a>), and Germany (<a href="./references#CD009608-bbs2-0002" title="BechdolfA , KnostB , KuntermannC , SchillerS , HambrechtM , KlosterkotterJ , et al. Coping-oriented versus psychoeducational group therapy for post acute patients with schizophrenia: results of a 6 month follow-up. Schizophrenia Research2002;53(Suppl 1):263-4. [CSZG: Ref8053]BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110:21-8. [CSZG: Ref11268]BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144-50. [CSZG: Ref19694]BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112:173-9. [CSZG: Ref18491]BechdolfA . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia: commentary reply. Acta Psychiatrica Scandinavica2006;113:73-4. [CSZG: Ref18490]Munk-JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSZG: Ref18577]">Bechdolf 2004</a>). </p> <p>Three studies enrolled both inpatients and outpatients (<a href="./references#CD009608-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR , JesteDV . Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome. American Journal of Geriatric Psychiatry2013;21(3):251-62. [CSZG: Ref28246]NCT00237796. Functional rehabilitation of older patients with schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00237796 (first received 12 October 2005). ">Granholm 2013</a>; <a href="./references#CD009608-bbs2-0021" title="SongX , LiJ , ZhangY , WangX , WangE . Group CBT for patients with schizophrenia and auditory hallucinations: the impact of quality of life [团体cbt对精神分裂症幻听患者生存质量的影响]. International Medicine and Health Guidance News2014;20:2572-4. ">Song 2014</a>; <a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a>). Eleven studies recruited inpatients only (<a href="./references#CD009608-bbs2-0001" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive behavioural therapy for schizophrenia – randomised controlled trial. British Journal of Psychiatry2006;189:527-32. [CSZG: Ref14559]BarrowcloughC . An evaluation of the effectiveness of group cognitive therapy for people with recent onset schizophrenia. National Research Register2001;1. [CSZG: Ref12948]">Barrowclough 2006</a>; <a href="./references#CD009608-bbs2-0002" title="BechdolfA , KnostB , KuntermannC , SchillerS , HambrechtM , KlosterkotterJ , et al. Coping-oriented versus psychoeducational group therapy for post acute patients with schizophrenia: results of a 6 month follow-up. Schizophrenia Research2002;53(Suppl 1):263-4. [CSZG: Ref8053]BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110:21-8. [CSZG: Ref11268]BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144-50. [CSZG: Ref19694]BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112:173-9. [CSZG: Ref18491]BechdolfA . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia: commentary reply. Acta Psychiatrica Scandinavica2006;113:73-4. [CSZG: Ref18490]Munk-JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSZG: Ref18577]">Bechdolf 2004</a>; <a href="./references#CD009608-bbs2-0005" title="DengM , DingN . Observation on the effect of implementing group CBT for patients with schizophrenia during rehabilitation [对精神分裂症康复期患者实施团体cbt的效果观察]. Contemporary Nurse2014;10:116-8. ">Deng 2014</a>; <a href="./references#CD009608-bbs2-0010" title="GuanT , YangD , HanP . The effect of olanzapine combined with group therapy on paranoid schizophrenia [奥氮平合并团体治疗对偏执型精神分裂症的影响]. Modern Chinese Doctor2016;54:58-61. ">Guan 2016</a>; <a href="./references#CD009608-bbs2-0012" title="LiX , GuoY , FuC , ChenL , ZhangZ . Group cognitive behavioral therapy efficacy for refractory auditory hallucinations in schizophrenia [小组认 知行 为治疗对 精神分裂症顽 固性幻 听的疗效 观察]. Chinese Journal of Rehabilitation2013;28:313-5. ">Li 2013a</a>; <a href="./references#CD009608-bbs2-0013" title="LiJ , DengX , XieY , LiangL . Effects on cognitive function in patients with chronic schizophrenia, cognitive behavioral therapy [认知行为治疗对慢性精神分裂症患者认知功能的影响]. Chinese and foreign medical research2013;24:130-2. ">Li 2013b</a>; <a href="./references#CD009608-bbs2-0016" title="QiH , LiuH . Studies on the efficacy of combining episode male schizophrenic cognitive behavioral therapy [结合认知行为治疗对首发男性精神分裂症的 疗效研究]. Hebei Medical Journal2012;34:3229-31. ">Qi 2012</a>; <a href="./references#CD009608-bbs2-0017" title="QuW . Exploring the impact of cognitive psychotherapy applied to patients with schizophrenia on their cognitive function [探析认知心理治疗应用于精神分裂症患者中对其认知功能的影响]. Psychologist2016;22:32-3. ">Qu 2016</a>; <a href="./references#CD009608-bbs2-0019" title="ShiY , JiaoY , JiangL , SunY , BaiZ , WuQ , et al. The effect of cognitive behavioral therapy on executive function of patients with chronic schizophrenia [认知行为治疗对慢性精神分裂症患者执行功能的影响]. Neurological diseases and mental health2015;15:497-9. ">Shi 2015</a>; <a href="./references#CD009608-bbs2-0020" title="SongX , LuiY , ZhangY , ZhouL . Study on the effect of cognitive behavioral therapy on improving the negative symptoms of schizophrenia patients [认知行为治疗对改善精神分裂症病人阴性症状的效果研究]. Psychologist2012;7:30-1. ">Song 2012</a>; <a href="./references#CD009608-bbs2-0024" title="ZhouJJ . The effect of cognitive behavior therapy on the social function and life quality of schizophrenia patients [认知行为疗法对精神分裂症患者社会功能和生活质量的影响]. Health Research2015;35:539-41. ">Zhou 2015</a>). Nine studies recruited outpatients only (<a href="./references#CD009608-bbs2-0003" title="ChadwickP , StraussC , JonesAM , KingdonD , EllettL , DannahyL , et al. Group mindfulness-based intervention for distressing voices: a pragmatic randomised controlled trial. Schizophrenia Research2016;175:168-73. ">Chadwick 2016</a>; <a href="./references#CD009608-bbs2-0004" title="DanielsL . A group cognitive-behavioural and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness. Journal of Psychotherapy Practice and Research1998;7:167-76. ">Daniels 1998</a>; <a href="./references#CD009608-bbs2-0006" title="GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520-9. [CSZG: Ref11453]GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. Journal of Clinical Psychiatry2007;68:730-7. [CSZG: Ref14560]">Granholm 2007</a>; <a href="./references#CD009608-bbs2-0009" title="GranholmE ,  HoldenJL , DwyerK , LinkP . Mobile-assisted cognitive-behavioral social skills training in older adults with schizophrenia. Journal of Behavioral and Cognitive Therapy2020;30:13-21. ">Granholm 2020</a>; <a href="./references#CD009608-bbs2-0011" title="JonesA . Targeting Reasoning Biases in Delusions; a Pilot Study of the 'Thinking Well Group' [Doctoral thesis]. London (UK): King's College, 2014. ">Jones 2014</a>; <a href="./references#CD009608-bbs2-0014" title="Mortan SeviO , Tekinsav SutcuS , YesilyurtS , Turan ErogluS , GunesB . Comparison of the effectiveness of two cognitive-behavioral group therapy programs for schizophrenia: results of a short-term randomized control trial. Community Mental Health Journal2020;56:222-8. ">Mortan Sevi 2020</a>; <a href="./references#CD009608-bbs2-0015" title="PennD . A 24-week investigation of group cognitive behavioral therapy (CBT) for medication-resistant auditory hallucinations in 60 patients. Stanley Foundation Research Programs2004. PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52-9. [CSZG: Ref18213]">Penn 2009</a>; <a href="./references#CD009608-bbs2-0018" title="ShenF , YangYC , DengH . The effect of group cognitive-behavioural therapy for schizophrenia after acute episode. West China Medical Journal2007;22:236-7. ">Shen 2007</a>; <a href="./references#CD009608-bbs2-0022" title="TaoC , DingS , ZhuY , LiX . Evaluation of comprehensive family knowledge, belief and behavior intervention on the rehabilitation efficacy of schizophrenia patients in the rehabilitation period [家庭综合知信行干预对康复期精神分裂症患者康复疗效的评价]. China Journal of Health Psychology2015;23:970-2. ">Tao 2015</a>). </p> </section> <section id="CD009608-sec-0098"> <h5 class="title">5. Interventions and comparators</h5> <p>For this review, we defined group CBTp as a group intervention targeting psychotic symptoms, based on the cognitive model. In group CBTp, people work collaboratively on coping with distressing hallucinations, analysing evidence for their delusions, problem‐solving skills and social skills. As for concomitant medication, three studies did not report whether participants received any medication (<a href="./references#CD009608-bbs2-0004" title="DanielsL . A group cognitive-behavioural and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness. Journal of Psychotherapy Practice and Research1998;7:167-76. ">Daniels 1998</a>; <a href="./references#CD009608-bbs2-0009" title="GranholmE ,  HoldenJL , DwyerK , LinkP . Mobile-assisted cognitive-behavioral social skills training in older adults with schizophrenia. Journal of Behavioral and Cognitive Therapy2020;30:13-21. ">Granholm 2020</a>; <a href="./references#CD009608-bbs2-0020" title="SongX , LuiY , ZhangY , ZhouL . Study on the effect of cognitive behavioral therapy on improving the negative symptoms of schizophrenia patients [认知行为治疗对改善精神分裂症病人阴性症状的效果研究]. Psychologist2012;7:30-1. ">Song 2012</a>), while in the remaining 15 studies, all or most of the participants received concomitant medication.  </p> <p>The comparator interventions (control psychological therapies and medications) described in the studies can be considered the treatment that a person with schizophrenia would usually receive in a standard mental health service. For this reason, we grouped the comparator interventions together, and we considered them as "standard care" for analyses. </p> <p>One study compared group CBTp to a control psychoeducational group (<a href="./references#CD009608-bbs2-0002" title="BechdolfA , KnostB , KuntermannC , SchillerS , HambrechtM , KlosterkotterJ , et al. Coping-oriented versus psychoeducational group therapy for post acute patients with schizophrenia: results of a 6 month follow-up. Schizophrenia Research2002;53(Suppl 1):263-4. [CSZG: Ref8053]BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110:21-8. [CSZG: Ref11268]BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144-50. [CSZG: Ref19694]BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112:173-9. [CSZG: Ref18491]BechdolfA . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia: commentary reply. Acta Psychiatrica Scandinavica2006;113:73-4. [CSZG: Ref18490]Munk-JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSZG: Ref18577]">Bechdolf 2004</a>). Twelve studies compared group CBTp to standard care (<a href="./references#CD009608-bbs2-0001" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive behavioural therapy for schizophrenia – randomised controlled trial. British Journal of Psychiatry2006;189:527-32. [CSZG: Ref14559]BarrowcloughC . An evaluation of the effectiveness of group cognitive therapy for people with recent onset schizophrenia. National Research Register2001;1. [CSZG: Ref12948]">Barrowclough 2006</a>; <a href="./references#CD009608-bbs2-0003" title="ChadwickP , StraussC , JonesAM , KingdonD , EllettL , DannahyL , et al. Group mindfulness-based intervention for distressing voices: a pragmatic randomised controlled trial. Schizophrenia Research2016;175:168-73. ">Chadwick 2016</a>; <a href="./references#CD009608-bbs2-0005" title="DengM , DingN . Observation on the effect of implementing group CBT for patients with schizophrenia during rehabilitation [对精神分裂症康复期患者实施团体cbt的效果观察]. Contemporary Nurse2014;10:116-8. ">Deng 2014</a>; <a href="./references#CD009608-bbs2-0006" title="GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520-9. [CSZG: Ref11453]GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. Journal of Clinical Psychiatry2007;68:730-7. [CSZG: Ref14560]">Granholm 2007</a>; <a href="./references#CD009608-bbs2-0012" title="LiX , GuoY , FuC , ChenL , ZhangZ . Group cognitive behavioral therapy efficacy for refractory auditory hallucinations in schizophrenia [小组认 知行 为治疗对 精神分裂症顽 固性幻 听的疗效 观察]. Chinese Journal of Rehabilitation2013;28:313-5. ">Li 2013a</a>; <a href="./references#CD009608-bbs2-0014" title="Mortan SeviO , Tekinsav SutcuS , YesilyurtS , Turan ErogluS , GunesB . Comparison of the effectiveness of two cognitive-behavioral group therapy programs for schizophrenia: results of a short-term randomized control trial. Community Mental Health Journal2020;56:222-8. ">Mortan Sevi 2020</a>; <a href="./references#CD009608-bbs2-0017" title="QuW . Exploring the impact of cognitive psychotherapy applied to patients with schizophrenia on their cognitive function [探析认知心理治疗应用于精神分裂症患者中对其认知功能的影响]. Psychologist2016;22:32-3. ">Qu 2016</a>; <a href="./references#CD009608-bbs2-0020" title="SongX , LuiY , ZhangY , ZhouL . Study on the effect of cognitive behavioral therapy on improving the negative symptoms of schizophrenia patients [认知行为治疗对改善精神分裂症病人阴性症状的效果研究]. Psychologist2012;7:30-1. ">Song 2012</a>; <a href="./references#CD009608-bbs2-0021" title="SongX , LiJ , ZhangY , WangX , WangE . Group CBT for patients with schizophrenia and auditory hallucinations: the impact of quality of life [团体cbt对精神分裂症幻听患者生存质量的影响]. International Medicine and Health Guidance News2014;20:2572-4. ">Song 2014</a>; <a href="./references#CD009608-bbs2-0022" title="TaoC , DingS , ZhuY , LiX . Evaluation of comprehensive family knowledge, belief and behavior intervention on the rehabilitation efficacy of schizophrenia patients in the rehabilitation period [家庭综合知信行干预对康复期精神分裂症患者康复疗效的评价]. China Journal of Health Psychology2015;23:970-2. ">Tao 2015</a>; <a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a>; <a href="./references#CD009608-bbs2-0024" title="ZhouJJ . The effect of cognitive behavior therapy on the social function and life quality of schizophrenia patients [认知行为疗法对精神分裂症患者社会功能和生活质量的影响]. Health Research2015;35:539-41. ">Zhou 2015</a>). Two studies compared group CBTp with a wait‐list control (<a href="./references#CD009608-bbs2-0004" title="DanielsL . A group cognitive-behavioural and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness. Journal of Psychotherapy Practice and Research1998;7:167-76. ">Daniels 1998</a>; <a href="./references#CD009608-bbs2-0011" title="JonesA . Targeting Reasoning Biases in Delusions; a Pilot Study of the 'Thinking Well Group' [Doctoral thesis]. London (UK): King's College, 2014. ">Jones 2014</a>). Three studies compared group CBTp to a form of supportive therapy (<a href="./references#CD009608-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR , JesteDV . Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome. American Journal of Geriatric Psychiatry2013;21(3):251-62. [CSZG: Ref28246]NCT00237796. Functional rehabilitation of older patients with schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00237796 (first received 12 October 2005). ">Granholm 2013</a>; <a href="./references#CD009608-bbs2-0008" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82:1173-85. GranholmE , HoldenJ , WorleyM . Improvement in negative symptoms and functioning in cognitive-behavioral social skills training for schizophrenia: mediation by defeatist performance attitudes and asocial beliefs. Schizophrenia Bulletin2018;44:653-61. ">Granholm 2014</a>; <a href="./references#CD009608-bbs2-0015" title="PennD . A 24-week investigation of group cognitive behavioral therapy (CBT) for medication-resistant auditory hallucinations in 60 patients. Stanley Foundation Research Programs2004. PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52-9. [CSZG: Ref18213]">Penn 2009</a>). Five studies compared group CBTp to medication alone (<a href="./references#CD009608-bbs2-0010" title="GuanT , YangD , HanP . The effect of olanzapine combined with group therapy on paranoid schizophrenia [奥氮平合并团体治疗对偏执型精神分裂症的影响]. Modern Chinese Doctor2016;54:58-61. ">Guan 2016</a>; <a href="./references#CD009608-bbs2-0013" title="LiJ , DengX , XieY , LiangL . Effects on cognitive function in patients with chronic schizophrenia, cognitive behavioral therapy [认知行为治疗对慢性精神分裂症患者认知功能的影响]. Chinese and foreign medical research2013;24:130-2. ">Li 2013b</a>; <a href="./references#CD009608-bbs2-0016" title="QiH , LiuH . Studies on the efficacy of combining episode male schizophrenic cognitive behavioral therapy [结合认知行为治疗对首发男性精神分裂症的 疗效研究]. Hebei Medical Journal2012;34:3229-31. ">Qi 2012</a>; <a href="./references#CD009608-bbs2-0018" title="ShenF , YangYC , DengH . The effect of group cognitive-behavioural therapy for schizophrenia after acute episode. West China Medical Journal2007;22:236-7. ">Shen 2007</a>; <a href="./references#CD009608-bbs2-0019" title="ShiY , JiaoY , JiangL , SunY , BaiZ , WuQ , et al. The effect of cognitive behavioral therapy on executive function of patients with chronic schizophrenia [认知行为治疗对慢性精神分裂症患者执行功能的影响]. Neurological diseases and mental health2015;15:497-9. ">Shi 2015</a>). </p> <p>Two studies were three‐arm trials. <a href="./references#CD009608-bbs2-0014" title="Mortan SeviO , Tekinsav SutcuS , YesilyurtS , Turan ErogluS , GunesB . Comparison of the effectiveness of two cognitive-behavioral group therapy programs for schizophrenia: results of a short-term randomized control trial. Community Mental Health Journal2020;56:222-8. ">Mortan Sevi 2020</a> compared group CBTp with standard care and a modified CBT called COPE‐CBT, while <a href="./references#CD009608-bbs2-0009" title="GranholmE ,  HoldenJL , DwyerK , LinkP . Mobile-assisted cognitive-behavioral social skills training in older adults with schizophrenia. Journal of Behavioral and Cognitive Therapy2020;30:13-21. ">Granholm 2020</a> compared group CBTp with a mobile‐assisted group CBTp and an electronic device control. However, we excluded the third arms (COPE‐CBT for <a href="./references#CD009608-bbs2-0014" title="Mortan SeviO , Tekinsav SutcuS , YesilyurtS , Turan ErogluS , GunesB . Comparison of the effectiveness of two cognitive-behavioral group therapy programs for schizophrenia: results of a short-term randomized control trial. Community Mental Health Journal2020;56:222-8. ">Mortan Sevi 2020</a> and electronic device control for <a href="./references#CD009608-bbs2-0009" title="GranholmE ,  HoldenJL , DwyerK , LinkP . Mobile-assisted cognitive-behavioral social skills training in older adults with schizophrenia. Journal of Behavioral and Cognitive Therapy2020;30:13-21. ">Granholm 2020</a>) from the analysis as we deemed them as not part of a CBTp treatment. </p> </section> <section id="CD009608-sec-0099"> <h5 class="title">6. Outcomes</h5> <section id="CD009608-sec-0100"> <h6 class="title">6.1 General</h6> <p>All studies provided efficacy data (either as dichotomous or as continuous outcome) that could be entered into a meta‐analysis. </p> <p>The studies used a variety of scales to assess clinical response, functioning and quality of life. </p> <p>Thirteen studies also reported the number of participants leaving the study early, due to any reason, while the remaining studies did not report this outcome (<a href="./references#CD009608-bbs2-0001" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive behavioural therapy for schizophrenia – randomised controlled trial. British Journal of Psychiatry2006;189:527-32. [CSZG: Ref14559]BarrowcloughC . An evaluation of the effectiveness of group cognitive therapy for people with recent onset schizophrenia. National Research Register2001;1. [CSZG: Ref12948]">Barrowclough 2006</a>; <a href="./references#CD009608-bbs2-0002" title="BechdolfA , KnostB , KuntermannC , SchillerS , HambrechtM , KlosterkotterJ , et al. Coping-oriented versus psychoeducational group therapy for post acute patients with schizophrenia: results of a 6 month follow-up. Schizophrenia Research2002;53(Suppl 1):263-4. [CSZG: Ref8053]BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110:21-8. [CSZG: Ref11268]BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144-50. [CSZG: Ref19694]BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112:173-9. [CSZG: Ref18491]BechdolfA . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia: commentary reply. Acta Psychiatrica Scandinavica2006;113:73-4. [CSZG: Ref18490]Munk-JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSZG: Ref18577]">Bechdolf 2004</a>; <a href="./references#CD009608-bbs2-0003" title="ChadwickP , StraussC , JonesAM , KingdonD , EllettL , DannahyL , et al. Group mindfulness-based intervention for distressing voices: a pragmatic randomised controlled trial. Schizophrenia Research2016;175:168-73. ">Chadwick 2016</a>; <a href="./references#CD009608-bbs2-0005" title="DengM , DingN . Observation on the effect of implementing group CBT for patients with schizophrenia during rehabilitation [对精神分裂症康复期患者实施团体cbt的效果观察]. Contemporary Nurse2014;10:116-8. ">Deng 2014</a>; <a href="./references#CD009608-bbs2-0006" title="GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520-9. [CSZG: Ref11453]GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. Journal of Clinical Psychiatry2007;68:730-7. [CSZG: Ref14560]">Granholm 2007</a>; <a href="./references#CD009608-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR , JesteDV . Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome. American Journal of Geriatric Psychiatry2013;21(3):251-62. [CSZG: Ref28246]NCT00237796. Functional rehabilitation of older patients with schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00237796 (first received 12 October 2005). ">Granholm 2013</a>; <a href="./references#CD009608-bbs2-0008" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82:1173-85. GranholmE , HoldenJ , WorleyM . Improvement in negative symptoms and functioning in cognitive-behavioral social skills training for schizophrenia: mediation by defeatist performance attitudes and asocial beliefs. Schizophrenia Bulletin2018;44:653-61. ">Granholm 2014</a>; <a href="./references#CD009608-bbs2-0012" title="LiX , GuoY , FuC , ChenL , ZhangZ . Group cognitive behavioral therapy efficacy for refractory auditory hallucinations in schizophrenia [小组认 知行 为治疗对 精神分裂症顽 固性幻 听的疗效 观察]. Chinese Journal of Rehabilitation2013;28:313-5. ">Li 2013a</a>; <a href="./references#CD009608-bbs2-0014" title="Mortan SeviO , Tekinsav SutcuS , YesilyurtS , Turan ErogluS , GunesB . Comparison of the effectiveness of two cognitive-behavioral group therapy programs for schizophrenia: results of a short-term randomized control trial. Community Mental Health Journal2020;56:222-8. ">Mortan Sevi 2020</a>; <a href="./references#CD009608-bbs2-0015" title="PennD . A 24-week investigation of group cognitive behavioral therapy (CBT) for medication-resistant auditory hallucinations in 60 patients. Stanley Foundation Research Programs2004. PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52-9. [CSZG: Ref18213]">Penn 2009</a>; <a href="./references#CD009608-bbs2-0019" title="ShiY , JiaoY , JiangL , SunY , BaiZ , WuQ , et al. The effect of cognitive behavioral therapy on executive function of patients with chronic schizophrenia [认知行为治疗对慢性精神分裂症患者执行功能的影响]. Neurological diseases and mental health2015;15:497-9. ">Shi 2015</a>; <a href="./references#CD009608-bbs2-0022" title="TaoC , DingS , ZhuY , LiX . Evaluation of comprehensive family knowledge, belief and behavior intervention on the rehabilitation efficacy of schizophrenia patients in the rehabilitation period [家庭综合知信行干预对康复期精神分裂症患者康复疗效的评价]. China Journal of Health Psychology2015;23:970-2. ">Tao 2015</a>; <a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a>). </p> </section> <section id="CD009608-sec-0101"> <h6 class="title">6.2 Outcome scales providing useable data</h6> <section id="CD009608-sec-0102"> <p><b>6.2.1 Mental state</b></p> <p> <ul id="CD009608-list-0009"> <li> <p>Positive and Negative Syndrome Scale (PANSS) (<a href="./references#CD009608-bbs2-0152" title="KaySR , FiszbeinA , OplerLA . The Positive And Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin1987;13:261-76.">Kay 1987</a>) </p> </li> </ul> </p> <p>The PANSS was developed from the BPRS and the Psychopathology Rating Scale. It is used to evaluate the positive, negative and general symptoms in schizophrenia. The scale has 30 items, and each item is rated on a 7‐point scoring system varying from 'absent' (1) to 'extreme' (7). Higher scores indicate more pronounced symptomatology.  </p> <p> <ul id="CD009608-list-0010"> <li> <p>Brief Psychiatric Rating Scale (BPRS) (<a href="./references#CD009608-bbs2-0180" title="OverallJE , GorhamDR . The Brief Psychiatric Rating Scale. Psychological Reports1962;10:799-812.">Overall 1962</a>) </p> </li> </ul> </p> <p>The BPRS is a scale used to measure the severity of psychiatric symptoms, including psychotic symptoms. The scale usually has 18 items (depending on the version the number of items varies from 16 to 24), and each item is rated on a 7‐point scoring system varying from 'not present' (1) to 'extremely severe' (7). Higher scores indicate more pronounced symptomatology. </p> <p> <ul id="CD009608-list-0011"> <li> <p>Psychotic Symptom Rating Scale (PSYRATS) (<a href="./references#CD009608-bbs2-0137" title="HaddockG , McCarronJ , TarrierN , FaragherEB . Scales to measure dimensions of hallucinations and delusions: the Psychotic Symptom Rating Scales (PSYRATS). Psychological Medicine1999;29:879-89.">Haddock 1999</a>) </p> </li> </ul> </p> <p>The PSYRATS is a medical scale used to measure symptom severity in schizophrenia. It consists of two scales rating auditory hallucinations and delusions. It has 11 items related to auditory hallucinations (frequency, duration, location, loudness, beliefs regarding origin of voices, amount of negative content of voices, degree of negative content of voices, amount of distress, intensity of distress, disruption to life caused by voices and controllability of voices) and six items related to delusions (amount of preoccupation with delusions, duration of preoccupation with delusions, conviction, amount of distress, intensity of distress and disruption to life caused by beliefs). Each symptom is rated on a scale from 0 to 4. Minimum score for PSYRATS is 0 and maximum score is 68. Higher scores indicate more pronounced symptomatology. </p> <p> <ul id="CD009608-list-0012"> <li> <p>Symptom Checklist‐90‐Revised (SCL‐90‐R) (<a href="./references#CD009608-bbs2-0125" title="DerogatisLR . SCL-90-R, Administration, Scoring and Procedures Manual-II for the R(evised) Version and Other Instruments of the Psychopathology Rating Scale Series. Townson (MD): Clinical Psychometric Research, 1992.">Derogatis 1992</a>) </p> </li> </ul> </p> <p>This scale is used to evaluate a broad range of psychological problems and symptoms of psychopathology. It consists of 90 items and yielding nine scores along primary symptom dimensions and three scores among global distress indices. The primary symptom dimensions are: somatisation, obsessive‐compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism and a category of "additional items". The three indices are global wellness index, hardiness and symptom free. Higher scores indicate more pronounced symptomatology. </p> <p> <ul id="CD009608-list-0013"> <li> <p>Scale for the Assessment of Positive Symptoms (SAPS) (<a href="./references#CD009608-bbs2-0108" title="AndreasenNC , FlaumM , ArndtS , AlligerR , SwayzeVW . Positive and negative symptoms: assessment and validity. In: MarnerosA , AndreasenNC , TsuangMT , editors(s). Negative Versus Positive Schizophrenia. Berlin (Germany): Springer, 1991.">Andreasen 1991</a>) </p> </li> </ul> </p> <p>The SAPS is used to measure the positive symptoms of schizophrenia. It consists of four subscales that evaluate four different aspects of positive symptoms: hallucinations, delusions, bizarre behaviour and positive formal thought disorder. Higher scores indicate more pronounced symptomatology. </p> <p> <ul id="CD009608-list-0014"> <li> <p>Scale for the Assessment of Negative Symptoms (SANS) (<a href="./references#CD009608-bbs2-0108" title="AndreasenNC , FlaumM , ArndtS , AlligerR , SwayzeVW . Positive and negative symptoms: assessment and validity. In: MarnerosA , AndreasenNC , TsuangMT , editors(s). Negative Versus Positive Schizophrenia. Berlin (Germany): Springer, 1991.">Andreasen 1991</a>) </p> </li> </ul> </p> <p>The SANS is used to measure the negative symptoms of schizophrenia. It consists of five subscales that evaluate five different aspects of negative symptoms: alogia, affective blunting, avolition‐apathy, anhedonia‐asociality and attentional impairment. Higher scores indicate more pronounced symptomatology. </p> <p> <ul id="CD009608-list-0015"> <li> <p>Auditory Hallucinations Rating Scale (AHRS) (<a href="./references#CD009608-bbs2-0145" title="HoffmanRE , HawkinsKA , GueorguievaR , BoutrosNN , RachidF , CarrollK , et al. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Archives of General Psychiatry2003;60:49-56.">Hoffman 2003</a>) </p> </li> </ul> </p> <p>The AHRS is an English‐language structured tool developed to measure the effect of repetitive transcranial magnetic stimulation in hallucinating people with schizophrenia. It has seven items. It aims at assessing hallucination frequency, number of distinct speaking voices, perceived loudness, vividness, attentional salience (the degree to which hallucinations captured the attention of the patient), length of hallucinations (single words, phrases, sentences, or extended discourse) and degree of distress. Higher scores indicate more pronounced symptomatology. </p> <p> <ul id="CD009608-list-0016"> <li> <p>Hospital Anxiety and Depression Scale (HADS) (<a href="./references#CD009608-bbs2-0209" title="ZigmondAS , SnaithRP . The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica1983;67:361-70.">Zigmond 1983</a>) </p> </li> </ul> </p> <p>The HADS is used to detect states of depression and anxiety in the setting of a hospital medical outpatient clinic. The anxiety and depressive subscales are also measures of severity of the emotional disorder. Higher scores indicate more pronounced symptomatology. </p> <p> <ul id="CD009608-list-0017"> <li> <p>Hamilton Rating Scale for Depression (HAMD) (<a href="./references#CD009608-bbs2-0139" title="HamiltonM . Development of a rating scale for primary depressive illness. British Journal of Social Psychology1967;6:278-96.">Hamilton 1967</a>) </p> </li> </ul> </p> <p>The HAMD is 17‐item scale used to assess the severity of depression. Each item is rated on 3‐ or 5‐point scale. Higher score indicates severe depression. Higher scores indicate more pronounced symptomatology. </p> <p> <ul id="CD009608-list-0018"> <li> <p>Hamilton Anxiety Rating Scale (HARS) (<a href="./references#CD009608-bbs2-0138" title="HamiltonM . The assessment of anxiety states by rating. British Journal of Medical Psychology1959;32:50-5.">Hamilton 1959</a>) </p> </li> </ul> </p> <p>The HARs is 14‐item scale used to assess the severity of anxiety. Each item was rated on 5‐point scale. Higher score indicates severe anxiety. Higher scores indicate more pronounced symptomatology. </p> <p> <ul id="CD009608-list-0019"> <li> <p>Beck Depression Inventory‐II (BDI‐II) (<a href="./references#CD009608-bbs2-0115" title="BeckAT , SteerRA , BrownGK . Manual for the Beck Depression Inventory-II. San Antonio (TX): The Psychological Corporation, 1996.">Beck 1996</a>) </p> </li> </ul> </p> <p>The BDI‐II scale is a 21‐item, self‐report questionnaire which measures the severity of depressive symptoms. Higher scores indicate more pronounced symptomatology. </p> <p> <ul id="CD009608-list-0020"> <li> <p>Montgomery‐Asberg Depression Rating Scale (MADRS) (<a href="./references#CD009608-bbs2-0172" title="MontgomerySA , AsbergM . A new depression scale designed to be sensitive to change. British Journal of Psychiatry1979;134:382-9.">Montgomery 1979</a>) </p> </li> </ul> </p> <p>The MADRS is a 10‐item, self‐report questionnaire that measures the severity of depressive symptoms. It is designed to be sensitive to change resulting from antidepressant therapy. Higher scores indicate more pronounced symptomatology. </p> <p> <ul id="CD009608-list-0021"> <li> <p>Beck Anxiety Inventory (BAI) (<a href="./references#CD009608-bbs2-0114" title="BeckAT , SteerRA . Manual for the Beck Anxiety Inventory. San Antonio (TX): Psychological Corporation, 1990.">Beck 1990</a>) </p> </li> </ul> </p> <p>The BAI is a 21‐item self‐report questionnaire that measures the intensity of depressive symptoms. Higher scores indicate more pronounced symptomatology. </p> <p> <ul id="CD009608-list-0022"> <li> <p>Social Avoidance and Distress Scale (SAD) (<a href="./references#CD009608-bbs2-0202" title="WatsonD , FriendR . Measurement of social-evaluative anxiety. Journal of Consulting and Clinical Psychology1969;33:448-57.">Watson 1969</a>) </p> </li> </ul> </p> <p>The SAD is a 280‐item true/false scale that measures aspects of social anxiety including distress, discomfort, fear and avoidance. Higher scores indicate more pronounced symptomatology. </p> </section> <section id="CD009608-sec-0103"> <p><b>6.2.2. Quality of life</b></p> <p> <ul id="CD009608-list-0023"> <li> <p>Modular System for Quality of Life (MSQoL) (<a href="./references#CD009608-bbs2-0182" title="PukropR , MollerHJ , SteinmeyerEM . Quality of life in psychiatry. A systematic contribution to construct validation and the development of the integrative assessment tool modular system of quality of life. European Archives of Psychiatry and Clinical Neuroscience2000;250:120-32.">Pukrop 2000</a>) </p> </li> </ul> </p> <p>The MSQoL is an integrative questionnaire that consists of one "G‐factor" (life in general) and six specific dimensions (physical health, vitality, psychosocial relationships, material resources, affect, leisure time). This basic structure represents a core module measured by 47 items. Higher scores indicate better quality of life. </p> <p> <ul id="CD009608-list-0024"> <li> <p>Quality of Life Scale (QLS) (<a href="./references#CD009608-bbs2-0141" title="HeinrichsDW , HanlonTE , Carpenter WT Jr. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin1984;10:388-98.">Heinrichs 1984</a>) </p> </li> </ul> </p> <p>The QLS is a 21‐item scale based on a semi‐structured interview designed to assess deficit symptoms in interpersonal relations, instrumental role, intrapsychic foundations, common object and activities. Higher scores indicate better quality of life. </p> <p> <ul id="CD009608-list-0025"> <li> <p>WHOQOL‐BREF (<a href="./references#CD009608-bbs2-0204" title="The WHQOL Group. WHOQOL-BREF. Introduction, administration, scoring and generic version of the assessment: field trial version. apps.who.int/iris/handle/10665/63529 (accessed prior to 7 June 2022).">WHOQOL Group 1996</a>) </p> </li> </ul> </p> <p>The WHOQOL‐BREF is an abbreviated version of the World Health Organization Quality of Life Assessment Instrument (WHOQOL‐100; <a href="./references#CD009608-bbs2-0203" title="The WHOQOL Group. The development of the World Health Organization Quality of Life Assessment Instrument (the WHOQOL). In: OrleyJ , KuykenW , editors(s). Quality of Life Assessment: International Perspectives. Berlin (Germany): Springer, 1994.">WHOQOL Group 1994</a>). It is a 26‐item quality of life assessment consisting of four domains: Physical, Psychological, Social relationships and Environment. Higher scores indicate better quality of life. </p> <p> <ul id="CD009608-list-0026"> <li> <p>General Quality of Life Inventory‐74 (GQOLI‐74) (<a href="./references#CD009608-bbs2-0167" title="LuW , CuiY , ChenX , ZhengY , GuK , CaiH , et al. Changes in quality of life among breast cancer patients three years post-diagnosis. Breast Cancer Research and Therapy2009;114:357-69.">Lu 2009</a>) </p> </li> </ul> </p> <p>The GQOLI‐74 was developed based on the WHOQOL‐100 and was modified for use in a Chinese population. The inventory comprises 74 items that can be grouped into 20 facets and covers the following four domains: Physical well‐being (sleep and energy, pain and physical discomfort, eating function, sexual function, daily living capability); Psychological well‐being (psychological distress, negative feelings, positive feelings, cognitive function, body image); Social well‐being (social support, interpersonal relationships, work and study capacity, recreational and leisure activities, marriage and family); and Material well‐being (housing situation, community services, living environment, financial situation). Patients’ responses are converted to scores on a 0 to 100 scale for each domain and each facet. Higher scores indicate better quality of life. </p> </section> <section id="CD009608-sec-0104"> <p><b>6.2.3 Social functioning</b></p> <p> <ul id="CD009608-list-0027"> <li> <p>Global Assessment of Functioning (GAF) (<a href="./references#CD009608-bbs2-0110" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). 4th – revised edition. Washington (DC): American Psychiatric Press, 2000.">APA 2000</a>) </p> </li> </ul> </p> <p>GAF rates the social, occupational and psychological functioning on a hypothetical continuum of mental health illness. The lowest scores are 1 to 10 corresponding to 'Persistent danger of severely hurting self or others OR persistent inability to maintain minimal personal hygiene OR serious suicidal act with clear expectation of death' and the highest scores are 91 to 100 corresponding to 'No symptoms, life's problems never seem to get out of hand, is sought out by others because of his or her many positive qualities'. Higher scores indicate better social functioning. </p> <p> <ul id="CD009608-list-0028"> <li> <p>Social Behaviour Schedule (SBS) (<a href="./references#CD009608-bbs2-0206" title="WykesT , SturtE . The measurement of social behaviour in psychiatric patients: an assessment of the reliability and validity of the SBS schedule. British Journal of Psychiatry1986;148:1-11.">Wykes 1986</a>) </p> </li> </ul> </p> <p>The SBS is a 30‐item scale which measures 21 different social behaviours and nine activities. Higher scores indicate worse social functioning. </p> <p> <ul id="CD009608-list-0029"> <li> <p>Social Functioning Scale (SFS) (<a href="./references#CD009608-bbs2-0117" title="BirchwoodM , SmithJ , CochraneR , WettonS , CopestakeS . The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry1990;157:853-9.">Birchwood 1990</a>) </p> </li> </ul> </p> <p>The SFS measures social role and behavioural functioning across seven basic areas of community functioning: social engagement, interpersonal behaviour, prosocial activities, recreation, independence and employment. Higher scores indicate better social functioning. </p> <p> <ul id="CD009608-list-0030"> <li> <p>Independent Living Skills Survey (ILSS) (<a href="./references#CD009608-bbs2-0199" title="WallaceCJ , LibermanRP , TauberR , WallaceJ . The Independent Living Skills Survey: a comprehensive measure of the community functioning of severely and persistently mentally ill individuals. Schizophrenia Bulletin2000;26:631-58.">Wallace 2000</a>) </p> </li> </ul> </p> <p>The ILSS is a comprehensive, objective, performance‐focused measure of the basic functional living skills of individuals with severe and persistent mental illness to obtain a view of their community adjustment. Higher scores indicate better social functioning. </p> <p> <ul id="CD009608-list-0031"> <li> <p>Personal and Social Performance Scale (PSP) (<a href="./references#CD009608-bbs2-0174" title="MorosiniPL , MaglianoL , BrambillaL , UgoliniS , PioliR . Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatrica Scandinavica2000;101:323-9.">Morosini 2000</a>) </p> </li> </ul> </p> <p>This scale assesses functioning across four dimensions (socially useful activities, personal and social relationships, self‐care, disturbing and aggressive behaviours) rather than one global score. It is a revision of is a revision of the Social and Occupational Functioning Assessment Scale (SOFAS; <a href="./references#CD009608-bbs2-0109" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th edition. Washington (DC): American Psychiatric Press, 1994.">APA 1994</a>). Higher scores indicate better social functioning. </p> <p> <ul id="CD009608-list-0032"> <li> <p>Inpatient Psychiatric Rehabilitation Outcome Scale (IPROS) (<a href="./references#CD009608-bbs2-0164" title="LiG , HuX , JinD , TianW , PhillipsM . A rating instrument for the evaluation of in-patient rehabilitation programmes in China: results of reliability and validity testing. British Journal of Psychiatry1994;165:58-65.">Li 1994</a>) </p> </li> </ul> </p> <p>The IPROS aims at objectively evaluating inpatient rehabilitation programmes. It has five subscales: performance in occupational therapy, daily activities, socialisation, personal hygiene and level of interest in external events. Evaluators (physicians or nurses) observe patients for one week before coding items on a 5‐point scale. Higher scores indicate worse social functioning. </p> <p> <ul id="CD009608-list-0033"> <li> <p>Social Disability Screening Schedule (SDSS) (<a href="./references#CD009608-bbs2-0165" title="LiuZ , GaoB , YuanS . The rating scale of social ability: development, and testing of reliability and validity. Chinese Journal of Clinical Psychology2005;1:19-22.">Liu 2005</a>) </p> </li> </ul> </p> <p>The SDSS scale is composed of 10 items, which is used to assess social function. Each item is scored from 0 = healthy or very minor defects to 2 = severe defect. Higher scores indicate worse social functioning. </p> </section> </section> </section> </section> <section id="CD009608-sec-0105"> <h4 class="title">Excluded studies</h4> <p>Overall, we excluded 73 studies from the systematic review (see <a href="#CD009608-fig-0004">Figure 4</a> and <a href="./references#CD009608-sec-0226" title="">Characteristics of excluded studies</a> table for more information). </p> </section> <section id="CD009608-sec-0106"> <h4 class="title">Awaiting classification</h4> <p>We identified five studies awaiting classification (<a href="./references#CD009608-bbs2-0098" title="BrennerHD , HodelB , KubeG , RoderV . Cognitive therapy with schizophrenics: analysis of the problem and experimental results. Nervenarzt1987;58:72-83. ">Brenner 1987</a>; <a href="./references#CD009608-bbs2-0099" title="ChungYC , KimJH , EunHB , HwangIK . Effect of cognitive-behavioral therapy on the delusion in schizophrenic patients. Journal of the Korean Neuropsychiatric Association2001;40:63-71. ">Chung 2001</a>; <a href="./references#CD009608-bbs2-0101" title="KlingbergS , WiedemannG , BuchkremerG . Cognitive-behavioural therapy for schizophrenic patients – design and preliminary results of a randomised effectiveness trial. Zeitschrift Für Klinische Psychologie Und Psychotherapie2001;30:259-67. ">Klingberg 2001</a>; <a href="./references#CD009608-bbs2-0102" title="KraemerS , SulzKH , SchmidR , LassleR . Cognitive therapy of schizophrenic patients: a control study. Nervenarzt1987;58:84-90. ">Kraemer 1987</a>; <a href="./references#CD009608-bbs2-0103" title="McLeodT , MorrisM , BirchwoodM , DoveyA . Cognitive behavioural therapy group work with voice hearers. Part 1. British Journal of Nursing2007;16:248-52. McLeodT , MorrisM , BirchwoodM , DoveyA . Cognitive behavioural therapy group work with voice hearers. Part 2. British Journal of Nursing2007;16:292-5. ">McLeod 2007</a>; see <a href="./references#CD009608-bbs1-0003" title="">Studies awaiting classification</a> table for details), as it was not possible to obtain data based on the title, abstract, full‐text or a combination of these. We tried to contact the authors of most of those studies to request data, but were unsuccessful. See <a href="#CD009608-tbl-0002">Table 1</a> for details on the way we contacted authors. </p> </section> <section id="CD009608-sec-0107"> <h4 class="title">Ongoing studies</h4> <p>The search of the Cochrane Schizophrenia Trial registry found two ongoing studies (<a href="./references#CD009608-bbs2-0105" title="IRCT 20180817040818N. The effect of cognitive-behavioral group training of self-care skills on positive, negative symptoms, general psychopathology and self-care in patients with schizophrenia. en.irct.ir/trial/47632 (first received 25 July 2020). [IRANIAN REGISTRY OF CLINICAL TRIAL: IRCT20180817040818N2]">IRCT 20180817040818N</a>; <a href="./references#CD009608-bbs2-0106" title="NCT04144075. Application of a mindfulness and self-compassion program in patients with schizophrenia. Randomized controlled trial (ACAMP2020). clinicaltrials.gov/ct2/show/NCT04144075 (first received 30 October 2019). [CLINICALTRIALS.GOV: NCT04144075]">NCT04144075</a>; see <a href="./references#CD009608-sec-0228" title="">Characteristics of ongoing studies</a> table for more information). </p> </section> </section> <section id="CD009608-sec-0108"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="./references#CD009608-sec-0225" title="">Characteristics of included studies</a> table, <a href="#CD009608-fig-0002">Figure 2</a>, and <a href="#CD009608-fig-0003">Figure 3</a>. </p> <p>The overall methodological quality of the studies was medium to low; every study was judged as having high or unclear risk of bias in at least one domain (see <a href="#CD009608-fig-0002">Figure 2</a> and <a href="#CD009608-fig-0003">Figure 3</a> for summary graphs). </p> <section id="CD009608-sec-0109"> <h4 class="title">Allocation</h4> <p>We judged five studies that reported details of the randomisation procedure at low risk of bias (<a href="./references#CD009608-bbs2-0002" title="BechdolfA , KnostB , KuntermannC , SchillerS , HambrechtM , KlosterkotterJ , et al. Coping-oriented versus psychoeducational group therapy for post acute patients with schizophrenia: results of a 6 month follow-up. Schizophrenia Research2002;53(Suppl 1):263-4. [CSZG: Ref8053]BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110:21-8. [CSZG: Ref11268]BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144-50. [CSZG: Ref19694]BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112:173-9. [CSZG: Ref18491]BechdolfA . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia: commentary reply. Acta Psychiatrica Scandinavica2006;113:73-4. [CSZG: Ref18490]Munk-JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSZG: Ref18577]">Bechdolf 2004</a>; <a href="./references#CD009608-bbs2-0010" title="GuanT , YangD , HanP . The effect of olanzapine combined with group therapy on paranoid schizophrenia [奥氮平合并团体治疗对偏执型精神分裂症的影响]. Modern Chinese Doctor2016;54:58-61. ">Guan 2016</a>; <a href="./references#CD009608-bbs2-0015" title="PennD . A 24-week investigation of group cognitive behavioral therapy (CBT) for medication-resistant auditory hallucinations in 60 patients. Stanley Foundation Research Programs2004. PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52-9. [CSZG: Ref18213]">Penn 2009</a>; <a href="./references#CD009608-bbs2-0021" title="SongX , LiJ , ZhangY , WangX , WangE . Group CBT for patients with schizophrenia and auditory hallucinations: the impact of quality of life [团体cbt对精神分裂症幻听患者生存质量的影响]. International Medicine and Health Guidance News2014;20:2572-4. ">Song 2014</a>; <a href="./references#CD009608-bbs2-0024" title="ZhouJJ . The effect of cognitive behavior therapy on the social function and life quality of schizophrenia patients [认知行为疗法对精神分裂症患者社会功能和生活质量的影响]. Health Research2015;35:539-41. ">Zhou 2015</a>). The remaining studies did not report details about the randomisation procedure, and so we judged them as having unclear risk of bias. </p> <p><a href="./references#CD009608-bbs2-0001" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive behavioural therapy for schizophrenia – randomised controlled trial. British Journal of Psychiatry2006;189:527-32. [CSZG: Ref14559]BarrowcloughC . An evaluation of the effectiveness of group cognitive therapy for people with recent onset schizophrenia. National Research Register2001;1. [CSZG: Ref12948]">Barrowclough 2006</a>, <a href="./references#CD009608-bbs2-0008" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82:1173-85. GranholmE , HoldenJ , WorleyM . Improvement in negative symptoms and functioning in cognitive-behavioral social skills training for schizophrenia: mediation by defeatist performance attitudes and asocial beliefs. Schizophrenia Bulletin2018;44:653-61. ">Granholm 2014</a>, <a href="./references#CD009608-bbs2-0015" title="PennD . A 24-week investigation of group cognitive behavioral therapy (CBT) for medication-resistant auditory hallucinations in 60 patients. Stanley Foundation Research Programs2004. PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52-9. [CSZG: Ref18213]">Penn 2009</a>, and <a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a> described measures to prevent participants or trial personnel from knowing the forthcoming allocation, and we judged them at low risk of bias. The remaining studies report no details on allocation concealment, and we judged them at unclear risk of bias. </p> </section> <section id="CD009608-sec-0110"> <h4 class="title">Blinding</h4> <p>Given the nature of the intervention, blinding of participants and personnel was not attainable. Therefore, we considered all studies at high risk of bias for the blinding of participants and personnel risk of bias.  </p> <p>Concerning detection bias, 10 studies specified that raters were blind to treatment allocation, and were at low risk of bias (<a href="./references#CD009608-bbs2-0001" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive behavioural therapy for schizophrenia – randomised controlled trial. British Journal of Psychiatry2006;189:527-32. [CSZG: Ref14559]BarrowcloughC . An evaluation of the effectiveness of group cognitive therapy for people with recent onset schizophrenia. National Research Register2001;1. [CSZG: Ref12948]">Barrowclough 2006</a>; <a href="./references#CD009608-bbs2-0002" title="BechdolfA , KnostB , KuntermannC , SchillerS , HambrechtM , KlosterkotterJ , et al. Coping-oriented versus psychoeducational group therapy for post acute patients with schizophrenia: results of a 6 month follow-up. Schizophrenia Research2002;53(Suppl 1):263-4. [CSZG: Ref8053]BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110:21-8. [CSZG: Ref11268]BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144-50. [CSZG: Ref19694]BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112:173-9. [CSZG: Ref18491]BechdolfA . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia: commentary reply. Acta Psychiatrica Scandinavica2006;113:73-4. [CSZG: Ref18490]Munk-JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSZG: Ref18577]">Bechdolf 2004</a>; <a href="./references#CD009608-bbs2-0003" title="ChadwickP , StraussC , JonesAM , KingdonD , EllettL , DannahyL , et al. Group mindfulness-based intervention for distressing voices: a pragmatic randomised controlled trial. Schizophrenia Research2016;175:168-73. ">Chadwick 2016</a>; <a href="./references#CD009608-bbs2-0004" title="DanielsL . A group cognitive-behavioural and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness. Journal of Psychotherapy Practice and Research1998;7:167-76. ">Daniels 1998</a>; <a href="./references#CD009608-bbs2-0006" title="GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520-9. [CSZG: Ref11453]GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. Journal of Clinical Psychiatry2007;68:730-7. [CSZG: Ref14560]">Granholm 2007</a>; <a href="./references#CD009608-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR , JesteDV . Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome. American Journal of Geriatric Psychiatry2013;21(3):251-62. [CSZG: Ref28246]NCT00237796. Functional rehabilitation of older patients with schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00237796 (first received 12 October 2005). ">Granholm 2013</a>; <a href="./references#CD009608-bbs2-0008" title="GranholmE , HoldenJ , LinkPC , McQuaidJR . Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. Journal of Consulting and Clinical Psychology2014;82:1173-85. GranholmE , HoldenJ , WorleyM . Improvement in negative symptoms and functioning in cognitive-behavioral social skills training for schizophrenia: mediation by defeatist performance attitudes and asocial beliefs. Schizophrenia Bulletin2018;44:653-61. ">Granholm 2014</a>; <a href="./references#CD009608-bbs2-0009" title="GranholmE ,  HoldenJL , DwyerK , LinkP . Mobile-assisted cognitive-behavioral social skills training in older adults with schizophrenia. Journal of Behavioral and Cognitive Therapy2020;30:13-21. ">Granholm 2020</a>; <a href="./references#CD009608-bbs2-0015" title="PennD . A 24-week investigation of group cognitive behavioral therapy (CBT) for medication-resistant auditory hallucinations in 60 patients. Stanley Foundation Research Programs2004. PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52-9. [CSZG: Ref18213]">Penn 2009</a>; <a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a>). Thirteen studies provided no information on blinding of raters, and were at unclear risk of bias (<a href="./references#CD009608-bbs2-0005" title="DengM , DingN . Observation on the effect of implementing group CBT for patients with schizophrenia during rehabilitation [对精神分裂症康复期患者实施团体cbt的效果观察]. Contemporary Nurse2014;10:116-8. ">Deng 2014</a>; <a href="./references#CD009608-bbs2-0010" title="GuanT , YangD , HanP . The effect of olanzapine combined with group therapy on paranoid schizophrenia [奥氮平合并团体治疗对偏执型精神分裂症的影响]. Modern Chinese Doctor2016;54:58-61. ">Guan 2016</a>; <a href="./references#CD009608-bbs2-0012" title="LiX , GuoY , FuC , ChenL , ZhangZ . Group cognitive behavioral therapy efficacy for refractory auditory hallucinations in schizophrenia [小组认 知行 为治疗对 精神分裂症顽 固性幻 听的疗效 观察]. Chinese Journal of Rehabilitation2013;28:313-5. ">Li 2013a</a>; <a href="./references#CD009608-bbs2-0013" title="LiJ , DengX , XieY , LiangL . Effects on cognitive function in patients with chronic schizophrenia, cognitive behavioral therapy [认知行为治疗对慢性精神分裂症患者认知功能的影响]. Chinese and foreign medical research2013;24:130-2. ">Li 2013b</a>; <a href="./references#CD009608-bbs2-0014" title="Mortan SeviO , Tekinsav SutcuS , YesilyurtS , Turan ErogluS , GunesB . Comparison of the effectiveness of two cognitive-behavioral group therapy programs for schizophrenia: results of a short-term randomized control trial. Community Mental Health Journal2020;56:222-8. ">Mortan Sevi 2020</a>; <a href="./references#CD009608-bbs2-0016" title="QiH , LiuH . Studies on the efficacy of combining episode male schizophrenic cognitive behavioral therapy [结合认知行为治疗对首发男性精神分裂症的 疗效研究]. Hebei Medical Journal2012;34:3229-31. ">Qi 2012</a>; <a href="./references#CD009608-bbs2-0017" title="QuW . Exploring the impact of cognitive psychotherapy applied to patients with schizophrenia on their cognitive function [探析认知心理治疗应用于精神分裂症患者中对其认知功能的影响]. Psychologist2016;22:32-3. ">Qu 2016</a>; <a href="./references#CD009608-bbs2-0018" title="ShenF , YangYC , DengH . The effect of group cognitive-behavioural therapy for schizophrenia after acute episode. West China Medical Journal2007;22:236-7. ">Shen 2007</a>; <a href="./references#CD009608-bbs2-0019" title="ShiY , JiaoY , JiangL , SunY , BaiZ , WuQ , et al. The effect of cognitive behavioral therapy on executive function of patients with chronic schizophrenia [认知行为治疗对慢性精神分裂症患者执行功能的影响]. Neurological diseases and mental health2015;15:497-9. ">Shi 2015</a>; <a href="./references#CD009608-bbs2-0020" title="SongX , LuiY , ZhangY , ZhouL . Study on the effect of cognitive behavioral therapy on improving the negative symptoms of schizophrenia patients [认知行为治疗对改善精神分裂症病人阴性症状的效果研究]. Psychologist2012;7:30-1. ">Song 2012</a>; <a href="./references#CD009608-bbs2-0021" title="SongX , LiJ , ZhangY , WangX , WangE . Group CBT for patients with schizophrenia and auditory hallucinations: the impact of quality of life [团体cbt对精神分裂症幻听患者生存质量的影响]. International Medicine and Health Guidance News2014;20:2572-4. ">Song 2014</a>; <a href="./references#CD009608-bbs2-0022" title="TaoC , DingS , ZhuY , LiX . Evaluation of comprehensive family knowledge, belief and behavior intervention on the rehabilitation efficacy of schizophrenia patients in the rehabilitation period [家庭综合知信行干预对康复期精神分裂症患者康复疗效的评价]. China Journal of Health Psychology2015;23:970-2. ">Tao 2015</a>; <a href="./references#CD009608-bbs2-0024" title="ZhouJJ . The effect of cognitive behavior therapy on the social function and life quality of schizophrenia patients [认知行为疗法对精神分裂症患者社会功能和生活质量的影响]. Health Research2015;35:539-41. ">Zhou 2015</a>). One study clearly specified that it was not possible for the experimenter to be blind to the treatment allocation (<a href="./references#CD009608-bbs2-0011" title="JonesA . Targeting Reasoning Biases in Delusions; a Pilot Study of the 'Thinking Well Group' [Doctoral thesis]. London (UK): King's College, 2014. ">Jones 2014</a>). This could have created bias in assessment. Therefore, we judged it at high risk of bias.  </p> </section> <section id="CD009608-sec-0111"> <h4 class="title">Incomplete outcome data</h4> <p>Overall rate of participants leaving the study early was with group CBTp and standard care. All studies except for one (<a href="./references#CD009608-bbs2-0004" title="DanielsL . A group cognitive-behavioural and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness. Journal of Psychotherapy Practice and Research1998;7:167-76. ">Daniels 1998</a>) did not seem to have differences in attrition between the groups, and were at low risk of bias. <a href="./references#CD009608-bbs2-0004" title="DanielsL . A group cognitive-behavioural and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness. Journal of Psychotherapy Practice and Research1998;7:167-76. ">Daniels 1998</a> showed contradictory information on the number of participants, mentioning 40 in the "Subjects" section and 20 on the "Treatment" section. We judged this study at high risk of bias. </p> </section> <section id="CD009608-sec-0112"> <h4 class="title">Selective reporting</h4> <p>None of the studies had published protocols. Three studies did not report all the data, and were at high risk of bias (<a href="./references#CD009608-bbs2-0004" title="DanielsL . A group cognitive-behavioural and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness. Journal of Psychotherapy Practice and Research1998;7:167-76. ">Daniels 1998</a>; <a href="./references#CD009608-bbs2-0006" title="GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520-9. [CSZG: Ref11453]GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. Journal of Clinical Psychiatry2007;68:730-7. [CSZG: Ref14560]">Granholm 2007</a>; <a href="./references#CD009608-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR , JesteDV . Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome. American Journal of Geriatric Psychiatry2013;21(3):251-62. [CSZG: Ref28246]NCT00237796. Functional rehabilitation of older patients with schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00237796 (first received 12 October 2005). ">Granholm 2013</a>). <a href="./references#CD009608-bbs2-0004" title="DanielsL . A group cognitive-behavioural and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness. Journal of Psychotherapy Practice and Research1998;7:167-76. ">Daniels 1998</a> mentioned using PANSS as a screening tool for positive symptoms, but the author did not report the scores. <a href="./references#CD009608-bbs2-0006" title="GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520-9. [CSZG: Ref11453]GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. Journal of Clinical Psychiatry2007;68:730-7. [CSZG: Ref14560]">Granholm 2007</a> reported some outcomes in unusable diagrams. <a href="./references#CD009608-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR , JesteDV . Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome. American Journal of Geriatric Psychiatry2013;21(3):251-62. [CSZG: Ref28246]NCT00237796. Functional rehabilitation of older patients with schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00237796 (first received 12 October 2005). ">Granholm 2013</a> did not report data on PANSS negative outcome result. The remaining studies showed no evidence of selective outcome reporting. We judged them at low risk of bias. </p> </section> <section id="CD009608-sec-0113"> <h4 class="title">Other potential sources of bias</h4> <p>We found no evidence of other potential source of bias for all the included studies. </p> </section> </section> <section id="CD009608-sec-0114"> <h3 class="title" id="CD009608-sec-0114">Effects of interventions</h3> <p>See: <a href="./full#CD009608-tbl-0001"><b>Summary of findings 1</b> Group cognitive behavioural therapy for psychosis compared to standard care for schizophrenia</a> </p> <section id="CD009608-sec-0115"> <h4 class="title">Primary outcome</h4> <section id="CD009608-sec-0116"> <h5 class="title">1. Global state</h5> <section id="CD009608-sec-0117"> <h6 class="title">1.1 Clinically important change, shown as improved</h6> <p>No studies reported global state: clinically important change – as defined by individual studies.  </p> </section> </section> </section> <section id="CD009608-sec-0118"> <h4 class="title">Secondary outcomes</h4> <section id="CD009608-sec-0119"> <h5 class="title">1. Global state</h5> <section id="CD009608-sec-0120"> <h6 class="title">1.1 Any change</h6> <p>No studies reported global state: any change – as defined by individual studies. </p> </section> <section id="CD009608-sec-0121"> <h6 class="title">1.2 Relapse – end of treatment</h6> <p>No studies reported global change: relapse. </p> </section> <section id="CD009608-sec-0122"> <h6 class="title">1.3 Average endpoint or change score on global state scale</h6> <p>No studies reported global change: average endpoint or change score on global state scale. </p> </section> </section> <section id="CD009608-sec-0123"> <h5 class="title">2. Leaving the study early</h5> <section id="CD009608-sec-0124"> <h6 class="title">2.1 Leaving the study early: for any reason – end of treatment</h6> <p>There was no clear difference between CBTp and standard care and other psychosocial interventions for numbers of participants leaving the study early (RR 1.22, 95% CI 0.94 to 1.59; studies = 13, participants = 1267; I<sup>2</sup> = 9%; low‐certainty evidence; <a href="./references#CD009608-fig-0006" title="">Analysis 1.1</a>). </p> <p>The funnel plot based on this outcome was symmetrical, making the risk of publication bias low (<a href="#CD009608-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD009608-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Leaving the study early: for any reason – end of treatment." data-id="CD009608-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Leaving the study early: for any reason – end of treatment.</p> </div> </div> </div> </section> <section id="CD009608-sec-0125"> <h6 class="title">2.2 Leaving the study early: for specific reason – end of treatment</h6> <p>No studies reported leaving the study early: for specific reason.</p> </section> </section> <section id="CD009608-sec-0126"> <h5 class="title">3. Mental state</h5> <section id="CD009608-sec-0127"> <h6 class="title">3.1 Mental state: overall</h6> <section id="CD009608-sec-0128"> <p><b>3.1.1 Mental state: overall: clinically important change overall mental state – as defined by individual studies – end of treatment</b></p> <p>No studies reported mental state: overall: clinically important change overall mental state – as defined by individual studies – end of treatment. </p> </section> <section id="CD009608-sec-0129"> <p><b>3.1.2 Mental state: overall: any change in overall mental state – as defined by individual studies</b></p> <p>No studies reported mental state: overall: any change in overall mental state – as defined by individual studies.  </p> </section> <section id="CD009608-sec-0130"> <p><b>3.1.3a Mental state: overall: average endpoint score – end of treatment (PANSS total, high = poor)</b></p> <p>Results from PANSS total final score favoured group CBTp over standard care and other psychosocial interventions at the end of treatment (MD –3.73, 95% CI –4.63 to –2.83; studies = 12, participants = 1036; I<sup>2</sup> = 5%; low‐certainty evidence; <a href="./references#CD009608-fig-0007" title="">Analysis 1.2</a>). </p> <p>The funnel plot based on this outcome was asymmetrical, increasing the risk for publication bias (<a href="./full#CD009608-fig-0001">Figure 1</a>). </p> </section> <section id="CD009608-sec-0131"> <p><b>3.1.3b Mental state: overall: average endpoint score – end of treatment (BPRS total, high = poor)</b></p> <p>Results from BPRS total final score favoured group CBTp over standard care and other psychosocial interventions at the end of treatment (MD –4.26, 95% CI –7.50 to –1.02; studies = 3, participants = 180; I<sup>2</sup> = 65%; <a href="./references#CD009608-fig-0008" title="">Analysis 1.3</a>). Heterogeneity was high.  </p> </section> <section id="CD009608-sec-0132"> <p><b>3.1.3c Mental state: overall: average endpoint score – end of treatment (PSYRATS total, high = poor)</b></p> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on PSYRATS total scores at the end of treatment (MD –0.45, 95% CI –3.23 to 2.33; studies = 2, participants = 166; I<sup>2</sup> = 0%; <a href="./references#CD009608-fig-0009" title="">Analysis 1.4</a>). </p> </section> <section id="CD009608-sec-0133"> <p><b>3.1.3d Mental state: overall: average endpoint score – end of treatment (SCL‐90‐R, high = poor)</b></p> <p>Results from SCL‐90‐R total final score favoured group CBTp over standard care and other psychosocial interventions at the end of treatment (MD –33.26, 95% CI –51.26 to –15.26; studies = 1, participants = 82; <a href="./references#CD009608-fig-0010" title="">Analysis 1.5</a>). </p> </section> </section> <section id="CD009608-sec-0134"> <h6 class="title">3.2 Mental state: specific</h6> <section id="CD009608-sec-0135"> <p><b>3.2.1 Clinically important change in specific symptoms (e.g. positive or negative) – as defined by individual studies</b></p> <p>No studies reported clinically important change in specific symptoms (e.g. positive or negative) – as defined by individual studies.  </p> </section> <section id="CD009608-sec-0136"> <p><b>3.2.2 Any change in specific symptoms (e.g. positive or negative)</b></p> <p>No studies reported any change in specific symptoms (e.g. positive or negative).</p> </section> <section id="CD009608-sec-0137"> <p><b>3.2.3a Mental state: specific: depression – average endpoint score – end of treatment (BDI‐II, high = poor)</b></p> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on BDI‐II scores at the end of treatment (MD –0.46, 95% CI –3.29 to 2.37; studies = 5, participants = 229; I<sup>2</sup> = 0%; <a href="./references#CD009608-fig-0019" title="">Analysis 1.14</a>).  </p> </section> <section id="CD009608-sec-0138"> <p><b>3.2.3b Mental state: specific: depression – average endpoint score – end of treatment (HAMD, high = poor)</b></p> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on HAMD scores at the end of treatment (MD 0.80, 95% CI –2.26 to 3.86; studies = 1, participants = 65; <a href="./references#CD009608-fig-0020" title="">Analysis 1.15</a>). </p> </section> <section id="CD009608-sec-0139"> <p><b>3.2.3c Mental state: specific: depression – average endpoint score – end of treatment (MADRS, high = poor)</b></p> <p>Results from MADRS total final score favoured group CBTp over standard care and other psychosocial interventions at the end of treatment (MD –2.18, 95% CI –3.80 to –0.56; studies = 1, participants = 56; <a href="./references#CD009608-fig-0021" title="">Analysis 1.16</a>). </p> </section> <section id="CD009608-sec-0140"> <p><b>3.2.3d Mental state: specific: depression – average endpoint score – end of treatment (HADS depression, high = poor)</b></p> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on HADS depression subscores at the end of treatment (MD –1.75, 95% CI –3.59 to 0.09; studies = 1, participants = 93; <a href="./references#CD009608-fig-0022" title="">Analysis 1.17</a>). </p> </section> <section id="CD009608-sec-0141"> <p><b>3.2.4a Mental state: specific: positive symptoms – average endpoint score – end of treatment (PANSS positive, high = poor)</b></p> <p>Six studies included PANSS positive symptoms average endpoint scores (<a href="./references#CD009608-bbs2-0002" title="BechdolfA , KnostB , KuntermannC , SchillerS , HambrechtM , KlosterkotterJ , et al. Coping-oriented versus psychoeducational group therapy for post acute patients with schizophrenia: results of a 6 month follow-up. Schizophrenia Research2002;53(Suppl 1):263-4. [CSZG: Ref8053]BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110:21-8. [CSZG: Ref11268]BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144-50. [CSZG: Ref19694]BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112:173-9. [CSZG: Ref18491]BechdolfA . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia: commentary reply. Acta Psychiatrica Scandinavica2006;113:73-4. [CSZG: Ref18490]Munk-JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSZG: Ref18577]">Bechdolf 2004</a>; <a href="./references#CD009608-bbs2-0013" title="LiJ , DengX , XieY , LiangL . Effects on cognitive function in patients with chronic schizophrenia, cognitive behavioral therapy [认知行为治疗对慢性精神分裂症患者认知功能的影响]. Chinese and foreign medical research2013;24:130-2. ">Li 2013b</a>; <a href="./references#CD009608-bbs2-0016" title="QiH , LiuH . Studies on the efficacy of combining episode male schizophrenic cognitive behavioral therapy [结合认知行为治疗对首发男性精神分裂症的 疗效研究]. Hebei Medical Journal2012;34:3229-31. ">Qi 2012</a>; <a href="./references#CD009608-bbs2-0018" title="ShenF , YangYC , DengH . The effect of group cognitive-behavioural therapy for schizophrenia after acute episode. West China Medical Journal2007;22:236-7. ">Shen 2007</a>; <a href="./references#CD009608-bbs2-0019" title="ShiY , JiaoY , JiangL , SunY , BaiZ , WuQ , et al. The effect of cognitive behavioral therapy on executive function of patients with chronic schizophrenia [认知行为治疗对慢性精神分裂症患者执行功能的影响]. Neurological diseases and mental health2015;15:497-9. ">Shi 2015</a>; <a href="./references#CD009608-bbs2-0022" title="TaoC , DingS , ZhuY , LiX . Evaluation of comprehensive family knowledge, belief and behavior intervention on the rehabilitation efficacy of schizophrenia patients in the rehabilitation period [家庭综合知信行干预对康复期精神分裂症患者康复疗效的评价]. China Journal of Health Psychology2015;23:970-2. ">Tao 2015</a>). However, they showed skewness and, therefore, were removed from the analysis (see <a href="#CD009608-tbl-0003">Table 2</a> for more information). The analysis with the remaining studies showed that there was no clear difference between group CBTp and standard care and other psychosocial interventions (MD –0.45, 95% CI –1.30 to 0.40; studies = 8, participants = 539; I<sup>2</sup> = 0%; <a href="./references#CD009608-fig-0011" title="">Analysis 1.6</a>). </p> <div class="table" id="CD009608-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Mental state: specific: positive symptoms – average endpoint score – end of treatment (PANSS positive, high = poor): studies with skewed data</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>n</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0002" title="BechdolfA , KnostB , KuntermannC , SchillerS , HambrechtM , KlosterkotterJ , et al. Coping-oriented versus psychoeducational group therapy for post acute patients with schizophrenia: results of a 6 month follow-up. Schizophrenia Research2002;53(Suppl 1):263-4. [CSZG: Ref8053]BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110:21-8. [CSZG: Ref11268]BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144-50. [CSZG: Ref19694]BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112:173-9. [CSZG: Ref18491]BechdolfA . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia: commentary reply. Acta Psychiatrica Scandinavica2006;113:73-4. [CSZG: Ref18490]Munk-JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSZG: Ref18577]">Bechdolf 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0013" title="LiJ , DengX , XieY , LiangL . Effects on cognitive function in patients with chronic schizophrenia, cognitive behavioral therapy [认知行为治疗对慢性精神分裂症患者认知功能的影响]. Chinese and foreign medical research2013;24:130-2. ">Li 2013b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0016" title="QiH , LiuH . Studies on the efficacy of combining episode male schizophrenic cognitive behavioral therapy [结合认知行为治疗对首发男性精神分裂症的 疗效研究]. Hebei Medical Journal2012;34:3229-31. ">Qi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0018" title="ShenF , YangYC , DengH . The effect of group cognitive-behavioural therapy for schizophrenia after acute episode. West China Medical Journal2007;22:236-7. ">Shen 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.621</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0019" title="ShiY , JiaoY , JiangL , SunY , BaiZ , WuQ , et al. The effect of cognitive behavioral therapy on executive function of patients with chronic schizophrenia [认知行为治疗对慢性精神分裂症患者执行功能的影响]. Neurological diseases and mental health2015;15:497-9. ">Shi 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0022" title="TaoC , DingS , ZhuY , LiX . Evaluation of comprehensive family knowledge, belief and behavior intervention on the rehabilitation efficacy of schizophrenia patients in the rehabilitation period [家庭综合知信行干预对康复期精神分裂症患者康复疗效的评价]. China Journal of Health Psychology2015;23:970-2. ">Tao 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CBTp: cognitive behavioural therapy model targeting symptoms of psychosis; n: number of participants; PANSS: Positive and Negative Syndrome Scale; SD: standard deviation. </p> </div> </div> </section> <section id="CD009608-sec-0142"> <p><b>3.2.4b Mental state: specific: positive symptoms – average endpoint score – end of treatment (SAPS, high = poor)</b></p> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on SAPS positive symptoms scores at the end of treatment (MD –0.15, 95% CI –3.24 to 2.95; studies = 2, participants = 39; I<sup>2</sup> = 0%; <a href="./references#CD009608-fig-0012" title="">Analysis 1.7</a>). </p> </section> <section id="CD009608-sec-0143"> <p><b>3.2.4c Mental state: specific: delusions – average endpoint total score – end of treatment (PSYRATS delusions, high = poor)</b></p> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on PSYRATS delusions scores at the end of treatment (MD –3.39, 95% CI –8.50 to 1.71; studies = 2, participants = 71; I<sup>2</sup> = 50%; <a href="./references#CD009608-fig-0013" title="">Analysis 1.8</a>). Heterogeneity was high.  </p> </section> <section id="CD009608-sec-0144"> <p><b>3.2.4d Mental state: specific: voices – average endpoint total score – end of treatment (PSYRATS voices, high = poor)</b></p> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on PSYRATS voices scores at the end of treatment (MD –5.94, 95% CI –18.04 to 6.16; studies = 2, participants = 71; I<sup>2</sup> = 75%; <a href="./references#CD009608-fig-0014" title="">Analysis 1.9</a>). Heterogeneity was high.  </p> </section> <section id="CD009608-sec-0145"> <p><b>3.2.4e Mental state: specific: voices – average endpoint total score – end of treatment (AHRS, high = poor)</b></p> <p>Results from AHRS total final score favoured group CBTp over standard care and other psychosocial interventions at the end of treatment (MD –5.30, 95% CI –7.49 to –3.11; studies = 1, participants = 103; <a href="./references#CD009608-fig-0015" title="">Analysis 1.10</a>). </p> </section> <section id="CD009608-sec-0146"> <p><b>3.2.4f Mental state: specific: negative symptoms – average endpoint score – end of treatment (PANSS negative, high = poor)</b></p> <p>Two studies included PANSS negative symptoms average endpoint scores (<a href="./references#CD009608-bbs2-0018" title="ShenF , YangYC , DengH . The effect of group cognitive-behavioural therapy for schizophrenia after acute episode. West China Medical Journal2007;22:236-7. ">Shen 2007</a>; <a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a>). However, they showed skewness and, therefore, were removed from the analysis (see <a href="#CD009608-tbl-0004">Table 3</a> for more information). The analysis with the remaining studies showed that there was no clear difference between group CBTp and standard care and other psychosocial interventions (MD –0.73, 95% CI –1.68 to 0.21; studies = 9, participants = 768; I<sup>2</sup> = 65%; <a href="./references#CD009608-fig-0016" title="">Analysis 1.11</a>). Heterogeneity was high.  </p> <div class="table" id="CD009608-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Mental state: specific: negative symptoms – average endpoint score – end of treatment (PANSS negative, high = poor): studies with skewed data</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>n</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0018" title="ShenF , YangYC , DengH . The effect of group cognitive-behavioural therapy for schizophrenia after acute episode. West China Medical Journal2007;22:236-7. ">Shen 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CBTp: cognitive behavioural therapy model targeting symptoms of psychosis; n: number of participants; PANSS: Positive and Negative Syndrome Scale; SD: standard deviation. </p> </div> </div> </section> <section id="CD009608-sec-0147"> <p><b>3.2.4g Mental state: specific: negative symptoms – average endpoint score – end of treatment (SANS, high = poor)</b></p> <p>Results from SANS total final score favoured group CBTp over standard care and other psychosocial interventions at the end of treatment (MD –5.34, 95% CI –6.05 to –4.64; studies = 4, participants = 180; I<sup>2</sup> = 0%; <a href="./references#CD009608-fig-0017" title="">Analysis 1.12</a>). </p> </section> <section id="CD009608-sec-0148"> <p><b>3.2.4h Mental state: specific: depression/anxiety – average endpoint score – end of treatment (HADS total, high = poor)</b></p> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on HADS scores at the end of treatment (MD –0.53, 95% CI –3.58 to 2.52; studies = 1, participants = 90; <a href="./references#CD009608-fig-0018" title="">Analysis 1.13</a>). </p> </section> <section id="CD009608-sec-0149"> <p><b>3.2.4i Mental state: specific: anxiety – average endpoint score – end of treatment (BAI, high = poor)</b></p> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on BAI scores at the end of treatment (MD –0.49, 95% CI –14.53 to 13.54; studies = 2, participants = 77; I<sup>2</sup> = 66%; <a href="./references#CD009608-fig-0023" title="">Analysis 1.18</a>). Heterogeneity was high.  </p> </section> <section id="CD009608-sec-0150"> <p><b>3.2.4j Mental state: specific: anxiety – average endpoint score – end of treatment (HADS anxiety, high = poor)</b></p> <p>There was no clear difference between group CBTp and standard care on HADS anxiety subscores at the end of treatment (MD –0.71, 95% CI –2.33 to 0.91; studies = 1, participants = 93; <a href="./references#CD009608-fig-0024" title="">Analysis 1.19</a>). </p> </section> <section id="CD009608-sec-0151"> <p><b>3.2.4k Mental state: specific: anxiety – average endpoint score – end of treatment (HARS, high = poor)</b></p> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on HARS anxiety subscores at the end of treatment (MD –6.30, 95% CI –13.81 to 1.21; studies = 1, participants = 20; <a href="./references#CD009608-fig-0025" title="">Analysis 1.20</a>). </p> </section> <section id="CD009608-sec-0152"> <p><b>3.2.4l Mental state: specific: social anxiety – average endpoint score – end of treatment (SAD, high = poor)</b></p> <p>Results from SAD total final score favoured group CBTp over standard care and other psychosocial interventions at the end of treatment (MD –7.33, 95% CI –9.73 to –4.93; studies = 1, participants = 82; <a href="./references#CD009608-fig-0026" title="">Analysis 1.21</a>).  </p> </section> </section> </section> <section id="CD009608-sec-0153"> <h5 class="title">4. Compliance</h5> <section id="CD009608-sec-0154"> <h6 class="title">4.1 Taking drug treatment</h6> <p>No studies reported taking drug treatment. </p> </section> <section id="CD009608-sec-0155"> <h6 class="title">4.2 Adherence to non‐drug treatments</h6> <p>No studies reported adherence to non‐drug treatments. </p> </section> </section> <section id="CD009608-sec-0156"> <h5 class="title">5. Adverse effects/events</h5> <section id="CD009608-sec-0157"> <h6 class="title">5.1 At least one adverse effect/event </h6> <p>No studies reported at least one adverse effect/event.</p> </section> <section id="CD009608-sec-0158"> <h6 class="title">5.2 Incidence of specific adverse effects</h6> <p>No studies reported incidence of specific adverse effects.</p> </section> <section id="CD009608-sec-0159"> <h6 class="title">5.3 Average endpoint or change scores on adverse effect scales</h6> <p>No studies reported average endpoint or change scores on adverse effect scales.</p> </section> <section id="CD009608-sec-0160"> <h6 class="title">5.4 Adverse effects/events: dependency</h6> <p>No studies reported dependency.</p> </section> <section id="CD009608-sec-0161"> <h6 class="title">5.5 Adverse effects/events: death: suicide or natural causes</h6> <p>No studies reported death: suicide or natural causes.</p> </section> </section> <section id="CD009608-sec-0162"> <h5 class="title">6. Service utilisation outcomes</h5> <section id="CD009608-sec-0163"> <h6 class="title">6.1 Number of participants hospitalised during the study (hospital admissions)</h6> <p>There was no clear difference between CBTp and standard care and other psychosocial interventions for numbers of participants hospitalised during the study (RR 0.78, 95% CI 0.38 to 1.60; studies = 3, participants = 235; I<sup>2</sup> = 34%; <a href="./references#CD009608-fig-0027" title="">Analysis 1.22</a>). </p> </section> <section id="CD009608-sec-0164"> <h6 class="title">6.2 Average number days spent in hospital during the study</h6> <p>The data for average number days spent in hospital during the study were skewed and were not analysed as there was only one study (see <a href="#CD009608-tbl-0005">Table 4</a> for more information). </p> <div class="table" id="CD009608-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Service use: average number days spent in hospital during the study: studies with skewed data</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>n</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0001" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive behavioural therapy for schizophrenia – randomised controlled trial. British Journal of Psychiatry2006;189:527-32. [CSZG: Ref14559]BarrowcloughC . An evaluation of the effectiveness of group cognitive therapy for people with recent onset schizophrenia. National Research Register2001;1. [CSZG: Ref12948]">Barrowclough 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CBTp: cognitive behavioural therapy model targeting symptoms of psychosis; n: number of participants; PANSS: Positive and Negative Syndrome Scale; SD: standard deviation. </p> </div> </div> </section> </section> <section id="CD009608-sec-0165"> <h5 class="title">7. Quality of life</h5> <section id="CD009608-sec-0166"> <h6 class="title">7.1 Clinically important change – end of treatment</h6> <p>No studies reported quality of life: clinically important change – as defined by individual studies – end of treatment. </p> </section> <section id="CD009608-sec-0167"> <h6 class="title">7.2 Any change – end of treatment</h6> <p>No studies reported quality of life: any change – as defined by individual studies – end of treatment.  </p> </section> <section id="CD009608-sec-0168"> <h6 class="title">7.3 General impression of carer/rater or family member – end of treatment</h6> <p>No study reported quality of life: general impression of carer/rater or family member – end of treatment.  </p> </section> <section id="CD009608-sec-0169"> <h6 class="title">7.4a Average endpoint score – end of treatment (MSQoL, high = good)</h6> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on MSQoL scores at the end of treatment (MD 1.80, 95% CI –10.17 to 13.77; studies = 1, participants = 63; <a href="./references#CD009608-fig-0028" title="">Analysis 1.23</a>). </p> </section> <section id="CD009608-sec-0170"> <h6 class="title">7.4b Average endpoint score – end of treatment (QLS, high = good)</h6> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on QLS scores at the end of treatment (MD –6.58, 95% CI –15.84 to 2.69; studies = 2, participants = 40; I<sup>2</sup> = 0%; <a href="./references#CD009608-fig-0029" title="">Analysis 1.24</a>). </p> </section> <section id="CD009608-sec-0171"> <h6 class="title">7.4c Average endpoint score – end of treatment (WHOQOL‐BREF – Psychological domain subscale, high = good) </h6> <p>Results from WHOQOL‐BREF Psychological domain subscore slightly favoured group CBTp over standard care and other psychosocial interventions at the end of treatment (MD –4.64, 95% CI –9.04 to –0.24; studies = 2, participants = 132; I<sup>2</sup> = 77%; <a href="./references#CD009608-fig-0030" title="">Analysis 1.25</a>). Heterogeneity was high.  </p> </section> <section id="CD009608-sec-0172"> <h6 class="title">7.4d Average endpoint score – end of treatment (GQOLI‐74 – Psychological domain subscale, high = good) </h6> <p>Results from GQOLI‐74 final score favoured group CBTp over standard care and other psychosocial interventions at the end of treatment (MD –4.83, 95% CI –8.20 to –1.46; studies = 1, participants = 60; <a href="./references#CD009608-fig-0031" title="">Analysis 1.26</a>).  </p> </section> </section> <section id="CD009608-sec-0173"> <h5 class="title">8. Functioning</h5> <section id="CD009608-sec-0174"> <h6 class="title">8.1 Clinically important change in functioning – end of treatment</h6> <p>No studies reported functioning: clinically important change in functioning – as defined by individual studies – end of treatment. </p> </section> <section id="CD009608-sec-0175"> <h6 class="title">8.2 Any change in functioning</h6> <p>No studies reported functioning: any change in functioning – as defined by individual studies.  </p> </section> <section id="CD009608-sec-0176"> <h6 class="title">8.3a Functioning: overall: global assessment of functioning – average endpoint score – end of treatment (GAF, high = good) </h6> <p>Results from GAF score favoured group CBTp over standard care and other psychosocial interventions at the end of treatment (MD –3.61, 95% CI –6.37 to –0.84; studies = 5, participants = 254; I<sup>2</sup> = 0%; moderate‐certainty evidence; <a href="./references#CD009608-fig-0032" title="">Analysis 1.27</a>). </p> </section> <section id="CD009608-sec-0177"> <h6 class="title">8.3b Functioning: specific: living skills – average endpoint score – end of treatment (ILSS, high = good) </h6> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on ILSS scores at the end of treatment (MD 0.01, 95% CI –0.03 to 0.02; studies = 4, participants = 231; I<sup>2</sup> = 0%; <a href="./references#CD009608-fig-0033" title="">Analysis 1.28</a>). </p> </section> <section id="CD009608-sec-0178"> <h6 class="title">8.3c Functioning: specific: social – average endpoint score – end of treatment (SBS, high = poor) </h6> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on SBS scores at the end of treatment (MD –1.30, 95% CI –4.59 to 1.99; studies = 1, participants = 79; <a href="./references#CD009608-fig-0034" title="">Analysis 1.29</a>). </p> </section> <section id="CD009608-sec-0179"> <h6 class="title">8.3d Functioning: specific: social – average endpoint score – end of treatment (SFS, high = good) </h6> <p>There was no clear difference between group CBTp and standard care and other psychosocial interventions on SFS scores at the end of treatment (MD –1.11, 95% CI –9.03 to 6.81; studies = 2, participants = 140; I<sup>2</sup> = 0%; <a href="./references#CD009608-fig-0035" title="">Analysis 1.30</a>). </p> </section> <section id="CD009608-sec-0180"> <h6 class="title">8.3e Functioning: specific: social – average endpoint score – end of treatment (PSP, high = good) </h6> <p>Results from PSP score favoured group CBTp over standard care and other psychosocial interventions at the end of treatment (MD 3.30, 95% CI 2.00 to 4.60; studies = 1, participants = 100; <a href="./references#CD009608-fig-0036" title="">Analysis 1.31</a>). </p> </section> <section id="CD009608-sec-0181"> <h6 class="title">8.3f Functioning: specific: social – average endpoint score – end of treatment (IPROS, high = poor) </h6> <p>Results from IPROS score favoured group CBTp over standard care and other psychosocial interventions at the end of treatment (MD –8.90, 95% CI –12.62 to –5.18; studies = 1, participants = 80; <a href="./references#CD009608-fig-0037" title="">Analysis 1.32</a>). </p> </section> <section id="CD009608-sec-0182"> <h6 class="title">8.3g Functioning: specific: social – average endpoint score – end of treatment (SDSS, high = poor) </h6> <p>Results from SDSS score favoured group CBTp over standard care and other psychosocial interventions at the end of treatment (MD –1.27, 95% CI –2.46 to –0.08; studies = 1, participants = 116; <a href="./references#CD009608-fig-0038" title="">Analysis 1.33</a>). </p> </section> </section> <section id="CD009608-sec-0183"> <h5 class="title">8.4 Occupational status</h5> <p>No studies reported occupational status. </p> </section> </section> <section id="CD009608-sec-0184"> <h4 class="title">Subgroup analyses</h4> <p>The planned subgroup analyses were not performed since there were no data on the primary outcome (see <a href="#CD009608-sec-0078">Subgroup analysis and investigation of heterogeneity</a>).  </p> </section> <section id="CD009608-sec-0185"> <h4 class="title">Sensitivity analyses</h4> <p>The planned sensitivity analyses were not performed since there were no data on the primary outcome (see <a href="#CD009608-sec-0082">Sensitivity analysis</a>).  </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009608-sec-0186" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009608-sec-0186">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009608-sec-0413">Deutsch</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009608-sec-0186"></div> <section id="CD009608-sec-0187"> <h3 class="title" id="CD009608-sec-0187">Summary of main results</h3> <section id="CD009608-sec-0188"> <h4 class="title">1. General</h4> <p>This review included 24 studies with 1900 participants that compared group CBTp with standard care or other psychosocial interventions in people with schizophrenia or related disorders. The included studies were published from 1998 to 2020 and varied widely in duration (five weeks to one year). The total of 24 included studies with 1900 participants is a small base upon which to judge the effectiveness of group CBTp. Each study did not have a very large sample size. Trials with small sample sizes may lack sufficient power to detect a small to moderate effect, and thus results from such trials are often inconclusive, even when a real effect does exist. We decided to focus on end of treatment outcomes.  </p> </section> <section id="CD009608-sec-0189"> <h4 class="title">2. Treatment effects</h4> <section id="CD009608-sec-0190"> <h5 class="title">2.1 Global state: clinically important change, shown as improved – as defined by individual studies </h5> <p>No studies indicated reported clinically important change as defined by the authors, so we could draw no conclusion on our primary outcome.  </p> </section> <section id="CD009608-sec-0191"> <h5 class="title">2.2 Leaving the study early: for any reason – end of treatment</h5> <p>Thirteen studies included data on leaving the study early. There seems to be no difference in dropout rates between group CBTp and standard care or other psychosocial interventions. However, given the low number and quality of trials, it is difficult to draw firm conclusions. The confidence in the estimate is low. </p> </section> <section id="CD009608-sec-0192"> <h5 class="title">2.3 Mental state: overall – average endpoint score – end of treatment (PANSS total)</h5> <p>Twelve studies included data for PANSS total scores at the end of treatment. There seems to be some advantage of group CBTp overall over standard care or other psychosocial interventions on total PANSS. However, given the small number of participants in each study, no firm conclusion on the efficacy of group CBTp can be drawn. In addition, funnel plot analysis showed some evidence of publication bias. CBTp seems to be a promising treatment overall, but we need more robust data and further investigation on the probability of publication bias. The confidence in the estimate is low.  </p> </section> <section id="CD009608-sec-0193"> <h5 class="title">2.4 Mental state: overall: average endpoint score – end of treatment (BPRS total)</h5> <p>Three studies included data for BPRS scores at the end of treatment. There seems to be some advantage of group CBTp overall over standard care or other psychosocial interventions on total BPRS scores. However, data may not be generalisable as the number of studies and participants (180 in total) was small. In addition, results showed a high level of heterogeneity. This may be because the populations included, the lengths of the interventions and the control groups were different.  </p> </section> <section id="CD009608-sec-0194"> <h5 class="title">2.5 Mental state: specific: positive symptoms – average endpoint score – end of treatment (PANSS positive) </h5> <p>Fourteen studies included data for PANSS positive symptoms scores at the end of treatment. However, six studies showed skewness and were excluded from the analysis. After removing the studies with skewed data, CBTp group showed no clear advantage over standard care or other psychosocial interventions.  </p> </section> <section id="CD009608-sec-0195"> <h5 class="title">2.6 Mental state: specific: negative symptoms – average endpoint score – end of treatment (PANSS negative) </h5> <p>Eleven studies included data for PANSS negative symptoms scores at the end of treatment. However, two studies showed skewness and were excluded from the analysis. After removing the studies with skewed data, group CBTp showed no advantage over standard care or other psychosocial interventions for negative symptoms. Moreover, heterogeneity was high, possibly because of the different subpopulations of people with schizophrenia included, and the fact that response of negative symptoms to group CBTp may be less consistent and heavily dependent on context and population.  </p> </section> <section id="CD009608-sec-0196"> <h5 class="title">2.7 Mental state: specific: negative symptoms – average endpoint score – end of treatment (SANS) </h5> <p>Four studies included data for SANS. Interestingly, when negative symptoms were measured with SANS, instead of the PANSS, group CBTp showed some advantage over standard care or other psychosocial interventions. However, the sample size was small (180 participants in total), and it is very difficult to draw clear conclusions based on this analysis. One study in particular seemed to have participants with much higher endpoint SANS score than the other three studies included in this outcome (<a href="./references#CD009608-bbs2-0020" title="SongX , LuiY , ZhangY , ZhouL . Study on the effect of cognitive behavioral therapy on improving the negative symptoms of schizophrenia patients [认知行为治疗对改善精神分裂症病人阴性症状的效果研究]. Psychologist2012;7:30-1. ">Song 2012</a>).  </p> </section> <section id="CD009608-sec-0197"> <h5 class="title">2.8 Mental state: depression</h5> <p>Several scales were used to measure depression in the studies included in this review. The most common rating scale used to measure depression was the BDI‐II with five studies. Group CBTp offered no clear advantage of standard care or other psychosocial interventions on depression measured by BDI‐II. Depression was also measured with HAMD, MADRS and HADS Depression but each scale had only study using it, so no meaningful conclusions could be drawn by the analyses of these rating scales outcomes.  </p> </section> <section id="CD009608-sec-0198"> <h5 class="title">2.9 Overall: global assessment of functioning – average endpoint score – end of treatment (GAF) </h5> <p>Five studies included data for GAF. Group CBTp offers some advantage over standard care or other psychosocial interventions in global functioning. However, the sample size was quite small (254 participants in total), so it may be not be possible to draw firm conclusions on the efficacy of group CBTp. The confidence in the estimate was moderate.  </p> </section> <section id="CD009608-sec-0199"> <h5 class="title">2.10 Other outcomes</h5> <p>The other outcomes with data included in this review (PSYRATS total, delusions and voices endpoint scores, SAPS endpoint score, SCL‐90‐R endpoint score, AHRS endpoint score, all anxiety endpoint scores, all service utilisation and quality of life outcomes, including number of participants hospitalised, and SBS, SFS, PSP, IPROS, SDSS endpoint scores) had one to three studies each, with a small sample size or high heterogeneity (or both), which was not sufficient to draw clear conclusions on the effect of group CBTp over standard care or other psychosocial interventions. More research is needed, particularly on quality of life outcomes, as studies used several scales that measure different aspects. The outcome 'days in hospital' was skewed and so was not analysable. This may have limited the applicability of our data.  </p> </section> <section id="CD009608-sec-0200"> <h5 class="title">2.11 Secondary outcomes with no available data</h5> <p>We had no data on:</p> <p> <ul id="CD009608-list-0034"> <li> <p>global state:</p> <ul id="CD009608-list-0035"> <li> <p>any change – as defined by individual studies;</p> </li> <li> <p>relapse – end of treatment;</p> </li> <li> <p>average endpoint or change score on global state scale;</p> </li> </ul> </li> <li> <p>leaving the study early:</p> <ul id="CD009608-list-0036"> <li> <p>for specific reasons – end of treatment;</p> </li> </ul> </li> <li> <p>mental state:</p> <ul id="CD009608-list-0037"> <li> <p>clinically important change overall mental state – as defined by each of the studies – end of treatment; </p> </li> <li> <p>any change in overall mental state – as defined by individual studies;</p> </li> <li> <p>clinically important change in specific symptoms (e.g. positive or negative) – as defined by each of the studies; </p> </li> <li> <p>any change in specific symptoms (e.g. positive or negative) – as defined by each of the studies; </p> </li> </ul> </li> <li> <p>compliance:</p> <ul id="CD009608-list-0038"> <li> <p>taking drug treatment;</p> </li> <li> <p>adherence to non‐drug treatments;</p> </li> </ul> </li> <li> <p>adverse effects/events:</p> <ul id="CD009608-list-0039"> <li> <p>at least one adverse effect/event;</p> </li> <li> <p>incidence of specific adverse effects;</p> </li> <li> <p>average endpoint or change scores on adverse effect scales;</p> </li> <li> <p>dependency;</p> </li> <li> <p>death: suicide or natural causes;</p> </li> </ul> </li> <li> <p>quality of life:</p> <ul id="CD009608-list-0040"> <li> <p>clinically important change – as defined by individual studies;</p> </li> <li> <p>any change – as defined by individual studies;</p> </li> <li> <p>general impression of carer/rater or family member;</p> </li> </ul> </li> <li> <p>functioning:</p> <ul id="CD009608-list-0041"> <li> <p>clinically important change in functioning – as defined by individual studies;</p> </li> <li> <p>any change in functioning – as defined by individual studies.</p> </li> </ul> </li> </ul> </p> </section> </section> </section> <section id="CD009608-sec-0201"> <h3 class="title" id="CD009608-sec-0201">Overall completeness and applicability of evidence</h3> <p>This review examined group CBTp compared to standard care or other psychosocial interventions in people with schizophrenia. We considered standard care to be the care participants would normally receive in a standard mental health service, including medication. Several psychosocial interventions were also compared to group CBTp such as psychoeducational groups and supportive therapy. It is uncertain whether data can be generalised. The sample size of each included study was small, and our analysis could be underpowered at least for some outcomes. This is the main limitation of this review. The main finding is that there is no clear difference between group CBTp and standard care in terms of rates of participants leaving the study early. Total symptoms scores as well as positive symptoms outcomes seem to be associated with a better outcome for group CBTp. </p> <p>In addition, one relevant issue is that we grouped a mix of CBTp interventions. Even if they are all based on the CBT model, they may have some differences. We decided not to include meta‐cognitive training in this review (<a href="./references#CD009608-bbs2-0173" title="MoritzS , WoodwardTS . Metacognitive training in schizophrenia: from basic research to knowledge translation and intervention. Current Opinion in Psychiatry2007;20:619-25.">Moritz 2007</a>). This training is a well‐established and valid CBT‐based model, but we judged it deserves to be investigated separately. Moreover, at least three systematic reviews that specifically investigated meta‐cognitive training have been published (<a href="./references#CD009608-bbs2-0130" title="EichnerC , BernaF . Acceptance and efficacy of metacognitive training (MCT) on positive symptoms and delusions in patients with schizophrenia: a meta-analysis taking into account important moderators. Schizophrenia Bulletin2016;42:952-62.">Eichner 2016</a>; <a href="./references#CD009608-bbs2-0166" title="LiuYC , TangCC , HungTT , TsaiPC , LinMF . The efficacy of metacognitive training for delusions in patients with schizophrenia: a meta-analysis of randomized controlled trials informs evidence-based practice. Worldviews Evidence Based Nursing2018;15:130-9.">Liu 2018</a>; <a href="./references#CD009608-bbs2-0197" title="vanOosterhoutB , SmitF , KrabbendamL , CasteleinS , StaringAB , van derGaagM . Metacognitive training for schizophrenia spectrum patients: a meta-analysis on outcome studies. Psychological Medicine2016;46:47-57.">van Oosterhout 2016</a>). We will conduct a Cochrane Review specifically focused on meta‐cognitive training and including more recent studies.  </p> <p>As for the CBTp interventions, <a href="./references#CD009608-bbs2-0001" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive behavioural therapy for schizophrenia – randomised controlled trial. British Journal of Psychiatry2006;189:527-32. [CSZG: Ref14559]BarrowcloughC . An evaluation of the effectiveness of group cognitive therapy for people with recent onset schizophrenia. National Research Register2001;1. [CSZG: Ref12948]">Barrowclough 2006</a> and <a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a> applied cognitive therapy principles and are more in line with a classic CBTp model. They are also more structured. The CBTp model described in <a href="./references#CD009608-bbs2-0006" title="GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520-9. [CSZG: Ref11453]GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. Journal of Clinical Psychiatry2007;68:730-7. [CSZG: Ref14560]">Granholm 2007</a> and <a href="./references#CD009608-bbs2-0007" title="GranholmE , HoldenJ , LinkPC , McQuaidJR , JesteDV . Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome. American Journal of Geriatric Psychiatry2013;21(3):251-62. [CSZG: Ref28246]NCT00237796. Functional rehabilitation of older patients with schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00237796 (first received 12 October 2005). ">Granholm 2013</a> is more focused on social skills. The studies conducted in China seemed to use a more standard CBTp model (<a href="./references#CD009608-bbs2-0005" title="DengM , DingN . Observation on the effect of implementing group CBT for patients with schizophrenia during rehabilitation [对精神分裂症康复期患者实施团体cbt的效果观察]. Contemporary Nurse2014;10:116-8. ">Deng 2014</a>; <a href="./references#CD009608-bbs2-0010" title="GuanT , YangD , HanP . The effect of olanzapine combined with group therapy on paranoid schizophrenia [奥氮平合并团体治疗对偏执型精神分裂症的影响]. Modern Chinese Doctor2016;54:58-61. ">Guan 2016</a>; <a href="./references#CD009608-bbs2-0012" title="LiX , GuoY , FuC , ChenL , ZhangZ . Group cognitive behavioral therapy efficacy for refractory auditory hallucinations in schizophrenia [小组认 知行 为治疗对 精神分裂症顽 固性幻 听的疗效 观察]. Chinese Journal of Rehabilitation2013;28:313-5. ">Li 2013a</a>; <a href="./references#CD009608-bbs2-0013" title="LiJ , DengX , XieY , LiangL . Effects on cognitive function in patients with chronic schizophrenia, cognitive behavioral therapy [认知行为治疗对慢性精神分裂症患者认知功能的影响]. Chinese and foreign medical research2013;24:130-2. ">Li 2013b</a>; <a href="./references#CD009608-bbs2-0016" title="QiH , LiuH . Studies on the efficacy of combining episode male schizophrenic cognitive behavioral therapy [结合认知行为治疗对首发男性精神分裂症的 疗效研究]. Hebei Medical Journal2012;34:3229-31. ">Qi 2012</a>; <a href="./references#CD009608-bbs2-0017" title="QuW . Exploring the impact of cognitive psychotherapy applied to patients with schizophrenia on their cognitive function [探析认知心理治疗应用于精神分裂症患者中对其认知功能的影响]. Psychologist2016;22:32-3. ">Qu 2016</a>; <a href="./references#CD009608-bbs2-0018" title="ShenF , YangYC , DengH . The effect of group cognitive-behavioural therapy for schizophrenia after acute episode. West China Medical Journal2007;22:236-7. ">Shen 2007</a>; <a href="./references#CD009608-bbs2-0019" title="ShiY , JiaoY , JiangL , SunY , BaiZ , WuQ , et al. The effect of cognitive behavioral therapy on executive function of patients with chronic schizophrenia [认知行为治疗对慢性精神分裂症患者执行功能的影响]. Neurological diseases and mental health2015;15:497-9. ">Shi 2015</a>; <a href="./references#CD009608-bbs2-0020" title="SongX , LuiY , ZhangY , ZhouL . Study on the effect of cognitive behavioral therapy on improving the negative symptoms of schizophrenia patients [认知行为治疗对改善精神分裂症病人阴性症状的效果研究]. Psychologist2012;7:30-1. ">Song 2012</a>; <a href="./references#CD009608-bbs2-0021" title="SongX , LiJ , ZhangY , WangX , WangE . Group CBT for patients with schizophrenia and auditory hallucinations: the impact of quality of life [团体cbt对精神分裂症幻听患者生存质量的影响]. International Medicine and Health Guidance News2014;20:2572-4. ">Song 2014</a>; <a href="./references#CD009608-bbs2-0022" title="TaoC , DingS , ZhuY , LiX . Evaluation of comprehensive family knowledge, belief and behavior intervention on the rehabilitation efficacy of schizophrenia patients in the rehabilitation period [家庭综合知信行干预对康复期精神分裂症患者康复疗效的评价]. China Journal of Health Psychology2015;23:970-2. ">Tao 2015</a>; <a href="./references#CD009608-bbs2-0024" title="ZhouJJ . The effect of cognitive behavior therapy on the social function and life quality of schizophrenia patients [认知行为疗法对精神分裂症患者社会功能和生活质量的影响]. Health Research2015;35:539-41. ">Zhou 2015</a>). Since there is no unified model of group CBTp, some inconsistency in the findings may be explained by the different model of CBTp employed.  </p> <p>In addition, the overall participants group may be heterogeneous, since some studies were carried out among inpatients, some recruited a mix of inpatients and outpatients and some only recruited outpatients. Level of severity of schizophrenia may have also been different across the studies included.  </p> <p>Another aspect worth mentioning, which can limit the applicability of the evidence, is the fact that duration of treatment was variable, ranging from a few weeks to 12 months. It is recommended that CBT is given for at least 16 sessions (<a href="./references#CD009608-bbs2-0178" title="National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults: Treatment and Management. London (UK): National Institute for Health and Care Excellence, 2014.">NICE 2014</a>). Schizophrenia is a chronic illness; many of the patients included in this study are not first‐episode psychosis and may require a longer time to recover. This may be one of the possible reasons why there could have been differences in the outcomes. Also, we decided to focus on end of treatment outcomes. It may be possible that CBTp, if administered for a long period of time (i.e. six months or longer), may be effective. These different timepoints were analysed together and this could have added heterogeneity.  </p> <p>We consider that the aspects mentioned above may limit the applicability of evidence and more studies are needed to further explore the efficacy of group CBTp. </p> </section> <section id="CD009608-sec-0202"> <h3 class="title" id="CD009608-sec-0202">Quality of the evidence</h3> <p>We chose seven outcomes for assessing the quality of evidence and to construct the summary of findings tables. </p> <p>The chosen outcomes are:</p> <p> <ul id="CD009608-list-0042"> <li> <p>clinically important change, shown as improved – as defined by individual studies;</p> </li> <li> <p>relapse;</p> </li> <li> <p>leaving the study early: for any reason;</p> </li> <li> <p>mental state: overall: average endpoint score – end of treatment (PANSS total);</p> </li> <li> <p>days in hospital;</p> </li> <li> <p>quality of life: clinically important change – as defined by individual studies;</p> </li> <li> <p>functioning: overall: global assessment of functioning – average endpoint score – end of treatment (GAF). </p> </li> </ul> </p> <p>See <a href="./full#CD009608-tbl-0001">summary of findings Table 1</a>. </p> <p>The certainty of the evidence was low to moderate based on GRADE (<a href="./references#CD009608-bbs2-0185" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Available from handbook: training.cochrane.org/handbook/archive/v6.2.">Schünemann 2021</a>). We downgraded the evidence by one level for all outcomes due to high risk of performance bias for all studies and unclear selection bias for most studies. There was no heterogeneity in the rate of participants leaving the study early, PANSS total and GAF, so we did not downgrade further. The interventions tested, and the population included in the studies, are representative of the interventions and populations in clinical settings. Therefore, we decided not to downgrade the evidence for all outcomes included for indirectness. We found some imprecision on leaving the study early and therefore we downgraded certainty by one level. Exploration of the funnel plot for the 'PANSS total symptoms' outcome showed some evidence of asymmetry, suggesting some degree of publication bias (see <a href="./full#CD009608-fig-0001">Figure 1</a>), and, therefore, we downgraded the certainty of the evidence by one level. We found no data on: clinically important change, shown as improved (as defined by individual studies), relapse, days in hospital and quality of life: clinically important change – as defined by individual studies outcomes.  </p> </section> <section id="CD009608-sec-0203"> <h3 class="title" id="CD009608-sec-0203">Potential biases in the review process</h3> <p>We documented and justified changes to our methods from the published protocol in the <a href="#CD009608-sec-0223">Differences between protocol and review</a> section (<a href="./references#CD009608-bbs2-0210" title="GuaianaG , MorelliAC , ChiodoD . Cognitive behaviour therapy (group) for schizophrenia. Cochrane Database of Systematic Reviews2012, Issue 2. Art. No: CD009608. [DOI: 10.1002/14651858.CD009608]">Guaiana 2012</a>). </p> <p>We decided to pool all the interventions comparing group CBTp into a single 'standard care or other psychosocial interventions' category. We considered this was necessary, otherwise the analysis would have been too fragmented, and would have included too few studies for each outcome if we had to consider each control comparison separately. However, the control interventions were different, ranging from medication only to psychoeducation groups. This may have added a source of bias and heterogeneity in our review. </p> <p>The search was mainly based on the Cochrane Schizophrenia Group's register of trials. This is largely made up of searches of published literature. It is possible that there are unpublished studies. There seems to be some evidence of publication bias on one outcome (PANSS total, <a href="./full#CD009608-fig-0001">Figure 1</a>) but not on other outcomes. </p> <p>All the included studies had a limited sample size, which could have made our review underpowered.  </p> </section> <section id="CD009608-sec-0204"> <h3 class="title" id="CD009608-sec-0204">Agreements and disagreements with other studies or reviews</h3> <p>To our knowledge, this is the first meta‐analysis specifically focused on group CBTp. A previous Cochrane meta‐analysis, published in 2012 (<a href="./references#CD009608-bbs2-0149" title="JonesC , HackerD , CormacI , MeadenA , IrvingCB . Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database of Systematic Reviews2012, Issue 4. Art. No: CD008712. [DOI: 10.1002/14651858.CD008712.pub2]">Jones 2012</a>) and updated in 2018 (<a href="./references#CD009608-bbs2-0150" title="JonesC , HackerD , XiaJ , MeadenA , IrvingCB , ZhaoS , et al. Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia. Cochrane Database of Systematic Reviews2018, Issue 12. Art. No: CD007964. [DOI: 10.1002/14651858.CD007964.pub2]">Jones 2018</a>) focused on CBTp in general, and included some studies on group CBTp. They concluded that, based on the data available, relative to standard care alone, adding CBT to standard care appears to have no effect on long‐term risk of relapse. The authors also stated that the quality of evidence available was poor, and it was not possible to make firm conclusions until more high‐quality data were available. Another systematic review focused on low‐intensity CBTp for psychosis (<a href="./references#CD009608-bbs2-0140" title="HazellCM , HaywardM , CavanaghK , StraussC . A systematic review and meta-analysis of low intensity CBT for psychosis. Clinical Psychology Review2016;45:183-92.">Hazell 2016</a>), defined as CBTp lasting fewer than 16 sessions. The authors found that low‐intensity CBTp can be a promising treatment as it showed a decrease in symptoms of psychosis. This is somewhat in line with the findings of our review, as there were some differences between treatments. One systematic review on all group treatments in schizophrenia (including group CBTp) was published in 2020 (<a href="./references#CD009608-bbs2-0120" title="BurlingameGM , SvienH , HoppeL , HuntI , RosendahlJ . Group therapy for schizophrenia: a meta-analysis. Psychotherapy (Chicago, Ill.)2020;57:219-36.">Burlingame 2020</a>). It included some of the studies that were included in this review but not the studies in Chinese language, included in our review. <a href="./references#CD009608-bbs2-0120" title="BurlingameGM , SvienH , HoppeL , HuntI , RosendahlJ . Group therapy for schizophrenia: a meta-analysis. Psychotherapy (Chicago, Ill.)2020;57:219-36.">Burlingame 2020</a> concluded that group treatment as a whole works in schizophrenia, although they did not find a difference between group CBTp and standard care in their analysis. This is in line with our findings. <a href="./references#CD009608-bbs2-0120" title="BurlingameGM , SvienH , HoppeL , HuntI , RosendahlJ . Group therapy for schizophrenia: a meta-analysis. Psychotherapy (Chicago, Ill.)2020;57:219-36.">Burlingame 2020</a> found that the most effective group treatments for schizophrenia were cognitive remediation and social skills training.  </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009608-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Mental state: overall: average endpoint score – end of treatment (PANSS total, high = poor)." data-id="CD009608-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Mental state: overall: average endpoint score – end of treatment (PANSS total, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009608-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009608-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009608-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-03.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Leaving the study early: for any reason – end of treatment." data-id="CD009608-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Leaving the study early: for any reason – end of treatment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 1: Leaving the study early: for any reason – end of treatment" data-id="CD009608-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 1: Leaving the study early: for any reason – end of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 2: Mental state: overall: average endpoint score – end of treatment (PANSS total, high = poor)" data-id="CD009608-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 2: Mental state: overall: average endpoint score – end of treatment (PANSS total, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 3: Mental state: overall: average endpoint score – end of treatment (BPRS total, high = poor)" data-id="CD009608-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 3: Mental state: overall: average endpoint score – end of treatment (BPRS total, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 4: Mental state: overall: average endpoint score – end of treatment (PSYRATS total, high = poor)" data-id="CD009608-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 4: Mental state: overall: average endpoint score – end of treatment (PSYRATS total, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 5: Mental state: overall: average endpoint score – end of treatment (SCL‐90‐R, high = poor)" data-id="CD009608-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 5: Mental state: overall: average endpoint score – end of treatment (SCL‐90‐R, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 6: Mental state: specific: positive symptoms – average endpoint score – end of treatment (PANSS positive, high = poor)" data-id="CD009608-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 6: Mental state: specific: positive symptoms – average endpoint score – end of treatment (PANSS positive, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 7: Mental state: specific: positive symptoms – average endpoint score – end of treatment (SAPS, high = poor)" data-id="CD009608-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 7: Mental state: specific: positive symptoms – average endpoint score – end of treatment (SAPS, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 8: Mental state: specific: average endpoint total score – delusions – end of treatment (PSYRATS delusions, high = poor)" data-id="CD009608-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 8: Mental state: specific: average endpoint total score – delusions – end of treatment (PSYRATS delusions, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 9: Mental state: specific: average endpoint total score – voices – end of treatment (PSYRATS voices, high = poor)" data-id="CD009608-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 9: Mental state: specific: average endpoint total score – voices – end of treatment (PSYRATS voices, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 10: Mental state: specific: average endpoint total score – voices – end of treatment (AHRS, high = poor)" data-id="CD009608-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 10: Mental state: specific: average endpoint total score – voices – end of treatment (AHRS, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 11: Mental state: specific: negative symptoms – average endpoint score – end of treatment (PANSS negative, high = poor)" data-id="CD009608-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 11: Mental state: specific: negative symptoms – average endpoint score – end of treatment (PANSS negative, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 12: Mental state: specific: negative symptoms – average endpoint score – end of treatment (SANS, high = poor)" data-id="CD009608-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 12: Mental state: specific: negative symptoms – average endpoint score – end of treatment (SANS, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 13: Mental state: specific: depression/anxiety – average endpoint score – end of treatment (HADS total, high = poor)" data-id="CD009608-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 13: Mental state: specific: depression/anxiety – average endpoint score – end of treatment (HADS total, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 14: Mental state: specific: depression – average endpoint score – end of treatment (BDI‐II, high = poor)" data-id="CD009608-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 14: Mental state: specific: depression – average endpoint score – end of treatment (BDI‐II, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 15: Mental state: specific: depression – average endpoint score – end of treatment (HAMD, high = poor)" data-id="CD009608-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 15: Mental state: specific: depression – average endpoint score – end of treatment (HAMD, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 16: Mental state: specific: depression – average endpoint score – end of treatment (MADRS, high = poor)" data-id="CD009608-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 16: Mental state: specific: depression – average endpoint score – end of treatment (MADRS, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 17: Mental state: specific: depression – average endpoint score – end of treatment (HADS depression, high = poor)" data-id="CD009608-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 17: Mental state: specific: depression – average endpoint score – end of treatment (HADS depression, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 18: Mental state: specific: anxiety – average endpoint score – end of treatment (BAI, high = poor)" data-id="CD009608-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 18: Mental state: specific: anxiety – average endpoint score – end of treatment (BAI, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 19: Mental state: specific: anxiety – average endpoint score – end of treatment (HADS anxiety, high = poor)" data-id="CD009608-fig-0024" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 19: Mental state: specific: anxiety – average endpoint score – end of treatment (HADS anxiety, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 20: Mental state: specific: anxiety – average endpoint score – end of treatment (HARS, high = poor)" data-id="CD009608-fig-0025" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 20: Mental state: specific: anxiety – average endpoint score – end of treatment (HARS, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.21" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 21: Mental state: specific: social anxiety – average endpoint score – end of treatment (SAD, high=poor)" data-id="CD009608-fig-0026" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.21.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.21.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 21: Mental state: specific: social anxiety – average endpoint score – end of treatment (SAD, high=poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.21.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.22" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 22: Service use: number of people hospitalised during the study" data-id="CD009608-fig-0027" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.22.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.22.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 22: Service use: number of people hospitalised during the study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.22.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.23" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 23: Quality of life: average endpoint score – end of treatment (MSQoL, high = good)" data-id="CD009608-fig-0028" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.23.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.23.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 23: Quality of life: average endpoint score – end of treatment (MSQoL, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.23.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.24" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 24: Quality of life: average endpoint score – end of treatment (QLS, high = good)" data-id="CD009608-fig-0029" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.24.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.24.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 24: Quality of life: average endpoint score – end of treatment (QLS, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.24.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.25" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 25: Quality of life: average endpoint score – end of treatment (WHOQOL‐BREF – Psychological domain subscale, high = good)" data-id="CD009608-fig-0030" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.25.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.25.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 25: Quality of life: average endpoint score – end of treatment (WHOQOL‐BREF – Psychological domain subscale, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.25.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.26" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 26: Quality of life: average endpoint score – end of treatment (GQOLI‐74, high = good)" data-id="CD009608-fig-0031" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.26.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.26.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 26: Quality of life: average endpoint score – end of treatment (GQOLI‐74, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.26.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.27" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 27: Functioning: overall: global assessment of functioning – average endpoint score – end of treatment (GAF, high = good)" data-id="CD009608-fig-0032" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.27.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.27.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 27: Functioning: overall: global assessment of functioning – average endpoint score – end of treatment (GAF, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.27.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.28" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 28: Functioning: specific: living skills – average endpoint score – end of treatment (ILSS, high = good)" data-id="CD009608-fig-0033" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.28.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.28.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 28: Functioning: specific: living skills – average endpoint score – end of treatment (ILSS, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.28.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.29" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 29: Functioning: specific: social – average endpoint score – end of treatment (SBS, high = poor)" data-id="CD009608-fig-0034" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.29.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.29.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 29: Functioning: specific: social – average endpoint score – end of treatment (SBS, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.29.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.30" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 30: Functioning: specific: social – average endpoint score – end of treatment (SFS, high = good)" data-id="CD009608-fig-0035" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.30.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.30.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 30: Functioning: specific: social – average endpoint score – end of treatment (SFS, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.30.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.31" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 31: Functioning: specific: social – average endpoint score – end of treatment (PSP, high = good)" data-id="CD009608-fig-0036" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.31.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.31.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 31: Functioning: specific: social – average endpoint score – end of treatment (PSP, high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.31.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.32" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 32: Functioning: specific: social – average endpoint score – end of treatment (IPROS, high = poor)" data-id="CD009608-fig-0037" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.32.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.32.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 32: Functioning: specific: social – average endpoint score – end of treatment (IPROS, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.32.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009608-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/urn:x-wiley:14651858:media:CD009608:CD009608-CMP-001.33" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 33: Functioning: specific: social – average endpoint score – end of treatment (SDSS, high = poor)" data-id="CD009608-fig-0038" src="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.33.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_t/tCD009608-CMP-001.33.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1: Group cognitive behavioural therapy (CBT) versus standard care, Outcome 33: Functioning: specific: social – average endpoint score – end of treatment (SDSS, high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/media/CDSR/CD009608/image_n/nCD009608-CMP-001.33.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD009608-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Design of a future study</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Methods</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allocation: randomised (clearly described)</p> <p>Blinding: single‐blind (outcome assessors blinded to treatment)</p> <p>Duration: up to 52 weeks</p> <p>Design: parallel</p> <p>Setting: anywhere</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Participants</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis: schizophrenia or schizoaffective disorder</p> <p>n = 100</p> <p>Age: any</p> <p>Gender: males and females</p> <p>Inclusion criteria: standardised diagnostic criteria for schizophrenia or schizoaffective disorder </p> <p>Exclusion criteria: specific contraindication to evaluated treatments</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Interventions</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Group CBTp</p> <p>2. Standard care</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcomes</p> <p>1. Global state</p> <p>1.1 Clinically important change (as defined by individual studies)</p> <p>Secondary outcomes</p> <p>1. Leaving the study early</p> <p>1.1 For any reason</p> <p>1.2 For specific reason</p> <p>2. Mental state</p> <p>2.1 Clinically important change overall mental state – as defined by individual studies</p> <p>2.2 Relapse</p> <p>2.3 Average endpoint or change score, or both, on mental state scales</p> <p>2.4 Average endpoint or change scores, or both, on positive or negative symptom scales, or both </p> <p>2.5 Specific clinically important change in positive or negative symptoms, or both, – as defined by individual studies </p> <p>3. Adverse effects/events</p> <p>3.1 Incidence of clinically important depression/anxiety and psychotic symptoms</p> <p>3.2 Average endpoint and change scores on adverse effect scales</p> <p>3.3 Death: suicide or natural causes</p> <p>4. Service utilisation outcomes</p> <p>4.1 Hospital admission</p> <p>4.2 Days in hospital</p> <p>5. Quality of life</p> <p>5.1 Clinically important change – as defined by each of the studies</p> <p>5.2 General Impression of carer/rater or family member</p> <p>6. Social functioning</p> <p>6.1 Average endpoint or change score, or both, on social skills/functioning scales</p> <p>6.2 Occupational status</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>CBTp: cognitive behavioural therapy model targeting symptoms of psychosis.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Design of a future study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009608-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Group cognitive behavioural therapy for psychosis compared to standard care for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Group cognitive behavioural therapy compared to standard care and other psychosocial interventions for schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with schizophrenia <br/><b>Setting:</b> inpatient and outpatient <br/><b>Intervention:</b> group cognitive behavioural therapy<br/><b>Comparison:</b> standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with standard care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with group cognitive behavioural therapy for psychosis</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinically important change</b>, shown as improved – as defined by individual studies </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> —</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>— </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> —</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Relapse</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Leaving the study early: for any reason</b> – end of treatment </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.22</b><br/>(0.94 to 1.59) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1267<br/>(13 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>155 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>195 per 1000<br/>(144 to 259) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: overall:</b> average endpoint score – end of treatment (PANSS total) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean mental state: overall: average endpoint score – end of treatment (PANSS total) was 0 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 3.73 lower</b><br/>(4.63 lower to 2.83 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1036<br/>(12 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Days in hospital</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life: clinically important change –</b> as defined by individual studies. </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Functioning: overall: global assessment of functioning</b> – average endpoint score – end of treatment (GAF) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functioning: overall: global assessment of functioning – average endpoint score – end of treatment (GAF) was 0 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 3.61 lower</b><br/>(6.37 lower to 0.84 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>GAF:</b> Global Assessment of Functioning; <b>MD:</b> mean difference; <b>PANSS:</b> Positive and Negative Syndrome Scale; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of performance bias for all studies and unclear selection bias for most studies.<br/><sup>b</sup>Downgraded one level due to imprecision: confidence interval ranged from no difference to appreciable benefit with standard care.<br/><sup>c</sup>Downgraded publication bias domain one level as the funnel plot on PANSS total outcome (<a href="./full#CD009608-fig-0001">Figure 1</a>) was asymmetrical, increasing the risk for publication bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Group cognitive behavioural therapy for psychosis compared to standard care for schizophrenia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009608-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Contact of authors of studies awaiting classification</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study name</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Contacted</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Replied</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Provided data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Notes</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0098" title="BrennerHD , HodelB , KubeG , RoderV . Cognitive therapy with schizophrenics: analysis of the problem and experimental results. Nervenarzt1987;58:72-83. ">Brenner 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Could not find author's contact details</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0099" title="ChungYC , KimJH , EunHB , HwangIK . Effect of cognitive-behavioral therapy on the delusion in schizophrenic patients. Journal of the Korean Neuropsychiatric Association2001;40:63-71. ">Chung 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> —</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0100" title="ClassenW , KrajewskiC , BoeskenS . Cognitive and social processes during art (AT) or cognitive (CT) therapy and a simultaneous CT + AT therapy in schizophrenics. Verhaltenstherapie1993;Suppl 1:A45. ClassenW , KrajewskiC , BoeskenS . Comparison of art and cognitive therapy (IPT) with simultaneous cognitive and art therapy for schizophrenic patients regarding the change of cognitive processes. Pharmacopsychiatry1993;26:171. ">Classen 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> —</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0101" title="KlingbergS , WiedemannG , BuchkremerG . Cognitive-behavioural therapy for schizophrenic patients – design and preliminary results of a randomised effectiveness trial. Zeitschrift Für Klinische Psychologie Und Psychotherapie2001;30:259-67. ">Klingberg 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> —</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0102" title="KraemerS , SulzKH , SchmidR , LassleR . Cognitive therapy of schizophrenic patients: a control study. Nervenarzt1987;58:84-90. ">Kraemer 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Could not find author's contact details</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0103" title="McLeodT , MorrisM , BirchwoodM , DoveyA . Cognitive behavioural therapy group work with voice hearers. Part 1. British Journal of Nursing2007;16:248-52. McLeodT , MorrisM , BirchwoodM , DoveyA . Cognitive behavioural therapy group work with voice hearers. Part 2. British Journal of Nursing2007;16:292-5. ">McLeod 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> —</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009608-bbs2-0104" title="Shafiei AmiriM , Ahmadi GatabT , BabakhaniN . The efficacy of cognitive-behavior group therapy and social skill trainings on reduction of negative symptoms of schizophrenic patients. European Psychiatry2011;26(Suppl 2):1327. ">Shafiei 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> —</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Contact of authors of studies awaiting classification</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009608-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Mental state: specific: positive symptoms – average endpoint score – end of treatment (PANSS positive, high = poor): studies with skewed data</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>n</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0002" title="BechdolfA , KnostB , KuntermannC , SchillerS , HambrechtM , KlosterkotterJ , et al. Coping-oriented versus psychoeducational group therapy for post acute patients with schizophrenia: results of a 6 month follow-up. Schizophrenia Research2002;53(Suppl 1):263-4. [CSZG: Ref8053]BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkotterJ , HambrechtM , et al. A randomized comparison of group cognitive behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110:21-8. [CSZG: Ref11268]BechdolfA , KnostB , NelsonB , SchneiderN , VeithV , YungAR , et al. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Australian and New Zealand Journal of Psychiatry2010;44:144-50. [CSZG: Ref19694]BechdolfA , KohnD , KnostB , PukropR , KlosterkotterJ . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112:173-9. [CSZG: Ref18491]BechdolfA . A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia: commentary reply. Acta Psychiatrica Scandinavica2006;113:73-4. [CSZG: Ref18490]Munk-JorgensenP . Erratum. Acta Psychiatrica Scandinavica2004;110:483. [CSZG: Ref18577]">Bechdolf 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0013" title="LiJ , DengX , XieY , LiangL . Effects on cognitive function in patients with chronic schizophrenia, cognitive behavioral therapy [认知行为治疗对慢性精神分裂症患者认知功能的影响]. Chinese and foreign medical research2013;24:130-2. ">Li 2013b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0016" title="QiH , LiuH . Studies on the efficacy of combining episode male schizophrenic cognitive behavioral therapy [结合认知行为治疗对首发男性精神分裂症的 疗效研究]. Hebei Medical Journal2012;34:3229-31. ">Qi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0018" title="ShenF , YangYC , DengH . The effect of group cognitive-behavioural therapy for schizophrenia after acute episode. West China Medical Journal2007;22:236-7. ">Shen 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.621</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0019" title="ShiY , JiaoY , JiangL , SunY , BaiZ , WuQ , et al. The effect of cognitive behavioral therapy on executive function of patients with chronic schizophrenia [认知行为治疗对慢性精神分裂症患者执行功能的影响]. Neurological diseases and mental health2015;15:497-9. ">Shi 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0022" title="TaoC , DingS , ZhuY , LiX . Evaluation of comprehensive family knowledge, belief and behavior intervention on the rehabilitation efficacy of schizophrenia patients in the rehabilitation period [家庭综合知信行干预对康复期精神分裂症患者康复疗效的评价]. China Journal of Health Psychology2015;23:970-2. ">Tao 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CBTp: cognitive behavioural therapy model targeting symptoms of psychosis; n: number of participants; PANSS: Positive and Negative Syndrome Scale; SD: standard deviation. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Mental state: specific: positive symptoms – average endpoint score – end of treatment (PANSS positive, high = poor): studies with skewed data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009608-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Mental state: specific: negative symptoms – average endpoint score – end of treatment (PANSS negative, high = poor): studies with skewed data</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>n</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0018" title="ShenF , YangYC , DengH . The effect of group cognitive-behavioural therapy for schizophrenia after acute episode. West China Medical Journal2007;22:236-7. ">Shen 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0023" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77:201-10. [CSZG: Ref17574]WykesT , ParrAM , LandauS . Group cognitive treatment for persistent auditory hallucinations: a controlled trial. Schizophrenia Research1999;36:335. WykesT , ThompsonN , GreenN , SurgaldzeS , HaywardP . Changing voices: a randomised control trial of group cognitive behavioural treatment. Schizophrenia Research2003;60:331. WykesT , ThompsonN , HaywardP . Changing voices: a randomised control trial of group cognitive treatment. Schizophrenia Research2002;53(Suppl 1):12. ">Wykes 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CBTp: cognitive behavioural therapy model targeting symptoms of psychosis; n: number of participants; PANSS: Positive and Negative Syndrome Scale; SD: standard deviation. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Mental state: specific: negative symptoms – average endpoint score – end of treatment (PANSS negative, high = poor): studies with skewed data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009608-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Service use: average number days spent in hospital during the study: studies with skewed data</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>n</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD009608-bbs2-0001" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive behavioural therapy for schizophrenia – randomised controlled trial. British Journal of Psychiatry2006;189:527-32. [CSZG: Ref14559]BarrowcloughC . An evaluation of the effectiveness of group cognitive therapy for people with recent onset schizophrenia. National Research Register2001;1. [CSZG: Ref12948]">Barrowclough 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBTp group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CBTp: cognitive behavioural therapy model targeting symptoms of psychosis; n: number of participants; PANSS: Positive and Negative Syndrome Scale; SD: standard deviation. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Service use: average number days spent in hospital during the study: studies with skewed data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/full#CD009608-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009608-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Group cognitive behavioural therapy (CBT) versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Leaving the study early: for any reason – end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.94, 1.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Mental state: overall: average endpoint score – end of treatment (PANSS total, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1036</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.73 [‐4.63, ‐2.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Mental state: overall: average endpoint score – end of treatment (BPRS total, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.26 [‐7.50, ‐1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Mental state: overall: average endpoint score – end of treatment (PSYRATS total, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.45 [‐3.23, 2.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Mental state: overall: average endpoint score – end of treatment (SCL‐90‐R, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐33.26 [‐51.26, ‐15.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Mental state: specific: positive symptoms – average endpoint score – end of treatment (PANSS positive, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.45 [‐1.30, 0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Mental state: specific: positive symptoms – average endpoint score – end of treatment (SAPS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐3.24, 2.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Mental state: specific: average endpoint total score – delusions – end of treatment (PSYRATS delusions, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.39 [‐8.50, 1.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Mental state: specific: average endpoint total score – voices – end of treatment (PSYRATS voices, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.94 [‐18.04, 6.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Mental state: specific: average endpoint total score – voices – end of treatment (AHRS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.30 [‐7.49, ‐3.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Mental state: specific: negative symptoms – average endpoint score – end of treatment (PANSS negative, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>768</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.73 [‐1.68, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Mental state: specific: negative symptoms – average endpoint score – end of treatment (SANS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.34 [‐6.05, ‐4.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Mental state: specific: depression/anxiety – average endpoint score – end of treatment (HADS total, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.53 [‐3.58, 2.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Mental state: specific: depression – average endpoint score – end of treatment (BDI‐II, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>229</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.46 [‐3.29, 2.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Mental state: specific: depression – average endpoint score – end of treatment (HAMD, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [‐2.26, 3.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 Mental state: specific: depression – average endpoint score – end of treatment (MADRS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.18 [‐3.80, ‐0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 Mental state: specific: depression – average endpoint score – end of treatment (HADS depression, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.75 [‐3.59, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.18 Mental state: specific: anxiety – average endpoint score – end of treatment (BAI, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐14.53, 13.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.19 Mental state: specific: anxiety – average endpoint score – end of treatment (HADS anxiety, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.71 [‐2.33, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.20 Mental state: specific: anxiety – average endpoint score – end of treatment (HARS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.30 [‐13.81, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.21 Mental state: specific: social anxiety – average endpoint score – end of treatment (SAD, high=poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.33 [‐9.73, ‐4.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.22 Service use: number of people hospitalised during the study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.38, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.23 Quality of life: average endpoint score – end of treatment (MSQoL, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.80 [‐10.17, 13.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.24 Quality of life: average endpoint score – end of treatment (QLS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.58 [‐15.84, 2.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.25 Quality of life: average endpoint score – end of treatment (WHOQOL‐BREF – Psychological domain subscale, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.64 [‐9.04, ‐0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.26 Quality of life: average endpoint score – end of treatment (GQOLI‐74, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.83 [‐8.20, ‐1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.27 Functioning: overall: global assessment of functioning – average endpoint score – end of treatment (GAF, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.61 [‐6.37, ‐0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.28 Functioning: specific: living skills – average endpoint score – end of treatment (ILSS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.03, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.29 Functioning: specific: social – average endpoint score – end of treatment (SBS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.30 [‐4.59, 1.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.30 Functioning: specific: social – average endpoint score – end of treatment (SFS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.11 [‐9.03, 6.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.31 Functioning: specific: social – average endpoint score – end of treatment (PSP, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.30 [2.00, 4.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.32 Functioning: specific: social – average endpoint score – end of treatment (IPROS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.90 [‐12.62, ‐5.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.33 Functioning: specific: social – average endpoint score – end of treatment (SDSS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.27 [‐2.46, ‐0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Group cognitive behavioural therapy (CBT) versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009608.pub2/references#CD009608-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009608.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009608-note-0010">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009608-note-0019">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009608-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009608-note-0018">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD009608-note-0015">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD009608-note-0014">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD009608-note-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD009608-note-0017">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD009608-note-0012">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD009608-note-0011">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009608\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009608\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009608\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009608\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009608\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=tkZQC4GK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009608.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009608.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009608.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009608.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009608.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716497574"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009608.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716497578"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009608.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918da0f419a09379',t:'MTc0MDcxNjQ5Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 